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2 Introduction: the human gut microbiota. 
 
2.1 Microbiota composition 
 
Establishment of the intestinal microbiota has been shown to be a progressive process 
[1]. This process of increasing diversity is required for proper development and is 
important for overall health. The major functions attributed to the microbiota present 
in the gut begin to manifest at the end of the second year of life and comprise: i) 
nutrients absorption and food fermentation [2], ii) stimulation of the host immune 
system [3] and iii) barrier effects against pathogens [4]. Once climax composition is 
achieved near the end of adolescence, this ecosystem displays a high stability in 
healthy adults [5].  
In adults, Bacteroidetes and Firmicutes are the most prevalent phyla present, the 
latter of which combines the values obtained for the dominant C. leptum and C. 
coccoides groups and the sub-dominant Lactobacillus group [6]. The Bifidobacterium 
genus is present in eight to ten-fold lower numbers than the two major phyla. E. coli 
was found to be present at 7.7 log10 CFU/g, also consistent with its characteristic sub-
dominant population in adults [7] where this species is considered a dominant species 
in infants. Members of the Actinobacteria phylum such as bifidobacteria are minor 
constituents of the microbiota with tremendous health effect to the host. 
Bifidobacteria enhance the barrier function of the gut epithelium [8]. Low abundance 
of bifidobacteria has been associated with LPS-induced endotoxaemia, a chronic low-
grade inflammation [9]. Recent studies indicated that modifications occur in the 
microbiota composition in elderly individuals. For example, a reduction in the 
numbers of Bifidobacteria and Bacteroides has been observed, accompanied also by a 
decrease of Lactobacilli. A commensurate increase in the number of facultative 
anaerobes also highlights the variation between adults and elderly individuals [10, 11, 
12, 13]. 
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The Firmicutes are by far the most diverse phylum in the human GI tract. Members of 
Firmicutes are involved in fermentation of non-digestible carbohydrates and 
production of short chain fatty acids (SCFAs). Short chain fatty acids are intermediates 
and end products of microbial breakdown of polysaccharides. In the GI tract the 
following SCFAs are prevalent: formate, acetate, propionate, butyrate, isobutyrate, 
valerate, isovalerate and caproic acid. Formate is likely to be used as substrate in the 
one-carbon-metabolism of intestinal bacteria [14]. Acetate and propionate serve for 
gluconeogenesis in the liver [15]. Butyrate is the major energy source of colonocytes 
and stimulates proliferation in healthy colonic epithelial cells [16, 17]. In colonic tumor 
butyrate is known to inhibit proliferation in cells and cell lines [18, 19]. One 
explanation for the butyrate paradox is that healthy cells have an efficient butyrate 
metabolism resulting in low intracellular butyrate concentrations and therefore a 
decrease in capacity to inhibit growth [20]. In colon cancer cell lines, -oxidation and 
mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase (HMGCS2) expression are 
impaired [20]. HMGCS2 converts acetyl-CoA to ketone bodies [21] thereby preventing 
the accumulation of acetyl-CoA [22]. The decreased oxidation rate of butyrate may 
result in increased intra-cellular butyrate concentrations in tumor cells, hence causing 
increased histone deacetylation and subsequently decreased proliferation [23]. Some 
of the most prominent butyrate producers are Firmicutes: the Clostridium clusters IV 
and XIV, among which the Roseburia spp. and Eubacterium spp. have drawn a lot of 
attention recently for their high butyrate production rate [24]. 
Commensal bacteria promote angiogenesis and development of the intestinal 
epithelium and have been shown to be essential for normal development and function 
of the immune system [25]. 
It has been suggested that every human possesses an individual core microbiota of 
some species that is resilient to modifications throughout the life span [26]. The 
hypothesis of a global core microbiota that all humans share has been cast into doubt. 
Recent results suggest that there is a core microbiome [27], a collection of microbial 
genes that all human beings have in common. Such a core microbiome comprises 
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genes rather than organismal lineages. Metabolic reconstruction of the ‘core’ 
microbiome revealed significant enrichment for a number of expected functional 
categories, including those involved in transcription and translation [27]. Metabolic 
profile-based clustering indicated that the representation of the ‘core’ functional 
groups was highly consistent across samples, and includes a number of pathways 
likely important for life in the gut, such as those for carbohydrate and amino acid 
metabolism (fructose/mannose metabolism, aminosugar metabolism, and N-glycan 
degradation) [27]. 
Kurokawa et al. described 2007 that the gene repertoires in the gut microbiomes are 
more variable and functionally less redundant in infants than in adults and children. 
All human gut microbiomes showed a significant over-representation of COGs (Cluster 
of Orthologous Groups of proteins) classified into ‘carbohydrate transport and 
metabolism’ and an under-representation of COGs classified into ‘lipid transport and 
metabolism’ *14+. In adults and in children COGs classified into ‘defence mechanisms’ 
were over-represented. The clusters ‘cell motility’, ‘secondary metabolite 
biosynthesis, transport and catabolism’ and ‘post-translational modification, protein 
turnover, chaperones’ were minor gene contents in the microbiomes assessed *14+. 
The low abundance of flagella in intestinal microbes is likely to be an adaptation to the 
human gut environment where i) the continuous movement of the luminal contents 
by peristalsis make bacterial cell motility reduandant and ii) flagellated 
microorganisms are effectively recognized by toll like receptor 5 and eliminated by the 
host immune cells. The microbiota of obese individuals have been found to be 
enriched in genes for energy harvest [27].  
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2.2 Host-microbe interactions I: how the gut microbiota interacts with the human 
immune system. 
 
The gastro-intestinal epithelium is the first line of the defence system against 
microbial pathogens such as Gram-positive and Gram-negative bacteria, fungi and 
viruses. Innate immune cells such as macrophages and DCs (dendritic cells) directly kill 
the pathogenic micro-organims through phagocytosis or induce the production of 
cytokines, which aid elimination of the pathogens [28, 29, 30]. Immunity against 
microbial pathogens and tolerance against commensals primarily depends on the 
recognition of pathogen components by innate receptors expressed on immune and 
non-immune cells. Innate receptors are evolutionarily conserved germ-line-encoded 
proteins and include TLRs (Toll-like receptors), RLRs [RIG-I (retinoic acid-inducible 
gene-I)-like receptors] and NLRs (Nod-like receptors). These families of receptors are 
collectively known as PRRs (pattern-recognition receptors) [31], which recognize the 
specific molecular structures of pathogens known as PAMPs (pathogen-associated 
molecular patterns) in various compartments of cells such as the plasma membrane 
the endolysosome and the cytoplasm. PRRs recognize pathogens or pathogen-derived 
products and components thereof in different cellular compartments such as the 
plasma membrane, the endosomes or the cytoplasm, and induce the expression of 
cytokines, chemokines and co-stimulatory molecules to eliminate pathogens and 
instruct pathogen-specific adaptive immune responses [32]. The adaptive immune 
system consists of B- and T-cells, which provide pathogen specific immunity to the 
host and –in absence of atopic disease- tolerance towards beneficial and commensal 
microorganisms of the GI tract. B- and T-cells are shaped through somatic 
rearrangement of antigen receptor genes. B-cells produce pathogen-specific 
antibodies to neutralise toxins produced by pathogens, whereas T-cells provide the 
cytokine milieu to clear pathogen-infected cells through their cytotoxic effects or via 
signals to B-cells [33].  
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According to the hygiene theory atopic diseases and autoimmune diseases are caused 
by a disturbed ratio of Th1, Th2 and Treg cells. 
Regulatory T Cells (Treg) excrete TGF-  and IL-10, two anti-inflammatory cytokines that 
are able to suppress the activation of Th1 and Th2 cells. Th17 T cells have recently been 
described as third subset of T helper cells induced by IL-1 , IL-6 and TGF  [34]. 
Secretion of IL-23 is thought to be important for the maintenance of Th17 cells found 
to be associated with autoimmune diseases such as multiple sclerosis and rheumatoid 
arthritis [35]. Macrophages are capable of excreting IL-10 too, thus suppressing pro-
inflammatory Th1 and Th2 cells as well. Epithelial cells and dendritic cells possess PRRs 
that are able to sample bacterial antigens from the gut lumen. Dendritic cells project 
their dendrites through the epithelial layer to sample the intestinal contents and 
subsequently migrate to afferent lymph nodes to present their cargo to T cells [36]. 
Macrophages dwelling in the lamina propria form a unique cell subset that fails to 
generate pro-inflammatory responses to TLR ligands and suppresses Th17 T cell 
priming by neighbouring dendritic cells [37]. This shows that also dynamic interactions 
of antigen presenting cell (APC) subsets residing in the lamina propria may play a role 
in effector T cell differentiation and polarization after (commensal) antigen 
recognition. Only dendritic cells are capable of inducing Tregs, which are 
immunesuppressive and regulate Th1/Th2 balance [38]. The differential ability to induce 
inflammatory responses of macrophages and dendritic cells may be attributable to 
different requirements for responsiveness to steady-state vs. inflammatory antigens 
for priming of T cells.  
In addition to dendritic cells- mediated antigen transport into the mesenteric lymph 
nodes there seem to be additional unknown mechanisms: In mice whose dendritic 
cells are deficient in CC chemokine receptor 7 the capsular polysaccharide from the 
commensal Bacteroides fragilis corrects systemic T cell deficiency and primes the 
splenic Th1 response of orally challenged or colonized mice [39]. Mucosal dendritic 
cells are considered more tolerogenic than other dendritic cells. Their expression 
patterns of TLRs are unique and characteristic for the microenvironment they 
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regularly encounter. Mucosal DCs from the lamina propria, Peyer’s patches, 
mesenteric lymph nodes and the lung have a property to induce TH2 responses in in 
vitro T cell priming assays and to induce the expression of IL-10 and possibly TGF- . 
Mucosal DCs may be specialized in inducing a non-inflammatory environment and in 
providing help to B cells via the activation of TH2 cells [40]. This is consistent with the 
fact that many ‘tolerogenic’ responses to mucosal antigens, for example, to 
commensal organisms, are associated with the generation of antibody responses [41] 
rather than with a broad immunological unresponsiveness [40].  
 
2.3 Host-microbe interactions II: examples of how the gut microbiota contributes 
to the human metabolism. 
In spite of tremendous progress in research the interplay between microbiota 
composition and microbiome functions is still limited. Recent work points out that the 
human gastro-intestinal microbiota must be understood as a microbial organ whose 
metabolism provide essential functions to the host rather than just supplementary 
nutrient acquisition. 
Phenolic compounds have been described to have beneficial health effects related to 
their anitoxidant, anti-inflammatory, antiestrogenic, cardioproective, cancer 
chemopreventive and neutoprotective properties [42]. Most dietary polyphenols are 
transformed in the colon by the intestinal microbiota before absorption. This 
conversion is often essential for absorption and modulates the biological activiy of 
these dietary compounds. Therefore the colon has to be considered as an active site 
for metabolism rather than a simple excretion route [42]. Microbial metabolites are 
absorbed from the colon after deconjugation and transformed by the human cell 
enzymes into phase II conjugates including methyl ether glucuronides and sulfates 
metabolized in the liver, resulting in their glucuronidated and sulfated derivatives [43]. 
Through enterohepatic recirculation, conjugated compounds are excreted by the liver 
as components of bile into the intestine, and the deconjugated compounds are 
regenerated by microbial enzymes before being reabsorbed. Onions, apples, broccoli, 
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tea, and red wine are rich in flavonols and are the main dietary sources of these 
compounds in Western populations [44]. Almost all soy isoflavones exist as glucosides, 
which are not absorbed intact across the enterocytes of healthy adults because of 
their hydrophilic properties and molecular weights. The isoflavon glucosides are very 
water-soluble. Their bioavailability requires the conversion of glucosides into the 
principal bioactive aglycones (daidyein, genistein and glycitein) via the action of 
intestinal -glucosidase from bacteria that colonize the small intestine for uptake to 
the peripheral circulation [45]. The aglycones are either absorbed intact or further 
metabolized by intestinal microbiota [46]. Genistein is converted to p-ethylphenol and 
4-hydroxyphenyl-2-propionic acid, whereas daidzein is reduced to O-
demethylangolensin (O-DMA) and equol [47]. Humans that consume dadzein produce 
relatively low amounts of the highly antioxidant equol as a consequence of specific 
compounds in the intestinal microbiota [47]. Only approximately one third to half of 
the population is able to metabolize dadzein to equol [47]. Bacteroides ovatus, 
Streptococcus intermedius, Ruminococcus productus, Enteroccuse faecium EPI1, 
Lactobacillus mucosae EPI2, Finegoldia magna EPI3 and Veillonella sp. EP have been 
demonstrated to be capable of this conversion [48]. Bacteria that possess -
glucosidase enabling them to hydrolyse glycosides are Streptococcus faecalis, 
Eubacterium rectale, Clostridium spenoides, C. saccharogumia, C. cocleatum, 
Bacteroides ovatus, B. fragilis and B. distasonis [48].  
 
2.4 Molecular methods for the assessment of the human microbiota. 
 
Classical microbiological methods depend on culturing techniques and have been 
applied to various ecosystems including the human gastro-intestinal microbiota. 
Comparison of those results with modern molecular techniques allows estimating that 
with culturing only 20-40% of the microbiota diversity can be targeted [49]. The 
isolation of microbiota constituents allows analyzing their phenotype and metabolic 
capacities and behaviour in coculture with defined microorganisms. Coculture studies 
 18 
 
show that many ecological niches such as living of short chain fatty acids can only be 
filled by syntrophic consortia of different microbes [50] [51]. Coculture of the 
xylanolytic Roseburia intestinalis with H2-utilizing Ruminococcus hydrogenotrophicus 
dramatically increased butyrate production [52]. 
Molecuar methods, many of which are based on the polymerase chain reaction, 
overcome the limitations due to the fastidious nature of many gut microbes.  
 
2.4.1 Polymerase chain reaction (PCR) 
 
PCR was developed by Kary Mullis and firstly published in 1985 [53]. It is an in vitro 
method for DNA amplification using a polymerase from thermophilic microbes such as 
the Thermus aquaticus from which the frequently used Taq polymerase is derived. A 
region of dsDNA is amplified using two primers, a polymerase, dNTPs and a buffer 
containing stabilizing salts and MgCl2. The introduction of PCR in microbial ecology of 
the human gut revolutionized our knowledge about this ecosystem. Culturing studies 
have overestimated the prevalence of coliform bacteria such as the Proteobacterium 
E.coli in the human gut. Molecular analyses showed that facultative anaerobic 
bacteria were only a minority within the colon (0.1%) and that strictly anaerobic 
microbes were by far the most dominant group of microorganisms [54]. 
 
PCR bias 
All PCR-based methods are affected by bias. Biases are introduced by different primer 
binding energy, or by rehybridisation of PCR products so that species evenness in PCR 
products appears to be even, even if the initial species abundances were not so at all 
[55]. The formation of heteroduplexes can be problematic in downstream applications 
such as cloning and sequencing [56]. Another risk PCR reactions bear is the formation 
of chimera through incompletely extended primers and template switching [57]. 
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Limiting the number of PCR cycles and choosing reasonable PCR conditions that allow 
for complete elongation of primers can avoid all the biases mentioned above.  
Biases are furthermore introduced through incomplete lysis of bacteria during DNA 
extraction and differential affinity of PCR primers. Hong et al estimate that a single 
DNA extraction and primer combination recovers only half of the richness/species 
diversity that can be recovered using three such combinations [58]. Applied on 
environmental samples from anoxic waters, multiple PCR primer sets retrieved novel 
lineages that escaped the single PCR primer approach. Surprisingly there was even 
hardly any overlap between datasets retrieved from different primer sets on 
microeukariotic diversity in anoxic waters [58].  
Quantitative PCR (q-PCR)  
In real-time or quantitative PCR a targeted DNA molecule is simultaneously amplified 
and quantified. Two common methods for detection of products in q-PCR are the use 
of fluorescent dyes that intercalate with ds DNA fragment and the use of fluorescently 
labelled oligonucleotides.  
Fluorescent dyes such as SybrGreen or ethidiumbromide intercalate with ds DNA in a 
non-specific manner. The increase in PCR product is measured at the end of each 
elongation step after excitation with a laser. The generated DNA fragments can be 
further analyzed after cycling in a melt curve analysis wereby the temperature is 
gradually increased until the PCR products melt and the fluorescence decreases. 
Primer dimers, different PCR products as well as unspecific binding can be 
distinguished from each other. Given that PCR products of different strains melt at 
different temperatures their relative abundances can be estimated according to their 
peak area in melt curve analysis. Quantification using fluorescent dyes is easy to apply, 
but can be affected by several sources of bias such as unspecific binding or the 
formation of primer dimers as these fragments equally contribute to increase in 
florescence.  
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Different approaches for real-time quantification with fluorescently labelled 
oligonucleotides have been developed to specifically detect a fragment of interest. In 
multiplex q-PCR different amplicons can be simultaneously detected via use of 
different probes that are labelled with fluorophors emitting at different wavelengths. 
Multiplex PCR has been applied to differentiate the phylogenetic groups and virulence 
genes in Enterobacteriaceae isolates from children with coeliac disease [59]. The 
authors elegantly demonstrated that celiac disease was associated with higher 
prevalence of virulence factors P fimbriae (papC), capsule K5 (sfaD/E) and haemolysin 
(hlyA) gene at lower diversity within Enterobacteriaceae. 
 
2.4.2 Molecular fingerprinting techniques 
 
In contrast to cloning and sequencing, fingerprinting techniques enable the rapid 
analysis of large sample numbers including replicates. They enable quantitative or 
semi-quantitative analysis of relative abundances of different community members 
[60]. The analysis of the microbiota of epidemiologically defined groups allows an 
estimation of microbial population dynamics in response to epidemiological variables 
such as e.g. diet, age and medication.  
Denaturing gradient gel electrophoresis (DGGE) is a form of electrophoresis where 
nucleic acids migrate in a chemical gradient according to their GC-content. A similar 
method is TGGE (temperature gradient gel electrophoresis) where nucleic acids are 
separated in a temperature gradient. 
Leonard Lerman invented DGGE in 1979 [61] and applied it to detect single base 
substitutions in genomic DNA [62]. Muyzer [63] introduced DGGE to analyze the 
genetic diversity of complex microbial populations. Alternative fingerprinting methods 
are terminal restriction length polymorphism (T-RFLP) [64] and single strand 
conformation polymorphism analysis (SSCP) [64, 65]. The interpretation of microbial 
fingerprinting techniques is very complex due to the vast diversity of microbial gut 
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communities. A number of methods have been used for quantitative analysis of 
fingerprint patterns and comparison of communities [66]. Statistical models applied to 
study plant and animal distributions in population ecology are gaining relevance 
among microbial ecologists, but the adaptation of such methods is still under 
development and these are mostly used for exploratory analysis of molecular data 
[67]. All methods suffer from a number of unavoidable limitations including bias 
resulting from samples run on different gels or machines; PCR bias or low quality 
amplification products; differences in detection limits, which affect the interpretation 
of “false” and “true” bands or peaks; and lack of distinction between closely adjacent 
bands or peaks, particularly when these differ significantly in intensity or size [68, 69]. 
A crucial step in the computational analysis of fingerprinting techniques is the 
digitalization of visual fingerprinting data. Variable staining of different gels is 
unavoidable and can be normalized via transforming fingerprinting data into 
functions. Then individual bands are expressed relative to the total lane intensities 
[68]. Bias that arises from comparison of different gels can be minimized by loading an 
artificial bandpattern in triplicate on each gel as a marker [68]. Closely adjacent bands 
or peaks forming a ‘shoulder’ are often hard to resolve correctly. Software developed 
for the digitalization of fingerprinting data such as GelComparII (www.applied-
maths.com) allows changing settings to find the best approximation for correct band 
definition. This trial-and-error approach and the necessity to inspect and adjust the 
assigned bands manually is clearly a weak point in fingerprinting analysis. It is quite 
likely that different investigators end up with slightly different band comparison 
datasets.  
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2.4.3 Multivariate statistical methods for the analysis of microbial population 
dynamics. 
 
Computational tools such as (functional) principal components analysis (PCA and 
FPCA), clustering of correlations after Dice or Pearson, self organising maps (SOM) or 
partial least squares regression (PLS-R) have been found to be useful in the 
interpretation of fingerprinting datasets.  
 
principal components analysis (PCA) 
Principal component analysis (PCA) was developed in 1901 by Karl Pearson. 
PCA is a bilinear modelling method that gives an interpretable overview of the main 
information in a multidimensional data table. The information carried by the original 
variables is projected onto a smaller number of underlying (latent) variables called 
principal components. The first principal component covers as much of the variation 
in the data as possible. The second principal component is orthogonal to the first and 
covers as much of the remaining variation as possible, and so on. By plotting the 
principal components, one can view relationships between different variables and 
detect and interpret sample patterns, groupings, similarities, or differences [70]. PCA 
is used as a tool in explorative data analysis and for making predictive models. 
Dollhopf et al [71] were the first to publish the application of PCA ordination on 
community fingerprinting. The disadvantage of PCA becomes apparent in noisy 
datasets that contain smear and differential special clearness. Although a valid 
method for the analysis of population dynamics PCA produces a considerable number 
of misclassifications. The difficulty that PCA has in clearly resolving underlying 
variables within a dataset becomes apparent when considering that typically only 
about 30% of variation can be explained with the first two principal components. 
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functional principal components analysis (FPCA) 
FPCA regards band intensities as a mathematical function of the location on the gel 
and explicitly includes neighbourhood structure in the analysis [60]. In experimental 
datasets generated from standardized soil samples, FPCA generated about only halve 
as many misclassifications as the classical PCA approach. Furthermore, FPCA was able 
to extract about 58.4% of variation with the first two principal components from the 
dataset, where PCA could only explain 31% of the variation. In FPCA [60] the scores of 
the individual samples on the principal components are basis for hierarchical cluster 
analysis using Ward’s method *60+.  
 
partial least squares analysis (PLS) 
Partial Least Squares regression (PLS) is based on linear transition from a large number 
of original descriptors to a new variable space based on small number of orthogonal 
factors (latent variables). In other words, factors are mutually independent 
(orthogonal) linear combinations of original descriptors. Unlike some similar 
approaches (e.g. principal component regression PCR), latent variables are chosen in a 
way to provide maximum correlation with dependent variable; thus, PLS model 
contains the smallest necessary number of factors [60]. PLS regression technique is 
especially useful in quite common cases where the number of descriptors 
(independent variables) is comparable to or greater than the number of compounds 
(data points) and/or there exist other factors leading to correlations between 
variables. In this case the solution of classical least squares problem does not exist or 
is unstable and unreliable. On the other hand, PLS approach leads to stable, correct 
and highly predictive models even for correlated descriptors [60]. PLS has been 
applied by Furet et al. 2009 to cluster the normalized results of a qPCR analysis of 
human and farm animal microbiota. The authors found a clear separation between 
human microbiota and the gut microbes of all farm animal assessed. They could 
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furthermore identify Enterococcus spp., the Blautia coccoies cluster and 
Staphylococcus salivarius as responsible for this clear separation [72]. 
 
self organizing maps neural networks (SOM) 
Artificial neural networks (ANNs) may provide an alternative to conventional statistical 
methods because they detect nonlinear relationships, allow the visualization of 
complex data, and remain robust despite experimental variation. Phylogenetic 
reconstruction, classification of proteins, and genomic analysis are only a few 
applications of SOMs in molecular biology [71, 73, 74, 75]. Ecological applications for 
SOMs are also being explored for classification and modeling of populations and 
ecosystems [76, 77]. Recently, the application of SOM was demonstrated on 
microbiota composition data generated with the phylogenetic chip-platform HIT-CHIP 
(oral presentation, Probiotics, Prebiotics & New Food, 13-15th sept 2009, rome, italy). 
 
2.4.4 linking phylogeny with metabolism 
 
PCR based molecular methods retrieve nucleotide sequences, which then are 
compared to previously described, cultured species. This approach allows only an 
approximate guess on the specific function of the particular microbes prevalent in an 
ecosystem. Several molecular methods have been developed that allow insight into 
specific functions of also uncultured microorganisms and biofilms. 
 
Fluorescence in situ hybridization (FISH) 
FISH is a cytogenetic technique that uses fluorescent nucleotide probes to detect and 
localize specific DNA- or RNA sequences. FISH has been applied to diverse 
environmental samples such as activated sludge [78] and the human microbiota [79]. 
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In contrast to PCR-based methods, where the spatial structure of the sample is 
disrupted in DNA/RNA extraction, FISH can be applied to resolve the spatial 
distribution of microorganisms in a biofilm. When fluorescent probes specific for a 
functional group of bacteria such as ammonia oxidizers are used, the comparison of 
probe-based enumeration with nitrification rates also provides a basis on which to 
measure the specific in situ activity per single cell [80]. Application of FISH to intestinal 
biopsies showed the spatial distribution of bacteria in the gut lumen and the mucus 
layer [81]. Van der Waaij et al did not observe any direct contact to the gut 
epithelium; bacteria were only detected at the luminal side of the mucus layer [81]. 
Bacteria in the transition zone from faeces to mucus: Fecomucus bacteria related to 
Faecalibacterium prausnitzii were mainly located in faeces; however, they can enter 
mucus in low concentrations. Mucophob bacteria were found to be related to 
bifidobacteria and avoid mucus and often even the edge of faeces. Mucotrop bacteria 
related to the Helicobacter genus prevail in the transition zone between faeces and 
mucus and may be completely absent in faeces [82]. 
 
Probing for answers with stable isotopes 
Biomarker labelling 
Several culture-independent approaches to linking microbial community function with 
the genetic identity of key organisms have begun to emerge. Stable-carbon-isotope 
labeling of cell wall lipid as biomarkers has been applied to study aquatic sediments 
[83]. The authors fed 13C-acetate to estuarine and brackish sediment samples and did 
not find incorporation of heavy label in the 17-carbon compounds polar-lipid-derived 
fatty acids (PLFAs) that have been proposed as specific biomarkers for Gram-negative 
bacteria. From this they conclude that the acetate reduction-coupled sulfate reduction 
in the marine sediments studied is mediated by the Gram-positive Desufomaculum 
acetoxidans and not by the more widely studied Gram-negative Desufobacter spp. A 
very clear knowledge of well studied biomarkers was a prerequisite for their heavy-
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carbon-labeling experiments. In situ PLFA profiles are likely to have been generated by 
more than one organism. This complexity cannot be resolved using PLFAs as 
biomarkers. 
When less is known about the microbial functions RNA or DNA are more elegant 
molecules to assess because unspecific primers allow unambiguously targeting the 
majority of microbial RNA varieties, especially when using a variety of different primer 
combinations as previously suggested [84]. 
 
FISH-MAR (fluorencence in sito hybridisation & microautoradiography) 
Lee et al. combined FISH with microautoradiography in order to combine phylogenetic 
information with radioactive labeling [85]. Fluorescently labelled microorganisms and 
silver grains could be simultaneously observed at a high resolution by inverse confocal 
laser scanning microscopy.  
FISH-MAR can be used to investigate in great detail the ecophysiology of defined 
organisms of interest, for which a FISH probe is available or can be designed. FISH-
MAR is also suitable to hunt for and to quantify those microorganisms that are 
responsible for a certain physiological process. 
Probes used for FISH only target small regions of the RNA. This may restrict their 
specificity and make taxonomic identification difficult- especially in environments such 
as the human GI tract that contain a large fraction of previously uncultured and 
undescribed species with strictly anaerobic and symbiotic growth requirements. 
Furthermore the number of bacterial populations that can be simultaneously 
identified in a single FISH experiment is limited by availability of different 
fluorophores, of which only seven have been thus-far identified. FISH-MAR does not 
measure total uptake of radiolabelled substrates but only assimilation into 
macromolecules [86]. Unincorporated labelled compounds are not retained within the 
cells and the detection of labelled macromolecules is not limited to nucleic acids. This 
being the case FISH-MAR is a very sensitive method that requires short incubation 
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times and thus can reduce the risk of false-positive results due to metabolic cross-
feeding.  
 
nucleotide stable isototope probing (SIP) 
Stable-isotope labelled DNA and RNA can be recovered from total community nucleic 
acid extractions on the basis of its increased buoyant density and can be used as 
alternative, unambiguous biomarkers [87]. When using DNA as a biomarker, the rate 
of DNA synthesis in situ plays a pivotal role. DNA synthesis reflects organism 
replication rate and limits the enrichment of this biomarker. RNA synthesis rates are 
higher than those of DNA and are a reflection of cellular activity independent of 
replication. Ribosomal RNA constitutes the ribosome whereby which a cell is capable 
of shaping its environment. DNA/RNA SIP allows the retrieval of the full 16S ribosomal 
nucleic acid sequences from enriched clone libraries. Comparison with the extensive 
NCBI database for ribosomal RNA and DNA allows the identification of specific strains 
involved in the specific assimilatory process studied. Another advantage of nucleotide-
stable isotope probing is that it provides access to the complete genome in a labelled 
nucleotide sample. Thus functional genes can be analyzed and previously unknown 
metabolic pathways can be elucidated. 
Several limitations might render it difficult to prove that the heavy label has been 
consumed. 
Dilution of the labelled substrate before assimilation and incorporation will dilute the 
proportion of 13C that is incorporated into DNA/RNA. In simultaneous presence of 12C 
substrate less DNA/RNA will be isotopically labelled and the analysis of primary 
consumers will become more difficult. Unlabelled carbon sources may include other 
organic compounds or the same substrate produced by internal processes in the 
environment.  
The fate of the 13C labelled atom of the heavy substrate can introduce considerable 
bias in stable isotope probing. Microbial metabolism of the heavy substrate may also 
 28 
 
lead to the incorporation of 13C into products and intermediates of metabolism, which 
might be assimilated by other, non-primary, organisms [88]. Production of the 
corresponding 12C-labelled compounds and trophic interactions would dilute these 
modified substrates in a complex environment such as the human GI tract. It is thus 
very important to keep incubation times with 13C-label short in order to avoid false-
positive results due to metabolic cross-feeding and dilution of the label by 
endogenously generated substrate.  
Manefield et al. [87] measured the 13C/12C ratio in an isotope ratio mass spectrometry 
(IRMS) analysis. For this analysis a minimal amount of 25µg carbon is required. To 
reach this bottom limit for IRMS analysis 1µg of DNA/RNA (0.36µg C) was cut with 
61.6 µg of glucose (24.64 µg of C). In spite of this dilution, enrichment of 13C in nucleic 
acid samples from a phenol-degrading bioreactor could be seen above natural levels 
(1.11% of all carbon). Members of the Thauera genus could be proved to be involved 
in phenol degradation in an aerobic industrial bioreactor. The stunningly sensitive 
IRMS analysis is promising for future application of SIP in linking phylogenetic identity 
with function in human gut microbiota science.  
The inability of stable isotope probing to resolve trophic transfer renders SIP almost 
impossible for in vivo experiments. On its route through the GI system the degree of 
trophic transfers between constituents of the microbiota would lead to a dispersal of 
13C label into virtually all microbes present. 
Thus SIP experiments targeting gut bacteria rely on in vitro experiments with faecal 
inoculum. Using an in vitro model system for the human intestine lactic acid bacteria 
and Clostridium perfringens could be shown to be the primary glucose-fermenting 
bacteria of the small intestine [89]. Streptococcus bovis and C.perfringens were found 
to be the most active glucose-fermenters. NMR analysis furthermore showed that 
lactate, acetate, butyrate and formate were the principal fermentation products [89] 
with significant enrichment of 13C label. After modification of the model system to 
resemble the colonic microbiota bacteria related to Ruminococcus bromii, Prevotella 
spp., and Eubacterium rectale could be shown to be involved in starch metabolism 
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[90]. Integration of molecular and metabolite data suggested metabolic cross-feeding 
in the system where populations related to Ruminococcus bromii were the primary 
starch degraders. Strains related to Prevotella spp., Bifidobacterium adolescentis and 
Eubacterium rectale were suggested to be further involved in the trophic chain [90].  
 
2.5 Aim of the thesis 
 
In the light of the rapidly changing knowledge on the human microbiota, is appears 
clearly necessary to combine existing molecular methods and multivariate statistical 
tools in order to gain meaningful information from this highly diverse and intertwined 
habitat. The aim of this thesis was to apply PCR-DGGE fingerprinting, qPCR, functional 
gene analysis and stable isotope probing on faecal samples of epidemiologically 
defined groups of individuals such as those following different diets, elderly citizens 
and individuals with different pathological conditions. Furthermore, statistical 
methods should be explored for the meaningful interpretation of results. 
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3 Combined PCR-DGGE fingerprinting and quantitative-PCR indicates 
shifts in faecal population sizes and diversity of Bacteroides, 
bifidobacteria and clostridium cluster IV in institutionalized elderly. 
 
3.1 Introduction 
With ageing, a decrease in beneficial organisms such as Lactobacilli and Bifidobacteria, 
amongst other anaerobes, and an increase in the number of facultative anaerobes 
[91] have been reported. Population cross-sectional studies with relevant numbers of 
healthy elderly also show age-related changes in GI microbiota. These include a 
consistent global increase in nonpathogenic Gram-negative bacteria (mainly 
Enterobacteria), as well as country-specific changes in Bifidobacteria [63]. This, along 
with a general reduction in species diversity within most bacterial groups, changes to 
diet and altered digestive physiologies such as intestinal transit time, may result in 
increased putrefaction in the colon and a greater susceptibility to disease. The aged 
gut is characterized by increased proteolytic activity, decreased amylolytic activity and 
reduced levels of SCFA [13, 92]. Ageing is associated with reduced levels of 
prostaglandins such as PGE2 and PGF2  as shown in specimens of stomach and 
duodenum biopsies [93]. Subclinical intestinal inflammation in elderly populations has 
been detected and is believed to contribute to impaired immune functions, the 
underlying cause of mortality beyond 75-80 years of age [92].  
Analyses of individual dispositions associated with changes of the microbiota should 
consider quantitative and qualitative aspects of gut community structure. Analysis of 
stool samples can target changes in colonic microbiota, since faeces are 
representative of inter-individual differences [94]. 
The aim of this work was to investigate shifts in GI microbiota associated with aging, 
by comparing institutionalized elderly with young healthy volunteers. To analyze 
changes in total bacterial community composition, along with specific compositional 
changes within the Bacteroidetes, Bifidobacteria and Clostridia cluster IV, we used the 
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polymerase chain reaction (PCR) based community fingerprinting method Denaturing 
Gradient Gel Electrophoresis. The resolution of this method allows for the 
characterization of the dominant members of a targeted microbial community. 
Further, we used quantitative-PCR (q-PCR) to determine the relative load of 
Bacteriodetes, Bifidobacteria and Clostridia cluster IV groups within our samples. Thus, 
use of these methods in combination allowed the characterization of both diversity 
and relative abundance of our targeted organisms. 
 
3.2 Material and methods 
3.2.1 study participants 
Seventeen institutionalized elderly aged 86 ± 8 years, BMI 21.75  5.08, from a 
geriatric department in Vienna and 17 students from Vienna joined the study. 
Probands were interviewed following a questionnaire assessing: age; gender; body 
length and weight; individual health status, including chronic or acute diseases and 
blood lipid levels; and life-style aspects, such as physical activity and dietary habits. 
Five percent of geriatric patients suffered from manifest diabetes mellitus type 2. Ten 
patients were bed-ridden and seven mobile. Causes for loss of mobility were 
Parkinson’s disease, dementia and osteoporosis. Nursing staff reported the 
application of NSAIDs (non-steroidal anti-inflammatory drugs) on demand. Seventeen 
young healthy volunteers were aged 24 ± 2.5 years, BMI 22.68  3.41 and their dietary 
habits were typical for Central Europe.  
Study populations were gender balanced, with 55% females in the group of elderly 
and 50% in the young group. Only non-pregnant probands with no diagnosed gastro-
intestinal disease and no antibiotic or chemotherapeutic treatment three months 
prior to sampling were included in the study. All probands agreed to participate in the 
study and gave their informed consent. 
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3.2.2 Sampling and DNA extraction from Stools and Type Strains 
From each proband, three stool samples were taken within the course of a week and 
immediately stored at –70°C. Portions of the three samples from each patient were 
pooled, a 200 mg aliquot was treated twice for 45 sec in a bead-beater (Mini-
Beadbeater-8) and DNA extracted with the QIAamp® DNA Stool Mini Kit (QIAGEN) 
following the manufacturer’s protocol and then immediately stored at –20°C.  
Type strains known to be associated with GI microbiota were grown, and DNA 
extracted, for use as part of the markers in DGGE analysis (see below). Type strains L. 
casei DSM 20011T, L. delbrueckii subsp. lactis DSM 20072T, Bacteroides fragilis DSM 
2151T, Bacteroides thetaiotaomicron DSM 2079T, Bifidobacterium longum DSM20219T, 
B.longum DSM 20211, B.pseudolongum DSM 20099 and B.thermophilus DSM 20210 
were anaerobically cultivated on blood agar, E.coli IMBH 252/07 and clones were 
aerobically cultivated on LB-agar (liquid broth medium). The biomass was 
resuspended in sterile phosphate buffered saline (1x PBS from 10x PBS Roti stock, 
ROTH). Tenfold dilutions from these suspensions in sterile 1x PBS were plated in 
duplicate on blood agar or LB-agar, colony forming units (CFU/ml) were counted and 
DNA extracted from serial dilutions. DNA was extracted from clones using the Wizard® 
Plus.SV Minpreps DNA Purification System (Promega). The DNA of all Gram-negative 
bacteria was extracted with the DNA Mini Kit (QIAGEN), for Gram- positive bacteria, 
the FastDNA Spin Kit for Soil (MP-Biomedicals) was used following the instructions of 
the manufacturer.  
 
3.2.3 Polymerase Chain Reaction (PCR) 
PCR was used to amplify 16S ribosomal RNA gene sequences from type strains and 
Bacteria in stool samples for use in DGGE analysis and manufacture of clone libraries 
(see below). All reactions were carried out using a ready-to-use mastermix (Promega) 
with 1.5mM MgCl2. Bovine serum albumin (10mg/ml, Fermentas) was added to a final 
concentration of 400 g/ml, primer concentration in the reaction volume was 0.5µM. 
Amplifications were carried out in a Robocycler (Stratagene). 
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3.2.4 Clone libraries 
Clone libraries were constructed from stool samples to identify dominant members of 
the Clostridium cluster IV and the Bacteroidetes. Selected clones were then used, 
along with the cultured type strains, to generate appropriate reference markers for 
DGGE analysis. Amplifications were carried out using primer pair 27f [95] and sg-Clep-
R [96], which are specific for members of the Clostridium cluster IV, and 32f and 708r 
[97], which are specific for members of the Bacteroides. Amplified products were 
cloned into a p-GEM Easy Vector (Promega) following the instructions of the 
manufacturer. Clone libraries were screened as previously described [68]. Clone 
inserts were sequenced by ‘DNA confidence’ (Vienna). Nucleotide sequences were 
corrected for vector and primer sequences in CodonCode Aligner 
(www.codoncode.com) and taxonomically identified by comparison to previously 
published sequences using the online tools of the ribosomal database project 
(http://rdp.cme.msu.edu/). 
 
3.2.5 DGGE (denaturing gradient gel electrophoresis) 
PCR amplifications of 16S rRNA gene fragments from total DNA extracted from stool 
samples were carried out using the specific primer sets outlined in Table 2. 
Separate DGGE gels were run to analyse samples for patterns in a) total Bacteria, b) 
Bifidobacteria, c) Clostridium cluster IV and d) Bacteroides. DGGE gels were prepared 
as described previously [98] with a linear gradient of 25-65% for Bacteria (general), 
30-65% for Bifidobacteria, 20-50% for Bacteroides and 30-50% for Clostridium cluster 
IV, using a gradient mixer (Hoefer SG 30) and a peristaltic pump. We generated 
reference markers appropriate for each set of DGGE analyses (i.e. a different 
reference marker was used for each of a,b,c and d above) to enable meaningful 
comparisons across multiple gels and to provide putative identification of some bands. 
These reference markers contained fragments of 16S rRNA genes from cultured 
 34 
 
bacteria and clones generated from faecal material (as described above). Each marker 
was loaded in triplicate on each gel to allow gel-to-gel comparison. The reference 
marker for DGGE fingerprinting of general Bacteria consisted of E.coli IMBH 252/07, 
Enterococcus faecium DSM 20477T, Bacteroides thetaiotaomicron DSM 2079T, 
Bifidobacterium longum DSM 20219T, Clostridium perfringens (laboratory isolate), 
clone BT11 (98.8% similarity with Bacteroides uniformis JCM 5828T), clone BT17 
(96.0% similarity with Bacteroides vulgatusT and bacterium LY88 previously identified 
in human faeces [54], and clone CL16 (98.4% similarity with an uncultured bacterium 
from human faeces [99], and 96.7% similarity with Faecalibacterium prausnitziiT). The 
reference marker for Bifidobacteria specific DGGE analysis consisted of Enterococcus 
faecium DSM 20477T, E.coli IMBH 252/07, Bifidobacterium longum DSM 20219T, B. 
longum DSM 20211, B. thermophilus DSM 20210T and B. pseudolongum DSM 20099T. 
The reference marker for Bacteroides specific DGGE analysis was composed of 
Bacteroides thetaiotaomicron DSM 2079T, faecal clones Bt 17 and Bt11 and 
Enterococcus faecium DSM 20477T. The reference marker for Clostridium cluster IV 
DGGE analysis was constructed from 7 clones all representing previously uncultured 
species from cluster IV: Similarities with type strains from this cluster were 81.8%, 
96.6%, 96.7% and 97.8% similarity with Faecalibacterium prausnitziiT, 92.1% and 
92.9% similarity with Eubacterium desmolansT and 95.9% similarity with 
Subdoligranulum variabileT.  
 
3.2.6 TaqMan RTQ-PCR 
The TaqMan-assay was carried out in a Rotorgene 3000 (Corbett Life Science) in 
duplicate in a volume of 10 µl containing 5 µl TaqMan SensiMix DNA Kit (Quantace), 1 
µl of each primer and probe (final concentrations table 1) and 2 µl of the 100-fold 
dilution of the template. All probes were labelled with 6-FAM at the 5’ end and carried 
a BHQ-1 quencher at the 3’ end. TaqMan Probe (Clep-P) for Clostridium cluster IV was 
designed with CLC DNA Workbench (www.clcbio.com). Analysis with ProbeMatch 
(rdp.9.58) indicated that Clep-P binds to all members of Clostridium cluster IV. The 
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PCR program for bifidobacteria, Bacteroides and universal bacteria consisted of 
denaturing at 95°C for 3min and 45 cycles of 95°/60°C for 15/ 45 sec. The amplification 
program for clostridium cluster IV was: denaturation at 95° for 5 min and 45 cycles at 
95°/ 55°C for 30/ 45 sec.  
 DNA of Bacteroides thetaiotaomicronT and Bifidobacterium longumT, clone CL16 and 
one faecal sample were used to construct standard curves for comparison of PCR 
reaction efficiencies among different experiments and enumeration of all bacterial 
groups. Reaction efficiency (E) was estimated using the slope of the standard curve 
and the formula E=10(-1/slope) -1 as described elsewhere [100]. Quantification was done 
using standard curves obtained from known concentrations of organisms containing 
the respective amplicons for each set of primers. The percentage of bacterial group 
rRNA gene copies in relation to total rRNA gene copies (relative abundance) was 
calculated for each individual, and the mean was determined for each subject group. 
Relative quantification (% of bacteria) was performed using Rotor-Gene 3000 
calculation software (Corbett operator manual) and Excel. Cross reactivity with non-
target strains was tested using the Probe-Match tool at the RDP website and using the 
strains mentioned above. 
Table 1: Primers and probes used for the quantification of faecal bacteria using 
TaqMan assays targeting 16S rRNA coding regions.  
Target organism 
Primer 
or probe 
Sequence (5' - 3') 
Fragment 
Size (bp) 
Conc. 
[nM] 
Reference 
bifidobacteria Fwd 
primer  
GCG TGC TTA ACA CAT GCA 
AGT C 
125 300  
 Rev 
primer  
CAC CCG TTT CCA GGA GCT 
ATT 
 300  
 Probe  (FAM)- TCA CGC ATT ACT CAC  150 [100] 
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CCG TTC GCC -(BHQ-1) 
Bacteroides AllBac29
6f 
GAG AGG AAG GTC CCC CAC 106 300  
 AllBac41
2r 
CGC TAC TTG GCT GGT TCA G  300  
 AllBac37
5Bhqr 
(FAM)-CCA TTG ACC AAT ATT 
CCT CAC TGC TGC CT-(BHQ-1) 
 100 [101] 
Bacteria 
(general) 
BAC-
338-F 
ACT CCT ACG GGA GGC AG 468 1000  
 BAC-
805-R 
GAC TAC CAG GGT ATC TAA 
TCC  
 1000  
 BAC-
516-P 
(FAM)-TGC CAG CAG CCG 
CGG TAA TAC-(BHQ-1) 
 200 [102] 
Clostridium 
cluster IV 
sg-Clep-
F 
GCA CAA GCA GTG GAG T 239 400   
 sg-Clep-
R 
CTT CCT CCG TTT TGT CAA  400 
[102] 
 
 
Clep-Pa 
(FAM)-AGG GTT GCG CTC 
GTT-(BHQ-1) 
 200 This study 
a position of target site (numbering corresponding to E . coli 16S rRNA gene) 1082 to 
1107. 
 
Table 2: Primers applied for PCR-DGGE fingerprinting of 16S rRNA coding regions. 
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Target 
organism 
Primer 
pairs 
Sequence (5’-3’) Ann.temp 
(°C) 
Reference 
bacteria 27f GTGCTGCAGAGAGTTTGATCCT
GGCTCAG 
57 [103] 
 985r GTAAGGTTCTTCGCGTT 57 [104] 
 341f-GC CCT ACG GGA GGC AGC AG 55 [63] 
 518r ATT ACC GCG GCT GCT GG 55 [91] 
Bacteroides 32f AACGCTAGCTACAGGCTT 56 [97] 
 708r CAATCGGAGTTCTTCGTG 56 [97] 
bifidobacteria g-BifidF CTCCTGGAAACGGGTGG 58 [105] 
 g-BifidR  GGTGTTCTTCCCGATATCTACA 58 [105] 
Clostridia 
cluster IV 
sg-Clep-F-
GC see table 1 55  
 sg-Clep-R    
 
3.2.7 Statistical analysis.  
Food frequency data were analyzed based on Chi-square approximation as 
implemented in SPSS. P values <0.05 were considered significant. Band comparison 
tables were analyzed with principal component analysis (PCA) using the default 
settings in ‘R-software environment for statistical computing’ (www.r-project.org) 
until 100% variance was explained. Transformed data were plot in a bi-plot as a 
function of the first two principal components. Clustering was applied to DGGE 
fingerprinting data as implemented in the GelComparII environment (www.applied-
maths.com). Clustering was performed based on Dice coefficient as well as based on 
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Pearson correlation. Those methods are supplementary to each other, clustering after 
Dice takes band positions into account, whereas Pearson correlation based clustering 
analyzes the densitometric curves of each fingerprint. UPGMA dendrograms were 
generated and Jackknife analysis was performed using average similarities and 100 
resamplings. Jackknife analysis is a leave-one-out method that tests the reliability of 
the clustering similar to bootstrap analysis. Shannon and Simpson’s diversity index 
were calculated on binary band information (presence-absence) with the default 
settings implemented in the ‘vegan’ package in ‘R’. Shannon index is defined as H = -  
pi ln pi, where pi is the proportional abundance of species i. For Simpson’s index D, this 
is 1-  ((pi)^2), where pi is the relative frequency of the i-th species. Prior to 
application of Student’s t-test for diversity indices and qPCR data, equality of variances 
of the three datasets was tested using the F-test as implemented in Microsoft Excel.  
 
3.3 Results 
3.3.1 Dietary aspects 
Analysis of the participant’s dietary habits indicated similar consumption patterns of 
fruits, vegetables and milk products in both groups. Young volunteers stated 
significantly less frequent (Chi2 Test; p<0.04) consumption of meat than elderly 
probands and regular consumption of whole grain products several times a week. The 
institutionalized elderly of this study did not consume any whole grain products at all 
but received supplements with soluble fiber (Benfiber , Novartis). 
 
3.3.2 TaqMan-quantification 
TaqMan assays were set up quantifying bacterial sub-populations as percentage of the 
total bacterial DNA. We detected no cross-reactivity of group-specific primers and 
probes with non-target strains. Test-retest variations were between 2.7% and 5.2%, 
values after relative quantification varied by less than 4%. The sensitivity was 
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corresponding to a 100 000 fold dilution of DNA from faeces, that is 20 copies of 16S 
rRNA gene per reaction.  
The elderly harbored only 69% 21.6% of the total bacterial load in their faeces 
compared to control (figure 1). Bacteroides were found to represent a larger 
percentage than Bifidobacteria in all samples (figure 1) and the institutionalized 
elderly harbored significantly more Bacteroides than young volunteers (p=0.016). 
Although relative levels of Bifidobacteria  were highly variable among samples, the 
differences between young and elderly probands were statistically significant 
(p=0.026). Furthermore, elderly citizens had significantly less members of Clostridium 
cluster IV (figure 1) in their faecal microbiota than young volunteers (p=0.036). 
 
 
Figure 1: Proportions of Bacteroides, bifidobacteria and Clostridium cluster IV of total 
bacteria in stool samples of institutionalized elderly and young healthy 
volonteers.Total amount of bacteria is depicted relative to the mean counts for 
healthy young volunteers. 
 
3.3.3 DGGE bandpattern analysis 
DGGE fingerprinting with primer pair 341GC-518, which amplified the total microbial 
community, showed high inter-individual variations (figure 2). The mean numbers of 
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bands per individual were 16.6 ± 3 bands for institutionalized elderly and 20 ± 3 bands 
in control. Two bands as highlighted in figure 2 occurred significantly less frequently in 
elderly probands. Shannon and Simpson indices of diversity were significantly lower 
for elderly than control (figure 3). The highly diverse dataset was subjected to 
principal component analysis (PCA). Extraction of underlying components within the 
dataset indicated grouping of samples according to their variance (figure 4) along the 
first two principal components. Cluster analysis could separate the fingerprints of 
young and elderly (figure 5). Jackknife analysis suggested that the dominant bacteria 
of the elderly microbiota are a subpopulation of the microbiota of young individuals: 
Predictability of groupings was 100% for young and only 13.33% for elderly.  
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Figure 2: PCR-DGGE bandpattern of 16S rRNA genes of dominant bacteria amplified 
with primer pair 341GC-518. Bands that were observed more frequently in young than 
in elderly are indicated with arrows. Organisms and sequences listed were used for 
the construction of the reference lanes. 
A, G, I, J, young; B, C, E, F, elderly; D, H, reference lanes 
 
 
3.3.4 Bifidobacteria 
An average of thirteen bands was observed in individual DGGE bandpatterns obtained 
with the primer pair specific for Bifidobacteria. Two bands with the same melting 
behaviour as the type strains B.longum DSM 20219T and B.pseudolongum DSM 20099T 
in our marker were abundant in the majority of probands. PCA was performed and the 
first two PC’s explained 23.64% of variance (figure 4). Although cluster analysis 
showed high similarity of young and elderly bandpatterns, jackknife testing 
demonstrated greater similarity of bandpattern for control than for elderly (expressed 
in predictability of groupings: 91.67% for control and 35.72% for elderly). PCA 
supported these results and could not separate young and elderly according to 
variances in the dominant bifidobacteria of their microbiota. 
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3.3.5 Bacteroides 
DGGE fingerprints obtained with the Bacteroides specific primers contained an 
average of 7.6 ± 2.5 bands for the elderly, whilst young individuals averaged 9.5 ±3 
bands. Diversity indices (figure 3) showed a tendency to be lower for elderly than for 
control. PCA results suggest a tendency for less Bacteroides diversity with ageing 
(figure 4). Elderly subjects grouped along the first principal component. Clustering of 
Pearson correlations could separate young and elderly individuals according to DGGE 
fingerprinting. Jackknife analysis using average similarities could predict groupings of 
young bandpattern with 76.92% reliability and 75% for elderly. 
 
3.3.6 Clostridium cluster IV 
DGGE fingerprints obtained with the Clostridium cluster IV specific primers yielded an 
average of 10 ±3 .5 bands per elderly individual and 13 ± 3 bands per young individual. 
Diversity indices (figure 2) were significantly (p=0.02) lower for aged citizens than for 
the young. One band that occurred more frequently in the young than in the elderly 
had the same melting characteristics as a band in our marker. This band was 
generated from a clone from our library related to the genus Faecalibacterium. This 
clone had the highest similarity (99.2%) to an uncultured bacterium EF403698 and 
also displayed 96.6% similarity to Faecalibacterium prausnitziiT. Three more bands 
occurred more frequently in the young than in elderly. These bands were identified 
from our clone libraries as relating to the genera Ruminococcus (clone had 95.9% 
similarity to Ruminococcus bromiiT, 99% similarity to uncultured AJ408987 from 
human colon) and Subdoligranulum (clones had 94.7%/ 97.5% similarity to 
Subdoligranulum variabileT, and 97.9%/ 98% similarity to uncultured bacterium 
DQ793301). 
PCA (figure 4) indicated separation of young and elderly according to their Clostridium 
cluster IV DGGE fingerprints along PC1.  
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Clustering and Jackknife analysis did not result in distinct clustering of elderly and 
young individuals. Clostridium cluster IV representatives in the elderly microbiota are 
most likely to be a subset of the species present in young individuals: Only in 35.71% 
of resamplings elderly bandpattern grouped with each other, whereas Jackknife value 
for young individuals was 100%. 
 
Figure 3: Diversity indices derived from DGGE fingerprinting of 16S rRNA coding 
regions. 
Y, young; E, elderly; Cl.IV, Clostridium cluster IV; B, Bacteroides, Bif, bifidobacteria;  
*, p < 0.05. 
 
 44 
 
 
Figure 4: PCA of DGGE fingerprints of 16S rRNA genes of dominant bacteria in faecal 
samples. 
Y, young; O, elderly 
 
Figure 5: UPMGA dendrogram showing clusterin (Dice) based on the similarities of 
DGGE fingerprints of dominant bacteria obtained with primer pair 341GC-518. 
      , elderly;      , young 
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3.4 discussion 
 
Metagenomic analysis of the human GI microbiota is presently the subject of large 
research consortia and has already substantiated the concepts of a ‘core microbiome’ 
and inter-individual variations *94+. However, the collection of data on ‘reference 
microbiota’ is far from complete and thus no definition of a healthy microbiota is 
available yet. Important information comes from analyses addressing the abundance 
and diversity of specific bacterial populations with relevance to disease, diet or 
probiotic intervention. We used a combined molecular approach to compare patterns 
in several target GI microbial groups between the institutionalized elderly and young 
healthy volunteers. The community fingerprinting method PCR-DGGE was used to 
compare the diversity present in total Bacteria and also specifically within the 
Clostridium cluster IV, Bifidobacteria and Bacteroides, whilst q-PCR was used to 
quantify the relative population abundance of these same bacterial groups in all 
samples. 
Our results demonstrate some significant shifts in patterns in GI microbiota between 
our study groups. Faeces from the institutionalized elderly had less total Bacterial 
abundance and lower total Bacterial diversity than that from the young subjects. 
However, samples from the elderly displayed an increase in the relative abundance of 
Bacteroides, although this group tended to display less diversity than Bacteroides in 
the young. The relative abundance of the Bifidobacteria and Clostridium cluster IV 
were significantly higher in the young, and the Clostridium cluster IV also displayed 
greater diversity in the young. Furthermore, cluster analysis revealed that for all 
microbial groups analysed, the members of the GI microbiota in the elderly could be 
considered a subset of that present in the young. 
The results of our Bifidobacteria analysis are in agreement with previous studies which 
have identified a reduction and loss of diversity of Bifidobacteria associated with aging 
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[13, 106] or hospitalization of aged citizens [95]. Our study population of elderly was 
supplemented with soluble fiber. This prebiotic intervention alone was apparently not 
able to antagonize ageing-related changes in the Bifidobacteria. In this respect 
Ouwehand et al. [107] recently reported that supplementation with lactitol and a 
probiotic Lactobacillus led to an increase in Bifidobacteria in the microbiota of elderly. 
Bartosch et al. [95] also reported a marked reduction in the abundance of 
Faecalibacterium prausnitzii, a member of the Clostridium cluster IV which decreased 
in our aged group. However several studies [106, 13, 95] have reported a decrease in 
the relative abundance of the Bacteroides, whereas our aged study population 
displayed a relative increase in abundance of this group. Like us, all the previous 
studies reported a decrease in Bacteroides diversity. Increased levels of Bacteroides 
have been found in individuals with infectious colitis [108]. Discrepancies in changes 
of the Bacteroides abundance might be due to country-specific differences in this 
bacterial subgroup as indicated by Mueller et al. [109]. Mueller et al. [109] also 
observed gender effects within Bacteroides, with levels being generally higher in 
males than in females. Our study populations were gender balanced with volunteers 
being 55% females in the group of elderly and 50% in the young. The results presented 
here do not support gender differences in Bacteroides abundance. Reductions in 
amylolytic activity observed in a healthy elderly population have been correlated with 
the occurrence and diversity of Bacteroides [13]. 
 
Reduced numbers of Bacteria in the faecal content of elderly reflect the physiological 
alterations associated with ageing. These include prolonged colonic transit time and 
reduced dietary energy requirement and food uptake [110]. Further reductions in the 
relative abundance of important sub-populations such as Clostridium cluster IV and 
Bifidobacteria might result in reduced formation of SCFAs, altered epithelial cell 
maturation and maintenance, and altered barrier function of the gut epithelium in 
elderly probands. Those changes in the GI microbiota have previously been linked to 
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impaired immune functions prevalent in individuals of advanced age and may result in 
a greater susceptibility to disease. 
 
Improved analytical concepts for the characterization of the microbiota of consumers 
and patients might become important as a rationale for individualized probiotic 
intervention. Probiotic supplementation is a promising concept in restoring impaired 
functions or enhancing specific desirable functions of the microbiota. Encouraging 
effects of probiotic supplementation have been reported for aspects such as direction 
of host immunity, pathogen defense, maintenance of integrity of the gut epithelium, 
alleviation of lactose intolerance symptoms and immune effects, such as in atopic 
disease. For further insight into the relationships between phylogenetic information 
and metabolic activities, sequence information in addition to 16S rRNA based 
fingerprinting will be mandatory. 
 
3.5 conclusion 
Studies comparing elderly and young volunteer microbiota with PCR-DGGE 
fingerprinting and qPCR are still rare. We found that ageing is associated with less 
overall bacteria and significantly decreased Clostridium cluster IV and bifidobacteria 
and an increase of Bacteroides. Diversity of dominant bacteria, Bacteroides and 
Clostridia cluster IV were reduced. Those changes in the GI microbiota are suggested 
to be cause and effect of impaired immune functions in individuals of advanced age 
and may result in a greater susceptibility to disease. 
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4 Characterization of Bacteria, Clostridia, Bacteroides in faeces of 
vegetarians using qPCR and PCR-DGGE fingerprinting 
4.1 introduction 
 
The highly diverse microbiota of the human gastrointestinal tract has been associated 
with the pathogenesis of colorectal cancer [111], inflammatory bowel diseases [112, 
113], obesity [27], metabolic syndrome [8] and atopic diseases [114]. Two of the most 
predominant subpopulations in the human faecal microbiota are the Clostridium 
leptum subgroup and Bacteroides [6, 115, 54]. Members of these populations contain 
butyrate and propionate producing fibrolytic bacteria [116, 117]. The metabolic 
activities of these organisms have a significant influence on colonic health as butyrate 
is known as the major energy source for colonocytes [118] and is involved in 
epigenetic regulation of gene expression in colonic epithelium [119, 23]. Furthermore 
it has been shown that vegetarian diet influences gene expression through epigenetic 
modification [120, 121]. Another important subgroup of the human microbiota is that 
of the bifidobacteria. Stimulation of these bacteria has previously been shown after 
prebiotic intervention with inulin and fructo-oligosaccharides [92]. Bifidobacteria have 
been shown to be involved in prevention of atopic disease [122], and prevention of 
obesity and insulin resistance via enhanced barrier function of the gut epithelium [9]. 
The prevalence of a vegetarian diet (e.g., little or no animal protein, low fat and high 
fiber content) increased substantially during the last few decades in the Western 
world and this trend is likely to continue in the future [123]. Vegetarianism has been 
associated with decreased risk for diseases such as heart diseases, various cancers and 
has been linked to a lower BMI and an overall decline in mortality [123]. Different 
lifestyle factors and diets were shown to have a significant impact on the faecal 
microbiota [124, 109, 125, 126]. To our knowledge only one investigation [127] of 
vegetarian microbiota has been performed with molecular methods. This analysis of a 
single individual revealed that Clostridium cluster XIVa, Clostridium cluster IV, 
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Clostridium cluster XVIII were the major components of the vegetarian gut microbiota 
[127]. 
In the present study, we applied qPCR and PCR-DGGE fingerprinting to investigate the 
dominant microbiota in 29 young omnivores and vegetarians assessing Clostridium 
leptum subgroup, Bacteroides and bifidobacteria.  
 
4.2 Material and methods 
 
4.2.1 Participants 
Twenty-nine healthy young individuals, 15 vegetarians (aged 19-34 years, BMI 22.06  
3.82) and 14 omnivores (aged 21-31 years, BMI 21.02  2.71) were compared. A 
questionnaire about dietary habits and health activities was given to all participants. 
Exclusion criteria were the use of antibiotics, chemotherapeutic treatment, pre- and 
probiotics three months prior to sampling. All trial subjects agreed to participate in 
the study and gave their informed consent. 
 
4.2.2 Sampling and DNA extraction 
Stool samples were immediately stored at –20°C after sampling. DNA was extracted 
using the DNA Stool Mini Kit (Qiagen) following the manufacturers’ protocol with 
minor modifications [128, 102] and immediately stored at -20°C.  
 
4.2.3 TaqMan qPCR 
Bacterial 16S rRNA was quantified by TaqMan qPCR using primers and probes 
previously published (table 1). TaqMan Probe (Clept-P) for Clostridium cluster IV was 
designed with CLC DNA Workbench (http://www.clcbio.com). DNA of Bacteroides 
thetaiotaomicronT and Bifidobacterium longumT, clone CL16 and one faecal sample 
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were used to generate standard curves for comparison of PCR reaction efficiencies 
among different experiments and enumeration of all bacterial groups. Relative 
abundances of bacterial subgroups were calculated in relation to total 16S rRNA gene 
copies for each individual using Rotor-Gene 3000 calculation software (Corbett 
operator manual) and Excel. 
 
4.2.4 PCR, DGGE fingerprinting  
16S rRNA coding regions were amplified using a ready-to-use mastermix (Promega) in 
a Robocycler (Stratagene). Group specific primers (table 2) were applied at the 
temperatures indicated in table 2. Reference markers containing fragments of 16S 
rRNA coding regions were loaded to each gel in triplicate to allow gel-to-gel 
comparison. DGGE gels were prepared as described previously [98] with a linear 
gradient of 25-65% for bacteria, 30-65% for bifidobacteria, 20-50% for Bacteroides and 
30-50% for Clostridium cluster IV using a gradient mixer (Hoefer SG 30) and a 
peristaltic pump.  
 
4.2.5 Statistical analysis.  
Quantitative PCA results were analyzed in Excel using F-test and Student’s T-test. Food 
frequency data and interesting bands of DGGE fingerprints were analyzed based on 
Chi-square approximation as implemented in SPSS15. PCR-DGGE band comparison 
tables were created in GelComparII (www.applied-maths.com) and analyzed with 
principal component analysis (PCA) using the default settings in ‘R-software 
environment for statistical computing’ (www.r-project.org) until 100% variance 
explained. Transformed data were plot in a bi-plot as a function of the first two 
principal components. Shannon diversity index were calculated on binary band 
information (presence-absence) with the default settings implemented in the ‘vegan’ 
package in ‘R’. Shannon index is defined as H = -  pi ln pi, where pi is the proportional 
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abundance of species i. All tests were double sided, p<0.05 was considered as 
significant. 
 
4.3 Results 
 
4.3.1 Dietary aspects 
Analysis of the participants’ dietary habits indicated similar consumption patterns of 
liquids, alcohol, fruits, grains and milk products in both groups. Exercise levels were 
comparable. Omnivores stated significantly less frequent (Chi2 Test; p<0.027) 
consumption of vegetables than vegetarians. Three of the vegetarians assessed 
followed vegan diet; all others followed a lacto-ovo vegetarian diet. Five vegetarians 
eat fish a few times a year. 
 
4.3.2 Relative quantitation with qPCR 
 
Bifidobacteria, members of Clostridium cluster IV and Bacteroides were quantified as 
percentage of the total bacterial DNA (figure 1). No cross reactivity of group-specific 
primers and probes with non-target strains could be detected. Test-retest variations 
were between 2.7 % and 5.2 %, values after relative quantification varied for less than 
4 %. Vegetarians showed 19 % higher counts of bacterial DNA than omnivores but 
these differences were not significant due to high interindividual deviations. The mean 
proportion of Clostridium leptum subgroup in stool samples of vegetarians was 31.86 
± 17.00 % and in omnivores 36.64 ± 14.22 %. The mean percentage of Bacteroides in 
vegetarians was 23.93 % ± 10.35 % and in omnivores 21.26 ± 8.05 %, while the mean 
proportion of bifidobacteria in vegetarians (1.52 ± 1.29 %) was unchanged to 
omnivores (1.59 ± 1.73 %). The 3 vegans did not show any differences in the group of 
vegetarians, even more they cluster nicely at the mean values. 
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4.3.3 PCR-DGGE quantitative analysis 
 
The highly diverse datasets of all bacterial groups were subjected to principal 
component analysis (PCA) which extracts underlying components within the dataset, 
separating samples according to their variance. This procedure resulted in a 
separation of omnivores and vegetarians according to their Clostridium cluster IV 
fingerprint and also in the dominant bacteria dataset some grouping was visible 
(figure 2). The mean numbers of bands observed with a primer pair (341-518) 
targeting most bacteria were 20.1 ± 3.3 for omnivores and 18.07 ± 3.7 for vegetarians. 
The fingerprints of bacterial subgroups were similar for all participants. Bacteroides 
bandpatterns were composed of 9.5 ± 2.9 bands, Clostridium cluster IV of 12.75 ± 3.37 
and 13.2 ± 3.1 bands related to Bifidobacterium spp. Shannon diversity indices based 
on the DGGE fingerprinting were similar for all bacterial groups. However, two bands 
(figure 3) from Clostridium cluster IV were more prevalent in omnivores than in 
vegetarians (Chi2 Test; p<0.005; p<0.022). The first sequence was 96.7 % similar to 
Faecalibacterium prausnitziiT and 99.5 % to Faecalibacterium prausnitzii AJ270469 and 
the second one matched next to Clostridium sp. BI-114T (similarity 94.7%) and 
uncultured bacterium DQ793301 (similarity 97.9 %). 
Table 1: Primers and probes used for the quantification of faecal bacteria using 
TaqMan assays targeting 16S rRNA coding regions.  
Target 
organism 
Primer and 
probe 
Sequence (5' - 3') 
Size 
(bp) 
Conc. 
(nM) 
Reference 
Bifidobacteriu
m spp. 
Forward 
primer  
GCG TGC TTA ACA CAT GCA 
AGT C 
125 300  
 Reverse CAC CCG TTT CCA GGA GCT  300  
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primer  ATT 
 
Probe  
(FAM)- TCA CGC ATT ACT CAC 
CCG TTC GCC  
-(BHQ-1) 
 150 [100] 
Bacteroides AllBac296f GAG AGG AAG GTC CCC CAC 106 300  
 AllBac412r CGC TAC TTG GCT GGT TCA G  300  
 AllBac375B
hqr 
(FAM)-CCA TTG ACC AAT ATT 
CCT CAC TGC TGC CT-(BHQ-1) 
 100 [101] 
All bacteria BAC-338-F ACT CCT ACG GGA GGC AG 468 1000  
 
BAC-805-R 
GAC TAC CAG GGT ATC TAA 
TCC  
 1000  
 
BAC-516-P 
(FAM)-TGC CAG CAG CCG 
CGG TAA TAC-(BHQ-1) 
 200 [102] 
Clostridium 
cluster IV 
sg-Clept-F GCA CAA GCA GTG GAG T 239 400   
 sg-Clept-R3 CTT CCT CCG TTT TGT CAA  400 [96] 
 
Clept-P++ 
(FAM)-AGG GTT GCG CTC 
GTT-(BHQ-1) 
 200 This study 
++ position of target site (numbering corresponding to E . coli 16S rRNA gene) 1082 to 
1107. 
 
Table 2: Primers applied for PCR-DGGE fingerprinting of 16S rRNA coding regions. 
Target Primer Sequence (5’-3’) Ann.tem Reference 
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organism pairs p 
(°C) 
All bacteria 27f 
GTGCTGCAGAGAGTTTGATCCT
GGCTCAG 
57 [103] 
 985r GTAAGGTTCTTCGCGTT 57 [104] 
 341f-GC CCT ACG GGA GGC AGC AG 55 [63] 
 518r ATT ACC GCG GCT GCT GG 55 [91] 
Bacteroides 32f AACGCTAGCTACAGGCTT 56 [97] 
 708r CAATCGGAGTTCTTCGTG 56 [97] 
bifidobacteria g-BifidF CTCCTGGAAACGGGTGG 58 [105] 
 g-BifidR GGTGTTCTTCCCGATATCTACA 58 [105] 
Clostridium 
cluster IV 
sg-Clept-
F-GC 
See table 1 55 [129] 
 
sg-Clept-
R3 
See table 1  [129] 
 
 
 55 
 
 
Figure 6: Proportions of Bacteroides, bifidobacteria and Clostridium cluster IV of the 
total bacterial load in stool samples of vegetarians and omnivores [130]. 
 
 
Figure 7: PCA of DGGE fingerprints of 16S rRNA coding regions of dominant bacteria, 
Clostridium cluster IV, Bacteroides and bifidobacteria in faecal samples.  
, omnivores; , vegetarians 
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Figure 8: PCR-DGGE bandpatterns of 16S rRNA coding regions of Clostridium cluster IV 
amplified with primer pair sg-Clept-F-GC/sg-Clept-R. Bands that were observed more 
frequently in omnivores than in vegetarians are indicated with a black box. 1: 94.7% 
similarity to Clostridium sp. BI-114T and 97.9 % similarity to uncultured bacterium 
DQ793301; 2: 96.7 % similar to Faecalibacterium prausnitziiT and 99.5 % to 
Faecalibacterium prausnitzii AJ270469 1: Clostridium sp. BI-114T (similarity 94.7%) and 
uncultured bacterium DQ793301 (similarity 97.9 %) [130]. 
, omnivores; , vegetarians; REF, reference lane 
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4.4 Discussion 
 
Vegetarianism has been frequently associated with a decreased risk for different 
diseases. Therefore, we want to see how vegetarian diet influences the human 
intestinal microbiota. In this study we could show that vegetarian diet has an effect, 
especially on Clostridium cluster IV. 
We found in vegetarians 19 % higher counts of bacterial DNA than in omnivores. 
Stephen et al showed in his study that a decreased transit time of stool is significant 
correlated to a higher bacterial cell mass [131]. We could confirm with our 
questionnaire that vegetarians have a higher dietary fibre intake, which leads to a 
decreased transit time [132]. We suppose that the higher counts of bacterial DNA in 
vegetarians may be attributed to that fact. 
Furthermore, we could see a tendency for higher proportions of Bacteroides and 
lower proportions of Clostridium cluster IV in faecal microbiota of vegetarians 
compared to omnivores. Bacteroides can utilize a wide variety of carbon sources, and 
they account for the majority of polysaccharide digestion in the large intestine [133] 
[134]. Nevertheless, members of Clostridium leptum subgroup have the same ability. 
One explanation could be that may dietary fibre enhance the development of 
Bacteroides more. 
Clostridium cluster IV and Bacteroides also play an important role in the hydrolysis and 
fermentation of endogenous mucins and probably dietary protein, as well as in the 
conversion of bile acids and the production of toxins [134] [135] [136]. Mueller et al. 
detected in a cross-sectional study the highest levels of the Clostridium cluster IV in 
their Swedish study population, whose dietary habits were characterized by a high 
consumption of fish and meat [109]. Therefore, we suppose that higher meat 
consumptions may increase the abundance of the Clostridium leptum subgroup in the 
gut microbiota. A higher prevalence of this subgroup was discussed to be associated 
with obesity and cancer [111] [125], where also increased diversity was observed.  
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PCR-DGGE fingerprinting of dominant bacteria and Clostridium cluster IV indicated a 
grouping of vegetarians and omnivores in our study. Clustering of Clostridium cluster 
IV fingerprints might be due to the observation that two sequences identified as 
Faecalibacterium sp. and Ruminococcus sp. were more prevalent in omnivores than in 
vegetarians. As this two subspecies are known as dietary fibre degraders we did not 
expect this finding. Two possible explanations for this observation may be the before 
discussed fact of a higher meat consumption or the very complex network of cross-
feeding species. However, certainly further investigations have to be done to clarify 
this aspect.  
Despite of enormous interindividual variations a tendency for smaller proportions of 
Clostridium cluster IV in vegetarians was observed. This might suggest a smaller 
capacity for energy harvest from food in vegetarians. Higher proportions of fibrolytic 
Bacteroides were found and might compensate for reductions in Clostridium cluster 
IV. This shift in these nutritionally important bacterial subgroups might account for the 
distinct grouping of omnivores and vegetarians in PCA of dominant bacterial 
fingerprints. Summarizing, it remains to be determined if these shifts result in 
differential metabolite profiles that might in turn affect host metabolism and disease 
risks.  
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5 microbiota analysis in immunocompromised patients under 
chemotherapeutic intervention 
 
5.1 introduction 
To prevent the invasion of endogenous bacteria from oral cavity and the 
gastrointestinal tract, three defense mechanisms are considered to be relevant: innate 
immunity, mechanical mucosal barrier, and colonization resistance [137]. However, 
chemotherapy and the use of antibiotics damage the rapidly generated mucosal cells 
of the gastrointestinal tract and disrupt the ecological balance, allowing pathogens 
such as Clostridium difficile to grow [138, 139]. This bacterium is thought to be the 
causative agent in up to 20% of antibiotic-associated diarrhea (AAD) cases [140]. It is 
evident that the intestinal microbial ecosystem has an important but incompletely 
defined role in mucosal protection [141]. 
Mucositis is a major oncological problem, caused by the cytotoxic effects of cancer 
chemotherapy and radiotherapy. Approximately 40% of patients receiving standard 
dose chemotherapy and up to 100% of patients receiving high dose chemotherapy 
and stem cell or bone marrow transplantation suffer from abdominal pain, ulceration, 
bloating and vomiting [142-145]. Although gastrointestinal disturbances (mucositis, 
diarrhoea and constipation) and immunosuppression are well recognised side-effects 
of cancer treatment, very little research has been conducted into the underlying 
mechanisms and the changes in the composition of the microbiota. Because of these 
changes, nutrient absorption and other intestinal functions involving the microbiota 
may also be altered [146]. 
For this reason, we investigated shifts in faecal microbiota of patients receiving cancer 
chemotherapy with or without antibiotics in comparison to healthy control 
individuals. We sampled at four time points before or after chemotherapy to study 
changes in faecal microbiota over the course of time. In this study we aimed to clarify 
how chemotherapy agents influence faecal bacteria, Bacteroides, bifidobacteria, 
Clostridium cluster IV, Clostridium cluster XIVa and C. difficile using culture-
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independent methods assessing abundance and diversity. Furthermore, we 
hypothesize that the human faecal microbiota is resilient in its ability to return to its 
original composition after cycles of chemotherapy. 
 
5.2 material and methods 
 
5.2.1 Study participants and study design 
Eleven subjects receiving chemotherapy with or without antimicrobial therapy (aged 
55 ± 14 years, BMI 28 ± 7) from the Sozialmedizinisches Zentrum Ost in Vienna and 
nine healthy individuals (aged 55 ± 21 years, BMI 24 ± 5) joined this study. Faecal 
samples of each ambulant oncology patient were collected at four time points within 
two weeks before and after the onset of treatment. Two out of eleven patients had 
never received any chemotherapy before, while the others had a history of 
chemotherapy. One subject receiving chemotherapy additionally suffered from 
rheumatism while another subject suffered from diabetes mellitus type II, 
hypertension and obesity. Anonymous medical records reported types of malignancies 
as well as chemotherapeutic and antimicrobial treatment. Four individuals suffered 
from a form of leukaemia, three patients suffered from a form of lymphoma (non-
hodgekin). Other malignancies were breast cancer, bladder cancer ovarian 
arrhenoblastoma and multiple myeloma. Among the chemotherapeutic regimens 
were bendamustin, bortezomib, cytarabin, dexamethosane, doxorubicin, etoposid, 
gemcitabine, idarubicin and melphalan. Leukaemia patients furthermore received G-
CSF (neupogen) and/or radiated erythrocyte concentrate. 
Stool samples of healthy individuals were collected once. Study populations were 
gender balanced, with 55% females in both oncology patients and healthy controls. 
We interviewed all study participants assessing: age; gender; body length; weight; 
health status (chronic and acute diseases); life-style aspects such as cigarette and 
alcohol consumption as well as physical activity. Dietary habits were assessed using a 
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food frequency questionnaire. Exclusion criteria for healthy controls were (a) 
antimicrobial medication (b) chemotherapeutic treatment and (c) pre- and probiotics 
at least three months before sample collection. All subjects gave written informed 
consent. The ethics committee of Vienna approved the study. 
 
5.2.2 Stool sample processing 
After collection, stool samples were brought to the laboratory and immediately stored 
at -70°C. A 200 mg aliquot of each sample was treated twice for 45 s in a bead-beater 
(Mini-Beadbeater-8). Thereafter DNA was extracted using the QIAamp® DNA Stool 
Mini Kit (QIAGEN) following the manufacturer’s protocol. Finally we stored the DNA at 
-20°C until analysis. 
 
5.2.3 Type strains 
We used type strains, known to be part of the human gastrointestinal microbiota and 
cloned sequences, to design a DGGE standard lane marker. Type strains Bacteroides 
thetaiotaomicron DSM 2079T, Enterococcus faecium DSM 20477T, Lactobaccilus reuteri 
ATCC 55730T, Bifidobacterium longum ssp. longum DSM 20097T, Escherichia coli IMBH 
252/07 and clones CL16 and CC34 (see below) were used creating a comparable 
standard lane marker for DGGE gels analyzing all bacteria (figure 1). 
 
5.2.4 Clone library 
To create a standard lane marker for DGGE analysis and to identify dominant 
members of the Clostridium cluster XIVa we constructed a clone library from stool 
samples. For this purpose PCR products amplified with primers 195-F [147] and Ccocc-
R [96,105] were inserted into a p-GEM Easy Vector (Promega) following the 
instructions of the manufacturer. Nucleotide sequences were corrected for primer 
and vector sequences in CodonCodeAligner (www.codoncode.com) and taxonomically 
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identified using the online tools of the ribosomal database project 
(http://rdp.cme.msu.edu/). The clone library used for creating a standard lane marker 
for DGGE analysis of Clostridium cluster IV has previously been described [126]. 
 
5.2.5 Polymerase chain reaction (PCR) 
PCR was carried out amplifying 16S rRNA gene sequences from bacteria in faecal 
samples, type strains and cloned sequences for DGGE analysis as well as for creation 
of the clone library using group-specific and kingdom-specific primers (table 1). The 
PCR reaction mixture consisted of ready-to-use mastermix (Promega) with 1.5 mM 
MgCl2, 500 nM of primers and 2 µl of template DNA. When amplifying faecal samples, 
bovine serum albumin (Fermentas) was added to a final concentration of 400µg/ml. 
We used a Robocycler (Stratagene) for all amplifications. 
 
5.2.6 PCR-DGGE-fingerprinting 
DGGE was performed as described by Muyzer et. al. [63]. Primer pairs and annealing 
temperatures to analyze the diversity of (a) bacteria, (b) Clostridium cluster IV and (c) 
Clostridium cluster XIVa are described in table 1.  
PCR products were separated by polyacrylamid gels with a denaturing gradient of 30-
60% for predominant bacteria, 30-50% for Clostridium cluster IV and 35-50% for 
Clostridium cluster XIVa. Electrophoresis was performed for 9 h at 129 V at 60°C 
(predominant bacteria), 5 h at 200V at 60°C (Clostridium cluster IV) and 7 h at 200 V at 
60°C (Clostridium cluster XIVa). We created a standard lane marker for each DGGE 
analysis assay to ensure reliable gel-to-gel comparison. These standard lane markers 
(described above) were loaded in triplicate on each gel to adjust for gradient-
variations within gels.  
Table1: 16S rRNA gene primers used for PCR-DGGE fingerprinting. 
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Target 
organism 
Primer 
pairs 
Sequence (5’-3’) 
Ann. 
temp 
(°C) 
Reference 
All bacteria 27f 
GTGCTGCAGAGAGTTTGATCCTGGC
TCAG 
57 [103] 
 985r GTAAGGTTCTTCGCGTT 57 [104] 
 
341f-
GC 
CCT ACG GGA GGC AGC AG 55 [63] 
 518r ATT ACC GCG GCT GCT GG 55 [91] 
Bacteroides 32f AACGCTAGCTACAGGCTT 56 [97] 
 708r CAATCGGAGTTCTTCGTG 56 [97] 
bifidobacteria 
g-
BifidF 
CTCCTGGAAACGGGTGG 58 [105] 
 
g-
BifidR 
GGTGTTCTTCCCGATATCTACA 58 [105] 
Clostridium 
cluster IV 
sg-
Clept-
F-GC 
GCA CAA GCA GTG GAG T 55 [129] 
 
sg-
Clept-
R3 
CTT CCT CCG TTT TGT CAA  [129] 
Clostridium 
cluster XIVa 
CcoccF-
GC 
AAATGACGGTACCTGACTAA 55 [129] 
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 CcoccR CTTTGAGTTTCATTCTTGCGAA  [129] 
GC-clamp  
CGCCCGGGGCGCGCCCCGGGCGGC
CCGGGGGCACCGGGGG 
 [63] 
 
 
5.2.7 Quantitative TaqMan-PCR 
The abundance of bacteria and bacterial subgroups was measured by 16S rRNA gene-
targeting TaqMan qPCR. Optimal annealing temperature of the PCR primer pairs and 
expected product sizes (table 2) were ascertained using a Robocycler (Stratagene), 
before the TaqMan-assay was performed in a Rotorgene 3000 (Corbett Life Science). 
We analyzed each sample in duplicate. Amplification reactions were carried out in a 
total volume of 10µl consisting of 5µl Taq-Man SensiMix DNA Kit (Quantance), 1µl of 
each primer and Taq-Man-probe (concentrations see table 2) and 10ng of bacterial 
DNA. Amplification programs included an initial denaturation at 95°C for 10 min 
followed by 40 cycles consisting of denaturation at 95°C for 30 s, annealing at 55°C 
(bacteria, Clostridium cluster IV), 56°C (Clostridium cluster XIVa), 58°C (C. difficile) or 
60 °C (bacteroides, Bifidobacteria) for 30 s and extension at 72°C for 50 s.  
We used tenfold serial DNA dilutions of type strains Bacteroides thetaiotaomicronT, 
Bifidobacterium longum ssp. longumT and C. difficile as well as the clones CL16 and 
CC34 and one faecal sample to construct standard curves for comparison of PCR 
reaction efficiencies among different experiments.  
We quantified DNA of Bacteroides thetaiotaomicronT, Bifidobacterium longum ssp. 
longumT and C. difficile, using the nanodrop method and calculated DNA copiel/µl 
through mean G+C content of each strain. Quantification of clones CL16 (Clostridium 
leptum 16) and CC34 (Clostridium coccoides 34) was done determining the numbers of 
CFU (colony forming units). Relative percentages of bacterial subgroups were 
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calculated in relation to total rRNA gene copies amplified with primer pair BAC-338-F 
and BAC-805-R [102].  
We reviewed sensitivity of PCR reactions with stepwise dilutions of standard curve 
DNA until we achieved sensitive detection levels of PCR. The specificity was confirmed 
using non-target DNA. 
 
Table 2: Primers and probes used for TaqMan qPCR quantification of 16S rRNA genes. 
Target organism 
Primer and 
probe 
Sequence (5' - 3') 
Size 
(bp) 
Conc. 
(nM) 
Reference 
Bifidobacterium spp. Forward 
primer  
GCG TGC TTA ACA CAT 
GCA AGT C 
125 300  
 Reverse 
primer  
CAC CCG TTT CCA GGA 
GCT ATT 
 300  
 
Probe  
(FAM)- TCA CGC ATT 
ACT CAC CCG TTC GCC  
-(BHQ-1) 
 150 [100] 
Bacteroides 
AllBac296f 
GAG AGG AAG GTC 
CCC CAC 
106 300  
 
AllBac412r 
CGC TAC TTG GCT GGT 
TCA G 
 300  
 
AllBac375Bhq
r 
(FAM)-CCA TTG ACC 
AAT ATT CCT CAC TGC 
TGC CT-(BHQ-1) 
 100 [101] 
All bacteria BAC-338-F ACT CCT ACG GGA GGC 468 1000  
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AG 
 
BAC-805-R 
GAC TAC CAG GGT ATC 
TAA TCC  
 1000  
 
BAC-516-P 
(FAM)-TGC CAG CAG 
CCG CGG TAA TAC-
(BHQ-1) 
 200 [102] 
Clostridium cluster 
IV 
sg-Clept-F 
GCA CAA GCA GTG 
GAG T 
239 400   
 
sg-Clept-R3 
CTT CCT CCG TTT TGT 
CAA 
 400 [96] 
 
Clept-P++ 
(FAM)-AGG GTT GCG 
CTC GTT-(BHQ-1) 
 200 This study 
Clostridium cluster 
XIVa 
195F 
GCA GTG GGG AAT ATT 
GCA 
 500 
www.micro
bial-
ecology.net
/probebase 
 
CcoccR 
CTT TGA GTT TCA TTC 
TTG CGA A 
 500 [96] 
 
CcoccP 
(6-FAM)-
AAATGACGGTACCTGAC
TAA-(BHQ-1) 
 150 [96] 
Clostridium diffficile 
CdiffF 
TTG AGC GAT TTA CTT 
CGG TAA AGA 
 1000 [100] 
 CdiffR TGT ACT GGC TCA CCT 151 1000  
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TTG ATA TTC A 
 
CdiffP 
(6-FAM)-CCA CGC GTT 
ACT CAC CCG TCC G-
(BHQ-1) 
 200  
 
5.2.8 Statistical analysis 
Statistical evaluation of differences between groups (chemotherapy and control) and 
changes within the chemotherapy group (all time points before and after 
chemotherapy) was carried out using the OriginPro version 8 (OriginLab, 
Northampton, MA). For two group comparisons of independent ordinal and interval 
values we used the two-sample-T-test and the nonparametric Mann-Whitney-U-test. 
For the analysis of related data we used the paired-sample-T-test or the non-
parametric Wilcoxon signed-rank test. P values <0.05 were considered statistically 
significant. 
We analyzed PCR-DGGE fingerprints in GelComparII (www.applied-maths.com) and 
applied principal component analysis (PCA) using the default settings in ‘R-software 
environment for statistical computing’ (www.r-project.org) until 100% variance was 
explained. Shannon and Simpson diversity indices were calculated on quantitative 
band information with the default settings implemented in the ‘vegan’ package in ‘R’. 
Shannon index is defined as H = -  pi ln pi, where pi is the proportional abundance of 
species i. For Simpson index, given as 1 - D, this is 1 - (( pi)^2), pi is the relative 
frequency of the i-th species. In short, the higher the Simpson (0-1) and Shannon 
indices are, the higher the diversity.  
 
 68 
 
5.3 Results 
5.3.1 Dietary aspects 
We assessed the participants` dietary habits using a food frequency questionnaire. All 
study participants (patients and controls) were omnivores and showed similar 
consumption patterns of liquids, alcohol, fruits, vegetables, grains and milk products. 
Healthy controls stated more frequent consumption of fruits, whole grain products 
and alcohol several times a week compared to patients receiving chemotherapy.  
 
5.3.2 Chemotherapeutic treatment with or without antibiotics decreases absolute 
bacterial numbers in comparison to healthy controls 
We investigated absolute numbers and relative percentages of bacterial subgroups to 
investigate whether chemotherapy with or without antibiotics changes the human GI 
microbiota composition in contrast to healthy individuals and over a time period. The 
ambulant patients receiving chemotherapy harboured only 25 ± 22% of the absolute 
bacterial load in their faeces compared to healthy controls and with it less 
Bacteroides, bifidobacteria, Clostridium cluster IV and XIVa. Despite high inter- and 
intraindividual variations the differences in absolute numbers of bacteria (p = 0.02), 
Bacteriodes (p=0.01), bifidobacteria (p=0.001) and Clostridium cluster XIVa (p=0.001) 
were statistically significant. Furthermore, oncology patients had less absolute 
numbers of Clostridium cluster IV, but not significantly. Abundance of all bacterial 
subgroups declined after chemotherapeutical intervention often followed by a 
rebound of bacterial abundance (figure 2).  
Subject ON007 shows a sharp decline at time point 4 of all bacteria and bacterial 
subgroups following blood stem cell transplantation and medical intervention. 
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Figure 9: Changes of PCR-DGGE fingerprinting of 16S rRNA coding regions of dominant 
bacteria after chemotherapeutic treatment. Bands that become stronger or nearly 
disappear are indicated with arrows.  
A, B, C and D, samples of ON001 after chemotherapy; E, healthy control; SL, standard 
lane. 
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Figure 10: Impact of medical treatment (chemotherapy and antibiotics) on human 
faecal microbiota. Absolute numbers of  Bacteroides (Bac), bifidobacteria (Bif), 
Clostridium cluster IV (Clept) and XIVa (Ccocc), C. difficile (Cdiff) and unidentified 
bacteria analyzed by TaqMan-qPCR [148]. 
ChT, Chemotherapy; Ab, Antibiotics; F, fever; T, blood stem cell transplantation; 
Subject ON001 received chemotherapy before first sampling. Subjects C001- C009 
represent the healthy age- and gender matched control group. 
 
5.3.3 Clostridium cluster IV and XIVa show great alterations due to 
chemotherapeutical interventions, while the geni Bacteroides and 
bifidobacteria seem to be marginally affected 
In contrast to absolute numbers in figure 2, figure 3 shows the relative quantification 
of Bacteroides, bifidobacteria, Clostridium cluster IV, Clostridium cluster XIVa and C. 
difficile as percentage of total bacterial DNA. The mean proportion of Bacteroides in 
stool samples was 27 ± 12% in chemotherapy patients and 23 ± 12% in healthy 
individuals. The mean percentage of bifidobacteria in patients was 1.17 ± 1% and 1% ± 
0.7% in controls. Patients harboured on average 16 ± 11% of Clostridium cluster IV and 
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20 ± 14% of Clostridium cluster XIVa, while controls harboured 10 ± 7% and 34 ± 22% 
of clostridial clusters IV and XIVa.  
It can be seen in figure 4A that there is a difference between the oncology and control 
group with regard to the subgroups Clostridium cluster IV and XIVa. Oncology patients 
harboured significantly more (p = 0.02) Clostridium cluster IV and less Clostridium 
cluster XIVa (p= 0,057) than healthy controls. 
 
5.3.4 Clostridium cluster IV higher before chemotherapy than after. 
Figure 4B illustrates the differences of the faecal microbiota composition before and 
after chemotherapeutic cycles. The mean percentage of Clostridium cluster IV before 
chemotherapy was 22 ± 10% compared to after chemotherapeutic cycles with 14 ± 9% 
of all analyzed bacteria. Hence, there is a significant difference (p = 0.01). The average 
amount of Bacteroides, bifidobacteria and Clostridium cluster XIVa were 30 ± 12%, 1.2 
± 1.7% and 22 ± 11% at time points before chemotherapy and 28 ± 12%, 1.6 ±1.5% 
and 24 ± 17% after chemotherapy.  
 
5.3.5 C. difficile colonization found in individuals receiving chemotherapeutic and 
antibiotic treatment 
To find out whether the chemotherapeutic and antibiotic disruption favours the 
growth of pathogens, we investigated the abundance of C. difficile. Two out of eleven 
patients (18%) receiving chemotherapy harboured C. difficile. Patient ON009 
harboured C. difficile at four time points investigated with a mean proportion of 0.4 ± 
0.7%, showing the highest level (1.22%) at sampling point 3 (highlighted in figure 3), 
when chemotherapeutic and antibiotic treatment took place. Pathogenic C. difficile 
grew up at time point 3 in patient ON011 (3.90% of all analyzed bacteria, highlighted 
in figure 3) after chemotherapeutic intervention at time point 2. 
 
 72 
 
 
 
Figure 11: Percentage of Bacteroides (Bac), bifidobacteria (Bif), Clostridium cluster IV 
(Clept) and XIVa (Ccocc), C. difficile (Cdiff) and unidentified bacteria of analyzed 
bacteria quantified by TaqMan-qPCR. Red circle indicates C. difficile. 
 
 
5.3.6 PCR-DGGE fingerprinting analysis shows decreased diversity of bacteria and 
Clostridium cluster XIVa in response to medical treatment compared to 
healthy individuals 
DGGE fingerprinting analyses of bacteria, Clostridium cluster IV and Clostridium cluster 
XIVa indicate a highly diverse dataset between individuals and uniqueness of faecal 
microbiota. The mean numbers of bands per patient receiving chemotherapy were 
21.8 ± 5 for bacteria, 9 ± 5 bands for clostridium cluster IV and of 14.9 ± 7 bands for 
clostridium cluster XIVa. DGGE profiles of healthy controls had 23.1 ± 5 bands for 
bacteria, 9 ± 5 for clostridium cluster IV and 18.9 ± 7 for clostridium cluster XIVa. The 
number of bands as well as Shannon and Simpson diversity indices (figure 5) show a 
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lower diversity of bacteria (figures 5A, 5B) and Clostridium cluster XIVa (figure 5E, 5F) 
in oncology patients. In line with increased abundance of cluster IV oncology patients 
had greater diversity of Clostridium cluster IV according to DGGE fingerprints (figure 
5C, 5D). The dataset was subjected to principal component analysis (PCA). PCA 
analysis extracts underlying components of samples according to their variance. 
Graphs A and B in figure 6 display PCA of Clostridium cluster IV fingerprints. Graph A 
shows an increase in variation in oncology patients compared to healthy controls. 
Graph B more precisely specifies that the microbiota differs before and after 
chemotherapy according to their Clostridium cluster IV DGGE fingerprints. PCA 
analysis shows increased variability in the DGGE fingerprints of individuals under 
therapy compared to healthy controls. Chemotherapy resulted in distinctive clustering 
of bandpatterns before and after chemotherapy.  
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Figure 12: (A) Relative abundances of faecal bacteria in patients receiving 
chemotherapy ± antibiotics in comparison to healthy individuals. (B) Comparison of 
samples before (bChT) and after chemotherapeutic cycles (aChT). Relative abundances 
of Bacteroides (bac), bifidobacteria (bif), Clostridium cluster IV (Clept) and cluster XIVa 
(Ccocc) are given relative to total bacteria. 
ON, oncology patient; C, healthy control; bac, Bacteroides; bif, bifidobacteria; Clept, 
Clostridium cluster IV; Ccocc, Clostridium cluster XIVa 
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Figure 13: Simpson and Shannon diversity indices derived from PCR-DGGE 
bandpatterns of 16S rRNA coding regions of (A, B) bacteria, (C, D) Clostridium cluster 
IV and (E, F) Clostridium cluster XIVa.  
ON, Oncology patients; C, healthy controls; ChT, chemotherapy 
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Figure 14: Principal component analysis (PCA) of Clostridium cluster IV DGGE 
fingerprints of 16S rRNA coding regions in faecal samples of ambulant oncology 
patient and healthy controls. 
O, oncology pateints; C, healthy control; A, after chemotherapy; B, before 
chemotherapy. 
 
5.4 discussion 
 
Chemotherapeutic and antibiotic use has both benefits and risks. Even if 
chemotherapy and antibiotics are used as life-prolonging measures for critically ill 
patients and to fight life-threatening infections, both are associated with severe side 
effects such as mucositis, diarrhoea or constipation. These side effects increase the 
cost of health services, and are often life-threatening [144]. Chemotherapeutic and 
antibiotic treatment has a detrimental impact on the host microbial ecosystem, which 
is important for host mucosal protection [141] and thereby increases the risk of 
infection [137]. Overgrowth of species with potential pathogenicity such as toxigenic 
C. difficile and inflammatory complications are among the most common serious 
complications of chemotherapy and antibiotic treatment among patients with cancer 
[138, 137]. 
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In this study, we investigated how the use of cancer chemotherapy mostly with 
antibiotic treatment perturbs the faecal microbial ecosystem during the course of 
therapy. We assessed if the microbiota is able to return to its original profile after 
chemotherapeutic and antibiotic intervention with special interest in the abundance 
of C. difficile. We used a combination of molecular methods to compare abundance 
(qPCR) and diversity (PCR-DGGE) of bacteria, Bacteroides, bifidobacteria, Clostridium 
cluster IV, Clostridium cluster XIVa and C. difficile between groups and different time 
points of chemotherapy.  
As mentioned above, we used faeces as source of information. Faecal microbial 
communities are composed of autochthonous gut members and by transient bacteria. 
Even though the analysis of faecal samples may overestimate the actual composition 
of the GIT microbiota of humans we chose faecal samples to investigate the microbial 
composition of the intestinal microbiota because they are easy to collect, do not 
involve any ethical issues and reflect shifts in microbial population composition [149]. 
In this study we used type strains Bacteroides thetaiotaomicronT, Bifidobacterium 
longum ssp. longumT and C. difficile as well as the clones CL16 and CC34 for 
quantification of faecal microbiota. However, a mixture of different strains for qPCR 
standards would show a better image of the human microbiota. Therefore absolute 
amounts should be considered as semiquantitative. 
The majority of previous studies on the effect of chemotherapy on human faecal 
microbiota used standard microbiological culture techniques [139, 144]. While other 
studies focused on the colonization with pathogenic bacteria [137, 150] among 
patients with cancer and chemotherapy-induced diarrhea [151, 144], to our 
knowledge, we are the first to show changes in faecal bacteria, Bacteroides, 
bifidobacteria, Clostridium cluster IV, Clostridium cluster XIVa populations in addition 
to C. difficile analysis. However, the results of our Bacteroides analysis are not in 
agreement with the results of Nyhlèn et al., 2007 [139] who showed increased counts 
of Bacteroides spp. of samples obtained during chemotherapy, but with the microflora 
stable in most patients. Discrepancies in changes of the Bacteroides abundance might 
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be due to differences in detection techniques. Nyhlèn et al. also reported significantly 
increased counts of yeast in patients, making it a focus for further research in 
immunocompromised patients. 
Our results indicate significant effects of chemotherapy and antibiotic treatment on 
intestinal microbiota. Despite high individual variations, we show a significantly lower 
absolute bacterial load in faeces of patients receiving chemotherapy in comparison to 
healthy controls. These findings are in line with data from van Vliet et al, 2009, who 
reported 100-fold lower total bacterial numbers during chemotherapy treatment than 
in healthy controls. In addition to lower abundance of bacteria and determined 
bacterial subgroups, PCR-DGGE fingerprints indicate lower diversity of bacteria and 
Clostridium cluster XIVa in oncology patients. The abundance of faecal microbiota 
decreases after cycles of chemotherapy. After the end of chemotherapeutic 
administration the bacterial abundance recovers within a few days sometimes even 
showing a “rebound-effect”. Relative numbers of Clostridium cluster IV and XIV show 
great alterations due to chemotherapeutical interventions, while the genera 
Bacteroides and bifidobacteria seem to be less affected. Interestingly, oncology 
patients harboured significantly more Clostridium cluster IV at higher diversity 
compared to healthy controls. This suggests that this class of bacteria is less 
susceptible to disruption by chemotherapeutic intervention. The incidence of C. 
difficile in subjects ON009 and ON011 is accompanied by a decrease of the genera 
bifidobacteria and Clostridium cluster IV. Further research is needed to elucidate if 
there is a causal relationship between growth of C. difficile and decreased abundance 
of bifidobacteria and Clostridium cluster IV. 
Species richness was assessed using PCR-DGGE fingerprinting. Each lane of a PCR-
DGGE gel represents a microbial fingerprint of a faecal sample; each band within a 
lane corresponds to one bacterial species, although different species may sometimes 
be represented by the same band [137]. It has also been observed that one bacterial 
strain may form several bands due to multipe 16S rRNA operons eg Escherichia coliT 
(FIG. 3). The limitations of DGGE in microbial analysis have been previously described 
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[98]. Nevertheless, substantial information about species composition can be 
obtained from very complex microbial communities such as the gut microbiota [98].  
The oncology patients assessed here suffered from a variety of malignancies and 
received different chemotherapy treatment regimes. Only two participants (ON001 
and ON008) had never received any cancer therapy before, while all others had a 
history of chemotherapeutic treatment. Therefore we could not hypothesize changes 
due to the beginning of the treatment. Most cancer patients also receive antibiotics. 
Microbial profiles were similar in individuals under chemotherapy regardless if they 
received antimicrobial treatment or not. The effects on the intestinal microbiota 
described here are thus unlikely to be due to antibiotics alone. Van Vliet et al. [137] 
tested the effect of chemotherapy in vitro and showed a direct bacteriostatic effect of 
chemotherapeutics on bacterial growth.  
Further research is needed to show whether changes in bacterial colonization play a 
role in the development and maintenance of mucosal barrier function, infection and 
inflammation. 
The use of prebiotics, probiotics and bacterial products, such as butyrate to prevent 
mucosal barrier injury and its complications could be a promising concept in restoring 
impaired functions or enhancing specific desirable functions of the microbiota [126]. 
The use of pro- and prebiotics to affect the composition and metabolic activity of the 
faecal microbiota in times of cancer chemotherapy and immunosuppression might be 
part of future research.  
In conclusion, chemotherapy treatment causes changes in faecal microbiota, which 
coincides with the development of C. difficile infection in some patients. These 
changes in microbiota may have systemic effects and may contribute to the 
development of chemotherapy-induced mucositis, influencing important beneficial 
functions of the microbial ecosystem.  
 
 80 
 
5.5 Acknowledgements 
I cordially thank the participants of the study and Elvira Kitzweger of the 
Sozialmedizinisches Zentrum Ost, Vienna. Furthermore I would like tothank my 
collegues at the Department of Nutritional Sciences, especially Mag.Cornelia Lassl; 
Dr.Viviana Klose and Mag.Verity-Ann Sattler of the IFA Tulln, Mag. Ewald Denner of 
the Institute for Bacteriology and Hygiene of the Veterinärmedizinische Universität 
Wien and Dr. Konrad Domig for their kind support. This study was funded by the FWF, 
Vienna, Austria. 
 
 81 
 
6 analysis of functional genes involved in butyrate production, and 
SCFA quantification 
 
6.1 introduction 
The indigenous microbiota in the mucosa, lumen and faeces of the human 
gastrointestinal tract (GI) is extremely complex with 300 to 1000 different species per 
individual. The number of microbial genes in the GI tract is between 2 million and 4 
million, representing an enormous metabolic potential far greater than that of its 
host. The GI tract is a very dense ecosystem composed of up to 1014 bacteria/ml. The 
number of viable bacteria and species diversity differs at different sites of the GI tract 
[152]. The community composition differs also among human subjects [6] and is 
influenced by diet- related behaviours [153], health status, age [92] as well as genetic 
factors [154]. 
The most frequently encountered organisms in the human GI tract belong to non-
sporulating anaerobic species mainly of the genera Bacteroides, Bifidobacterium, 
Clostridium, Eubacterium and Ruminococcus. Species of this group of GI bacteria 
produce particularly high amounts of short-chain fatty acids (SCFAs) from the 
breakdown of dietary carbohydrates (quantitative primary SCFA progenitors), protein, 
peptide and glycoprotein precursors [155]. 
Human colonic butyrate producers use butyrylcoenzyme A CoA transferase [156] for 
the last step of butyrate formation. A novel CoA-transferase gene is described for the 
colonic bacterium Roseburia sp. A2-183, with similarity to acetyl-CoA hydrolase as well 
as 4-hydroxybutyrate CoA-transferase sequences. 
SCFAs produced by resident bacteria include acetate, propionate and butyrate, which 
are biologically active compounds [155]. Cell culture studies have indicated that 
butyrate at physiological concentrations enhances the growth of normal enterocytes 
and inhibits colon cancer cells [157]. Butyrate may have an anticarcinogenic and anti-
inflammatory potential, affect the intestinal barrier and play a role in satiety and 
oxidative stress [158, 159]. Butyrate induces apoptosis in colorectal tumour cell lines, 
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reduces metastasis, and protects from genotoxic carcinogens by enhancing expression 
of phase II detoxification enzymes [160]. Acetate and butyrate promote methane 
production by GI Archaea. The formation of propionate is considered as a competitive 
pathway for hydrogen use by methanogens [161]. Organic acid degradation depends 
on the presence of syntrophic consortia of acetogenic bacteria and methanogenic 
Archaea [162]. The predominant archeaon, up to 11,5% of total human GI microbiota, 
is Methanobrevibacter smithii [6, 163]. Because of the rather low consumption of 
fermentable dietary fibers in today’s Central European diet, the microbial diversity in 
the lumen may vary, and with that the butyrate concentrations. 
We recently showed differences between the microbiota diversity in vegetarians and 
elderly compared to those consuming a mixed (omnivore) diet [126, 164]. 
Based on these results we analysed human faeces specimens of young healthy 
individuals with omnivore or vegetarian diets as well as institutionalized elderly by 
HPLC-RI and TaqMan real-time PCR to determine SCFAs content, microbiota diversity 
and butyryl-CoA CoA-transferase gene abundance. To assess a possible correlation 
between butyryl CoA CoA transferase gene abundances and the presence of Archaea a 
relative quantitation of archaeal 16S rRNA gene sequences was done. 
 
6.2 material and methods 
6.2.1 Study subjects: 
Group of individuals and sample material used in this study were the same as that 
used by Zwielehner et al. and Liszt et al. [126,164]. The geriatric group (elderly) 
consisted of 17 institutionalized subjects (age: 86 ± 8 yrs / BMI 21.75  5.08) from a 
geriatric department in Vienna. The vegetarian diet group (vegetarian) consisted of 16 
young healthy subjects with a vegetarian or vegan diet (age: 26 ± 5 yrs/ BMI 21.02 ± 
2.71). Seventeen young healthy subjects (age: 24 ± 2.5 yrs/BMI 22.68  3.4) with a 
Central European diet formed the mixed diet group (omnivores). 
 83 
 
All volunteers were interviewed using a questionnaire assessing: age, gender, body 
height, weight, individual health status (including chronic or acute diseases and blood 
lipid levels), life-style aspects such as physical activity and dietary habits. Group 
populations were gender balanced. Only non-pregnants and probands without 
digestive/gastrointestinal symptoms and no antibiotic or chemotherapeutic treatment 
up to three months prior to sampling participated on this study. All probands agreed 
to participate in the study and gave their informed consent. Approval was obtained 
from the viennese Human Ethics committee (Vienna 3., Thomas-Klestil-Platz 8/2).  
 
6.2.2 Sample material 
Faeces was collected from each proband individually and stored at -18°C until 
processed. For molecular genetics samples were kept frozen. For HPLC-based analyses 
sample material was defrosted at room temperature. 
 
6.2.3 Quantification of specific metabolic genes and archaeal 16S rRNA gene by 
real-time PCR (qPCR) 
Three different degenerated primer pairs were applied to cover the CoA-transferase 
gene in common gut bacteria [156]. The CoACT primer pair targets butyryl-CoA CoA 
transferase genes of Roseburia sp. A2-183, Desulfitobacterium hafniense 
(ZP_00098805, ZP_00099788), Clostridium kluyveri (P38942), Clostridium tetani 
(NP_781174), Archaeoglobus fulgidus (NP_069974) and Yersinia pestis (NP_405485); 
e.g. for CTFB primer pair: Clostridium beijerinckii (AF157306_3), Streptococcus 
pyogenes (NP_268527, NP_269686), Streptomyces coelicolor (T35020), Streptomyces 
sp. (T47110), E. coli (NP_416726) and Haemophilus influenzae (NP_438932). The PCT 
primer pair targets butyryl-CoA CoA transferase genes of Clostridium perfringens 
(NP_561012), C. tetani (NP_781170, NP_781374), Bradyrhizobium japonicum 
(NP_767528), Listeria innocua (NP_471607) and Fusobacterium nucleatum 
(NP_603711). A ramped annealing approach was chosen for amplification of specific 
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metabolic genes. Primer sets are given in Table 1. Initial denaturation for 10 min at 
94°C, then 35 cycles of denaturation for 30 s at 94°C, annealing with 20 s at 55°C, 5 s 
at 50°C, 5 s at 40°C, elongation for 1 min at 72°C, and a final extension for 5 min at 
77°C. Archaeal 16S rRNA gene sequences were amplified with a TaqMan qPCR as listed 
in Table 1. Conditions (primer and probe concentration 4 pmol): initial denaturation 
for 8 min at 95°C, 35 cycles of denaturation for 20 s at 95°C, annealing at 20 s at 57°C 
and extension for 20 s at 72°C, a final elongation for 1 min at 72°C. The different 
primer sets were applied to stool DNA samples. Quantification of PCR products was 
performed spectrophotometrically by using the Nanodrop method (NanoDrop 
Technologies, Inc.). PCR products served as standards for absolute and relative 
quantitation in qPCR analyses. Archaea were quantified using a PCR product from one 
of the samples was as a standard. 
 
Table 1: Primers and probes used for quantification 
 of CoA-transferase gene sequences and 16S rRNA genes of Archea 
Target 
organism/gene 
Primer /Probe Sequence (5`-3`) Reference 
CoA Transferase 
based on: Roseburia 
sp. A2-183 CoATD for AAGGATCTCGGIRTICAYWSIGARATG [156] 
 CoATD rev GAGGTCGTCICKRAAITYIGGRTGNGC   
CoA Transferase 
based on: C. 
acetobutylicum CTFB for GTAAACTTIGGIRTIGGIYTNCCNAC [156] 
 CTFB rev AACAGTAACATCIAYRTGICCNCCNC   
CoA Transferase 
based on: C. 
perfringens PCT for GTAGGATTARRIACITWYRTIGAYCC [156] 
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6.2.4 Determination of SCFAs by HPLC 
Concentration of SCFAs in faecal specimens were measured according to the method 
of Huel-Mel Chen et al.1998. Briefly, 3 g defrosted faeces was homogenised for 2 
minutes in 20 ml of 0.15 mmol l-1 H2SO4 in bidest-water using a Stomacher Lab-Blender 
400 (Carl Roth GmbH, Germany). The homogenate was centrifuged at 6000 x g at 2 °C 
for 60 min. The supernatant fluid was then filtered twice through a micro filter syringe 
with 0.22 µm. The filtrate received no further treatment and was directly injected into 
the HPLC. 
The HPLC apparatus (Dionex 3000) consisted of a mobile phase reservoir; a Dionex ICS 
3000 sp pump; an automatic sample injector, Dionex AS; a MetaCarb 67H organic acid 
chromatographic column, 300 mm; a temperature control module; a refractive index 
detector; a chromatography control station and a system interface module. The 
mobile phase was a 0.005 mMol solution of “ultra pure” sulphuric acid (VWR, Austria) 
in Milli-Q purified water (pH 3.1, background conductance <100 MS), filtered through 
a 0.2 µm (Herba Chemosan, Austria) membrane and degassed before use. Separation 
of SCFAs was best at a flow rate of 0.8 ml/min and a column temperature of 36 °C. To 
regenerate the column, the column temperature was increased to 65 °C while washing 
with 25 mmol l-1 ultra pure sulphuric acid at a flow rate of 0.8 ml min-1 for 2 h. 
Calibration of the system based upon the average of five measurements of each 
reference compound (Table 2).  
 
6.2.5 Data analysis and statistics 
Statistical analyses including mean, standard deviation and coefficient of variation (F-
test) was applied to the data using the OriginPro8 data analysis and graphing 
 PCT rev TCCACCACCATCRTARSARTCRAAYTG   
Archaea ARC787F  ATTAG ATACC CSBGT AGTCC [102] 
 ARC915R AGGAA TTGGC GGGGG AGCAC  
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software. Results for each group were normally distributed (Kolmogorov-Smirnov 
test). A two sample t-test was performed with OriginPro8. Correlations were 
calculated using Pearson’s linear regressions model and Spearman’s rank (OriginPro8). 
Data analysis of Ct values and comparative correlation results were calculated using 
Rotor-Gene 3000TM real-time analysis software system (Corbett Research, Australia) 
and transferred to Microsoft Excel. Food frequency data collected with a food 
frequency questionnaire was analysed using the Chi-square approximation as 
implemented in the Statistical Package for the Social Sciences SPSS release 15.0 (SPSS 
Inc., USA). Feaces samples were analysed in duplicates, p>0.05 was considered as 
significant. 
 
6.3 results 
6.3.1 Dietary analysis 
Exercise levels (vegetarians to omnivores) were comparable. Analysis of the 
participant’s dietary habits indicated similar consumer behavior in the respect of fruit 
and milk products in the individual groups. Omnivores stated significantly less 
frequent (Chi2 Test; p<0.027) consumption of vegetables than vegetarians. Three of 
the vegetarian probands assessed followed a vegan diet; all others followed a lacto-
ovo vegetarian diet. The omnivore group stated significantly less frequent (Chi2 Test; 
p<0.04) consumption of meat than elderly probands and regular consumption of 
whole grain products several times a week. The elderly of this study did not consume 
any whole grain products at all but received supplements with soluble fibre 
(Benfiber , Novartis). 
 
6.3.2 Detection of butyryl-CoA CoA-transferase in faeces by RT-PCR 
Applying the CoATD primer set (Figure 1), vegetarians had 7.46 x 108 ± 2.29 x 108 
copies-µl; omnivores 5,26 x 108 ± 2,38 x 108 copies-µl and elderly 5.26 x 108 ± 2.38 x 108 
copies- of the butyryl-CoA CoA-transferase. Quantification with a CTFB primer yielded 
 87 
 
a gene abundance of 4.12 x 108 ± 1.81 x 108 copies-µl in omnivores, 4.6 x 108 ± 2.51 x 
108 copies-µl in vegetarians and 3.7 x 108 ± 1.89 x 108 copies-µl in elderly. Applying the 
PCT primer pair, abundances of 8.61 x 108 ± 3.12 x 108 copies-µl in omnivores, 8.53 x 
108 ± 5.28 x 108 copies-µl in vegetarians and 6.55 x 108 ± 4.73 x 108 copies-µl were found 
in elderly (figure 3).  
 
6.3.3 Content of SCFAs in faeces as determined by HPLC 
Faecal concentrations of butyrate in specimens ranged from below detection limit up 
to 0.094 µmol g-1 faeces (wt/w). The average value for omnivores was 0,023 µmol g-1 ± 
0,027 µmol g-1 faeces, for elderly 0,007 µmol g-1 ± 0,011 µmol g-1 faeces and for 
vegetarians 0,008 µmol g-1 ± 0,008 µmol g-1 faeces. Butyric acid concentrations found 
in the faeces of omnivores were highest among all individuals. In spite of high inter-
individual differences these values were significantly different from butyrate in faeces 
of elderly (p= 0.04). 
 
6.3.4 Relation of specimen specific Archaea  
Analysis of 16S rRNA genes showed that Archaea were nine times more abundant in 
Omnivores than in Vegetarians. Elderly harboured 2.8 times more Archaea than 
Vegetarians. These differences were not significant due to high inter-individual 
variance.  
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Figure 15: Butyrate-CoA CoA transferase gene abundance as assessed with the CoATD 
primer pair. The boxplot shows median ± standard deviation [218]. 
 
 89 
 
 
Figure 16: Short chain fatty acid concentrations measured with HPLC [218].  
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Figure 17: concentration trends in 100% total of each measurement of specific 
bacterial relation, Archeae concentration, Butyric Acid Concentration and butyrl-CoA 
CoA-transferase gene abundance for Vegetarians, Omnivores and Elderly [218]. 
 
6.4 discussion 
Production and consumption of SCFAs is associated with GI microbiota diversity that is 
influenced by diet, age, activity and other lifestyle as well as host genetic factors. It 
was previously reported [126,164] that vegetarians have 12% more and elderly 31% 
less bacterial DNA in their faeces than omnivores, as shown in Figure 3. Clostridium 
cluster IV was not significantly different for vegetarians compared to omnivores. 
Elderly had significantly less Clostridium cluster IV compared to both other groups. 
Bacteroides abundance was significant higher in vegetarians. 
To study the effects of microbiota changes on metabolites, such as SCFAs, we 
compared SCFAs in faeces using HPLC-RI, and quantified Butyryl-CoA CoA transferase 
genes using degenerated primer pairs in real-time PCR. Archaea were quantified as 
potential consumers of fermentation products. 
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6.4.1  CoA-transferase genes, SCFAs and Archaea in tested specimen groups 
The major differences observed between the measured groups (omnivores, elderly 
and vegetarians) were the low level of butyrate in faeces of vegetarians compared to 
omnivores as seen in Figure 3c. However, the CoATD primer set amplification of 
butyrate genes was highest in vegetarians (Figure 3d). This unexpected finding might 
be attributable to a higher abundance of Bacteroides, one of the main SCFAs 
producers in the human gut, and a higher abundance of bacteria in vegetarians [164] 
(figure 3a) assuming that the bacterial surplus in those individuals carries genes that 
are amplified by this primer pair. Elderly had low levels of butyrate and low butyrl-CoA 
CoA-transferase gene abundance, but showed the highest levels of acetate among all 
subjects. Zwielehner et al. [126] reported the microbiota of elderly to be less diverse 
and less densely populated. Apparently the loss of diversity in the microbiota of 
elderly markedly affected the SCFA production, in spite of high functional redundancy 
in the human GI microbiome [165]. 
Furthermore previous work carried out by our group showed that vegetarian’s species 
composition of the Clostridium cluster IV differed from the one found in omnivores 
[164]. Adult omnivores are reported to consume 103 g meat day-1, 60 g more than 
recommended. Elderly Austrians are reported to consume 78 g meat day-1. The overall 
protein uptake in vegetarians matches the D-A-CH recommendations of 0.8 g kg-1 
body weight [166]. In contrast to protein, carbohydrates are fermented completely 
and thus lead to a high SCFAs abundance and high amounts of hydrogen and carbon 
dioxide, which are reduced by Archaea [52]. Up to 10% of all anaerobes in the colon in 
up to 85% of healthy adults are Archaea [167, 168]. The incidence of Archaea was 
highest in omnivores (Figure 3b). Similar to findings by Armougom et al. [167] we also 
found high concentrations of propionate in persons with high number of Archaea. Low 
levels of propionate in vegetarians might lead to low availability of hydrogen and thus 
may lead to a reduction of the archaeal gut population. In faeces of vegetarians the 
lowest archaeal 16S rRNA gene and the highest butyryl-CoA CoA transferase gene 
abundances were observed. Elderly were in between omnivores and vegetarians. The 
targeted genes might not be equally expressed in all individuals and the butyrate 
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could be removed from the gut lumen by the gut mucosa and microorganisms. 
Furthermore not all bacteria might use the targeted gene butyryl-CoA CoA transferase 
in the final steps of butyrate production and the three primer pairs might not cover all 
butyrate producing bacteria [156]. There was an enormous variability among elderly 
individuals with their data points being distributed within the ranges of young 
vegetarians and omnivores. One explanation might be a highly variable dietary 
behaviour throughout their lives, in some persons being predominantly vegetarian 
and in others truly omnivore. All subjects in the group “elderly” received prebiotic 
supplementation. 
 
6.4.2 4.2. Methodological Aspects 
qPCR for CoA-transferase genes 
Targeting metabolic genes rather than ‘molecular clock’ genes such as the 16S rRNA 
gene is a growing research need but we still lack whole genome sequences of bacteria. 
Furthermore, not all bacteria use the same gene locus for the same metabolic task. In 
spite of these limitations degenerate primers for the CoA-transferase gene of 
Roseburia sp. A2-183 were designed by Charrier et al. [156]. The authors also analyzed 
the specificity of primers for different strains, as summarized in methods. As 
degenerate primers are mixtures of similar, but not identical, primers the specificity of 
the PCR amplification can be reduced. To avoid unspecific binding a ramped annealing 
approach was chosen. The specificity of the primer pairs was tested in qPCR by 
comparing the melt curve peaks to a negative control (Bacteroides tethaiotaomicron 
DSM 2079) and a positive control standard (specimen PCR product, including all 
identical target butyryl-CoA CoA transferase gene regions). However, the three primer 
pairs used do not cover all butyrate production genes in exist, as described in Charrier 
et al. [156] because not all bacterial butyryl CoA transferase gene loci are known. 
 
HPLC analysis of SCFAs in faeces 
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The RI detector and the organic acid chromatographic column have regularly been 
used to measure SCFAs. Limited specimen volumes, their dilution and preparation 
influence detection limits. Weaver et al. [169] describe butyrate concentrations in 
human faeces ranging from 11 to 25 mM and molar ratios of acetate to propionate to 
butyrate of between 48:29:23 and 70:15:15, with mean values of approximately 
60:20:20 [169,170]. We found mean SCFA ratios in omnivores to be 63:13:24 and in 
elderly to be 78:14:8. Vegetarians differed considerably from these values with molar 
ratios of 72:15:13. However, the in situ production of total colonic SCFAs is difficult to 
determine because more than 95% of the SCFAs are rapidly absorbed and metabolized 
by the host [171]. As a consequence, faecal concentrations of SCFAs are not 
necessarily representative of those in the more proximal colon, and are also affected 
by intestinal transit time [172].  
 
6.5 Concluding remarks 
Applying molecular methods to detect specific metabolic genes with HPLC analysis of 
SCFAs and a food frequency and activity questionnaire, we obtained evidence that 
diet as well as ageing affect the human GI microbiome. How the differential SCFA 
metabolisms in individual microbiomes affect host mucosal health i.e. via epigenetic 
mechanisms remains to be determined.  
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7 Linking phylogeny with function- stable isotope probing for the 
identification of butyrate-consuming microorganisms. 
 
7.1 Introduction 
Short chain fatty acids (SCFAs) are derived from fermentation of non-digestible 
carbohydrates in the colon. The amount of SCFAs (primarily acetate, propionate and 
butyrate) produced in the colon depends on the site of fermentation, the diet and the 
composition of the residing microbiota, and can account for 5-15% of the total energy 
requirements for humans [173].  
Due to rapid absorption and metabolism of SCFAs, their concentrations in the colon 
may differ. Acetate and propionate are metabolites for gluconeogenesis in the liver 
[15]. Butyrate is the major energy source for colonocytes and is known to regulate 
various processes in the human distal gut. Butyrate may have an effect on 
inflammation [158], oxidative stress [158], intestinal barrier function [159, 174, 175], 
visceral perception and rectal compliance [176] and may play a role in satiety [177, 
178]. In vitro and animal studies showed that butyrate downregulates the expression 
of genes associated with proliferation and oxidative stress and upregulates the 
expression of Mucin associated genes (Muc 1–4), tight junction proteins (zonulin and 
occludin) and the butyrate transporter monocarboxylate transporter-1 (MCT1) [23].  
The formation of toxic products and lower availability of SCFAs in the distal colon were 
suggested to be involved in the pathogenesis of ulcerative colitis and cancer [179, 180, 
181]. In a recent genome-wide transcription study, oxidative stress related pathways 
and NFkB signalling were shown to be affected by butyrate. More specifically, the 
expression of glutathione peroxidases GPX 1 and GPX 3 and glutathione reductase 
(GSR) were upregulated in the oxidative stress pathway [23] thus offering a possible 
explanation of the health effects of butyrate. The pro-apoptotic effect of butyrate in 
colon cancer cells might be attributable to the decreased oxidation rate of butyrate in 
tumor cells, hence resulting in increased intra-cellular butyrate concentrations, 
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causing increased histone deacetylation and subsequently decreased proliferation 
[23]. Consequently, butyrate may have a positive anti-cancer effect in the colon. 
Hu et al. [182] recently reported the hypothesis that the beneficial effect of SCFAs on 
the metabolic syndrome was due to higher concentrations of SCFAs in the portal vein, 
which activates AMP activated protein kinase (AMPK) in the liver. AMPK functions as a 
major cellular fuel gauge and a master regulator of metabolic homeostasis [182]. Since 
SCFA levels in the distal colon are crucial for positive health effects, SCFA producing 
species have been in the focus of research in the past. It has previously been 
described that the colon epithelium very efficiently removes butyrate from the faecal 
stream [183]. Microbial SCFA consumption rates by the human microbiota have –to 
our knowledge- not yet been investigated in depth. 
In the environment, consumption of butyric acid has been described for river 
sediments and rice field mud [51], methanogenic sludges [184], and bioreactors by 
syntrophic consortia of acetogenic bacteria and methanogenic archaea [185-187]. 
Syntrophomonas spp., Tepidanaerobacter sp. and Clostridium sp. from cluster III and 
IV were suggested as butyrate consumers in those studies. Clostridium cluster III 
comprises the Clostridium cellobioparum, C.tremitidis, C.cellulolyticum, 
C.papyrosolvens, C.aldrichii, C.thermocellum, C.stercorarium and C.thermolacticum 
[188]. Clostridium cluster IV comprises Clostridium leptum, C.sporosphaeroides and 
C.cellulosi [188]. Zou et al [189] describe that apart from acetate, butyrate is the major 
methanogenic substrate in paddy field soils.  
Consumption of butyric acid in the colon can directly be measured by quantifying its 
levels over time. In faecal samples there is likely to be enough dietary fibre as a 
substrate for SCFA production. Butyrate production rates may exceed bacterial 
assimilation when the continuous removal of metabolites by the epithelium is not 
mimicked. Knowing which bacteria are capable of consuming butyrate will enhance 
our understanding of butyrate consumers in this system. In addition, quantification of 
microbial butyrate consumers will allow estimation of net colon butyrate production. 
Improved knowledge on metabolic capacities of the gut microbiota is needed to 
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correctly interpret individual analysis of gut microbiota composition as a basis for 
individualized dietary counseling and symbiotic supplementation.  
A direct way of linking identity of microorganisms to a specific function is stable 
isotope probing (SIP) of nucleic acids, and in particular of RNA [88, 190, 87]. Nucleic 
acid SIP capitalizes on the incorporation of heavy stable isotopes (13C, 15N, 18O) into 
RNA (or DNA). It is based on physical separation of isotopically labelled ‘heavy’ RNA 
from unlabelled, ‘light’ RNA, and the subsequent identification of actively label 
incorporating populations by cloning and sequencing of ‘heavy’ RNA.  
RNA-SIP has recently been applied in an in vitro model of the large intestine to identify 
bacterial consumers of starch and glucose [89, 90]. Barclay et al. [191] identified SIP in 
their review as a powerful technique to link the metabolic activity and diversity of 
"unculturable" bacteria in inflammatory bowel diseases. 
In this pilot study the ability of gut bacteria to consume butyric acid was assessed 
applying RNA-SIP in vitro in a stool sample of a healthy young donor. Cloning and 
sequencing of ‘heavy’ RNA was used to identify butyrate-consuming species.  
 
7.2 Material and methods 
 
7.2.1 Butyrate pulse conditions and sampling regime. 
A faecal sample was donated by a healthy young volunteer and immediately brought 
in an anaerobic chamber. The sample was divided into 0.5 g aliquots in sterile 2ml 
screw-cap tubes containing 5 sterile glass beads at 37˚C in order not to disrupt the 
microstructure of the sample. Aliquots were pulsed with 100mmol/g 13C butyrate, 12C 
butyrate or nuclease-free water. The volume of the pulse was always 500µl. At 2, 4, 8, 
12, 24 and 48h after the pulse two aliquots were removed from the anaerobic 
chamber. One aliquot was used for gas chromatography- flame ionization detector 
GC-FID analysis of SCFAs and the other one was used for RNA extraction.  
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7.2.2 GC-FID analysis of SCFAs 
Immediately after the incubation aliquots were homogenized for 10 seconds and 
stored at -80˚C upon analysis. Methylvaleric acid was added as internal standard in a 
concentration of 5µl/ sample. Supernatants were carefully thawed on ice and 
beadbeat twice at maximum speed for 90s with 1.5 intervening minutes on ice. 
Samples were centrifuged twice at 30 000 x g for 30 min at 4˚C. Supernatants were 
diluted ten fold with water and formic acid to a final concentration of 1% formic acid 
in 300µl vials. SCFAs were separated on an Alltech ATTM-1 column applying a ramped 
program 40 -180˚C at 20˚C /min. 
 
7.2.3 Nucleic acid extraction, isopycnic centrifugation and fractionation 
Immediately after the incubation, each aliquot was homogenized for 10s with 500µl 
RNAlater (Applied Biosystems) and immediately stored at -80˚C upon RNA extraction. 
RNA was extracted following a previously described protocol [192], quantified in a 
Nano-Drop Spectrophotometer (Thermo Scientific) and checked on a 1% agarose gel. 
RNA yield was 30-45 µg g-1. Extracted RNA (500ng) was density separated by isopycnic 
centrifugation in cesium trifluoroacetate [87]. Gradients of density-resolved RNA were 
fractionated, the cesium trifluoroacetate buoyant density (BD) of each fraction 
determined, and RNA precipitated from fractions as described earlier [87]. The 
fractionated centrifugation gradients from the 13C-butyrate pulse experiment covered 
an average density range of 1.819 g ml-1 (fraction 1) to 1.711 g ml-1 (fraction 14; figure 
3).  
 
7.2.4 Reverse trancriptase PCR (rt-PCR) and PCR-DGGE fingerprinting 
Fractionated RNA was reverse transcribed using and AMV transcriptase (Fermentas) 
and primer 985r [104]. cDNA was amplified using 341f [63] with a GC-clamp attached 
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to its 5’end and 518r *91+ in 100µl volumes and precipitated. PCR products were 
analyzed in DGGE applying a denaturing gradient of 30-62.5% for 12h at 100V. 
 
7.2.5 12C/13C isotope ratio mass spectrometry (IRMS) analysis 
RNA samples were prepared for isotope ratio mass spectrometry (IRMS) analysis by 
cutting with sucrose as described by Manefield et al [87] to ensure sufficient material 
for IRMS. 
 
7.2.6 Clone libraries 
Clone libraries were constructed from fraction 2 of the 13C-labelled sample after four 
hours of incubation. Amplifications were carried out using primer pair 341 and 985r 
which bind to most bacteria. Amplified products were cloned into a p-GEM Easy 
Vector (Promega) following the instructions of the manufacturer. Clone libraries were 
screened as previously described *68+. Clone inserts were sequenced by ‘DNA 
confidence’ (Vienna). Nucleotide sequences were corrected for vector and primer 
sequences in CodonCode Aligner (www.codoncode.com) and taxonomically identified 
by comparison to previously published sequences using the online tools of the 
ribosomal database project (http://rdp.cme.msu.edu/) and FASTA nucleotide 
similarity search (http://www.ebi.ac.uk/Tools/fasta33/nucleotide.html). GC contents 
were calculated using a pearl script. 
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Figure 18: Schematic diagram of the experimental setup and methods. 
 
7.3 Results 
 
To identify butyrate consuming microorganisms of the human gastro-intestinal (GI) 
tract, a faecal sample was anaerobically pulsed with 100µmol/g 13C-butyrate. Two 
controls were pulsed with either 12C-butyrate or water. Destructive sampling was 
applied in order not to disrupt the microstructure of the sample.  
 
7.3.1 GC-FID of short chain fatty acids (SCFAs) 
Initial concentrations of SCFAs in faecal supernatant were 25.4 mM acetate, 4.8 mM 
propionate, 1 mM isobutyrate, 11mM butyrate, 2.9 mM isovalerate and 1.8 mM 
valerate. The SCFAs concentrations continued to rise until the end of the incubation at 
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48h (57.4 mM acetate, 14.4 mM propionate, 5.8 mM isobutyrate, 22.2 mM butyrate, 
11.1 mM isovalerate and 5.2 mM valerate; figure 1). Butyrate concentrations reached 
a plateau at 23 mM after 4h in the untreated control sample (figure 1c). Butyrate 
concentration in the 13C-butyrate pulsed sample reached a plateau after 8h incubation 
(figure 1a). Production of SCFAs during the experiment indicates that microbes or 
microbial enzymes were still active ex vivo. The concentrations of SCFAs followed 
similar curves in experiment and controls (figure 1a, b, c). Thus the heavy pulse did 
not induce a significant disruption as compared to the control pulse to the SCFA 
producing metabolic pathways in the sample. This is an important prerequisite for all 
SIP experiments, in order not to describe a shift in microbiota composition that was 
induced by the experimental setting, having no representation in the actual 
environment studied. 
19a)  
19b)  
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19c)  
Figure 19: SCFAs in samples and controls as assessed with GC-FID.  
 
7.3.2 Reverse transcription PCR (RT-PCR) 
Reverse transcription PCR (RT-PCR) amplification of bacterial 16S rRNA fragments 
showed that all fractions of all samples, including control samples, contained RNA 
(figure 3). Thus some RNA was contained in the entire gradient. 
The intensities of individual fractions in agarose gel electrophoresis showed that RNA 
concentrations in the heavy butyrate pulse samples decreased with decreasing 
fraction densities. Highest amplicon intensities were found at densities ranging from 
1.819 to 1.788 g ml-1. A second peak became visible in fractions 12 (1.725 g ml-1) to 14 
(1.711 g ml-1). This indicated that RNA of heavy label consumers accumulated at 
higher density whereas RNA of bacteria thriving on non-labelled substrates peaked at 
lower density.  
In H2O control and 
12C-butyrate control samples the intensity of the individual 
fractions increased with decreasing fraction density (figure 3). Although there has 
been amplifiable RNA in all fractions, RNA concentrations peaked in the lighter 
fractions at densities from 1.780 to 1.718 g ml-1. In contrast to the samples pulsed 
with heavy label, RNA did not peak in the heavy fractions. This finding suggests that 
heavy label might have been assimilated in the samples pulsed with 13C-butyrate. 
After 8h of incubation the amplified 16S rRNA fragment was equally intense in all 
fractions, showing again that gradient centrifugation and fractionation did not resolve 
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RNA according to its density equally well in all samples. This is a critical source of bias; 
therefore it was indispensible to discuss the retrieved sequences with utmost 
diligence to avoid false-positive results. 
 
 
 
Figure 20: Buoyant density gradients and cDNA in fractions 2-15 in 2% agarose gels. 
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7.3.3 DGGE fingerprinting  
To compare the microbial communities in the gradient fractions from all samples, 
PCR-DGGE fingerprint analysis was applied.  
After 4 hours of incubation the bandpatterns of the heavy fractions differ from the 
light fractions. Sequences that might have been involved in butyrate consumption 
started to appear. This corroborated the incorporation of 13C-label into bacterial RNA. 
Control samples had uniform bandpatterns in all fractions as shown in figure 4. 
 
 
Figure 21: PCR-DGGE fingerprints obtained from fractions 2-16, four hours after 
incubation with 13C-label. The upper image shows the control sample. Arrows and 
numbers indicate sequences that are enriched in the heavy fractions.  
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Figure 22: PCR-DGGE fingerprints from fractions 3, 4, 9 and 10, four hours after 
incubation with 13C-label. Arrows indicate individual bands that increase in intensity in 
the heavy fractions 3 and 4. 
 
The heavy fractions 3 and 4 and lighter fractions 9 and 10 of a sample after four hours 
of incubation were run next to each other on the same gel to allow a closer inspection 
of the heavy and light fractions. 
Seven bands increased in intensity in the heavy fractions 3 and 4 compared to the 
light fractions 9 and 10. The cloned sequences corresponding to those bands are 
summarized in table 1. 
The 12C-butyrate pulsed control samples after four hours of incubation is depicted in 
figure 6. A closer inspection of the two heavy fractions 2 and 3 and two light fractions 
12 and 13 is shown in greater detail. In this 12C-butyrate control sample only three 
bands appeared to be enriched in the heavy fractions. These bands appeared only in 
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fraction number 2 and not in any of the other heavy fractions. The band indicated with 
the upper arrow had the same melting behaviour as clone 20. 
 
Figure 23: PCR-DGGE bandpattern of fractions 2 to 15 of the control butyrate sample 
after four hours incubation. Light and heavy fractions indicated with rectangles are 
shown in the center for better comparison. 
 
Fraction 2 of the sample incubated for 4h with heavy butyrate was used for the 
construction of a clone library. Aeveral sequences were cut out in parallel and 
reamplified for identification. Sequences that are enriched in the heavy fractions are 
indicated with arrows in figure 3. Table 1 shows their similarities to previously 
described sequences. G+C content in this dataset ranged between 48.8 and 60% 
(average 54 ± 3.5%, median 53.55%). These values were compared with G+C contents 
in a 16S rRNA dataset (full sequences) obtained in 2005 by Eckburg et al. [54]. In the 
Eckburg dataset composed of 1226 full-length 16S rRNA sequences the G+C content 
ranged from 49.5 to 65.4% (average 52.8± 1.2%, median 53%). The clones classified as 
bifidobacteria had GC contents above 54%, the average + standard deviation from the 
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Eckburg dataset. Due to their high GC content all bifidobacteria are likely to be false-
positive results. Clone 50, an unclassified Clostridales has GC content of 54.12% but its 
sequence has among all clones highest phylogenetic similarity with known syntrophic 
bacteria. The 16S rRNA sequence of Tepidanaerobacter syntrophicusT for example 
consists of 55.7% GC. 
Table: phylogenetic identification of 16S rRNA gene clone library. 
Sequence Length 
(bp) 
Closest match Accession 
number 
Similarity 
(%) 
Reference 
Sequence 
1 (clone 
45) 
679 uncultured bacterium 
clone, 
Erysipelotrichaceae 
from human faeces 
AM075627  
 
100 [193]  
  Uncultured 
Coprobacillus from 
human faeces 
FJ366449  
 
96.7 [27]  
  Uncultured 
Erysipelotrichaceae 
from human faeces 
AY916175  
 
96.7 [54] 
 
Sequence 
2 (cut1) 
120 Uncultured 
Ruminococcaceae 
from gorilla gorilla 
EU775497 97.5 [125] 
  Uncultured 
Ruminococcaceae 
from human faeces 
DQ801012 97.5 [194] 
  Uncultured 
Ruminococcaceae 
form swine intestine 
AF371778 97.5 [195] 
Sequence 
3 (clone 
31) 
566 Uncultured Alistipes 
sp. from human faeces 
EU202015 100 [196] 
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  Uncultured Alistipes 
sp. from human colon 
biopsy 
AY975278 97.0 [54] 
  Alistipes putredinis
T 
L16497 96.6 [197] 
Sequence 
4 (clone 
49) 
626 Uncultured bacterium 
‘Lachnospiraceae 
incertae sedis’ from 
human faeces 
EU201977 
 
100 [196] 
 
  Uncultured bacterium 
from human faeces 
Lachnospiraceae 
incerta sedis 
DQ307776  
 
100 [198] 
  Uncultured bacterium 
from human skin 
Lachnospiraceae 
incerta sedis 
GQ036333 98.1 [199] 
Sequence 
5 (clone 
5) 
647 Unclassified Sutterella 
sp. from human faeces 
EU202357 100 [196] 
  Uncultured Sutterella 
sp. from human faeces 
EU768635 96.2 [200] 
  Sutterella parvirubra
T
 AB300989 93.4 [201] 
Sequence 
6 (clone 
27 & 8) 
653 Uncultured Sutterella 
from canine duodenum 
FJ719241 99.7 Suchodolski 
et al. 
unpublished 
  Uncultured Sutterella 
from feline faeces 
FJ031979 
 
99.5 Ritchie et al.; 
unpublished 
  Uncultured Sutterella 
from human faeces 
FJ454360 98.8 [202]  
Sequence 
7 (clones 
26, 50) 
619 Unclassified 
Clostridiales from 
human faeces 
EU532804 
 
99.6 [154] 
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  Unclassified 
Clostridiales from 
human faeces 
EU201582 
 
99.4 [196] 
 
  Unclassified 
Clostridiales 
bacterium from human 
faeces 
DQ905219  
 
97.6 [203] 
 
Sequence 
8 (clone 
38) 
359 Uncultured 
bifidobacterium from 
human faeces 
EF063930  
 
100.0 [204] 
 
  Bifidobacterium 
catenulatum
T
  
AF432082 96.8 [205] 
  Bifidobacterium 
pseudocatenulatum
T
 
D86187 96.8 [206]  
Sequence 
9 (cut 11 
clone10) 
632 Uncultured 
Bifidobacterium sp. 
from human faeces 
EF063930 100 [204] 
  Bifidobacterium 
catenulatum YIT 4016 
AB437357 96.1 Watanabe et 
al. 2008 
unpublished 
  Bifidobacterium 
catenulatum
T 
AF432082 95.9 [205] 
Sequence 
10 (clone 
40) 
493 Bifidobacterium 
adolescentis
T
  
AP009256  
 
99.0 Suzuki et 
al.2006 
unpublished 
 
  Uncultured 
bifidobacterium from 
human faeces 
GQ896587 
 
99.0 Waddington 
et al. 2009; 
unpublished 
 
  Bifidobacterium 
ruminantium 
D86197 
  
98.8 Miyake et al. 
1996; 
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unpublished 
 
Clone 9 637 Uncultured 
Bifidobacterium sp. 
from human faeces 
AM238028 100 [207] 
  Bifidobacterium 
adolescentis isolate 
from human faeces 
AY305304 97.1 Louis P. 2003 
unpublished 
  Bifidobacterium 
adolescentis
T
 
AP009256 97.3 Suzuki et al 
2006 
unpublished 
Clone 19 639 Unclassified 
Ruminococcaceae 
from human faeces 
EU201646 100 [196] 
  Eubacterium siraeum EU266550 96.0 [208],  
  Ruminococcus 
callidus
T
 
L76596 88.3 Wilson et 
Duncan 1996, 
unpublished 
Clone 20 633 Uncultured 
Sporacetigenium from 
chicken litter 
DQ250647  [209] 
  Unclassified 
Peptostreptococcaceae 
sp. from human faeces 
EU762133 96.1 [54] 
  Clostridium 
irregulare
T
 
X73447 95.9 Lawson et al. 
1993, 
unpublished 
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Figure 24: phylogenetic tree displaying the sequences identified from the heavy 
fraction of the labelled sample after four hours incubation in comparison with known 
butyrate-consuming bacteria (underlined). 
 
7.4 Discussion 
 
A faecal sample was pulsed with 13C-labelled butyrate in vitro and incubated under 
anaerobic conditions at 37˚C.  
Previous studies have found that butyrate consumption occurs only in syntrophic 
consortia of acetogenic bacteria and methanogenic archaea [185-187]. Thus 
destructive sampling was chosen in order not to disrupt the microstructure of the 
sample. The colonic environment is anaerobic and the vast majority of its inhabitants 
are strictly anaerobic. The sampling procedure might have had an influence on the 
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metabolic capacity of the stool microbiota, since the sample was exposed to aerobic 
conditions for approximately 15 minutes before reaching the anaerobic chamber.  
The increase of SCFA level in the sample, most prominently acetate and propionate 
indicated that at least the enzymes involved in their synthesis were still active 
throughout the incubation. A further indication for active bacterial metabolism is the 
fact that the yield of RNA was constant 30-45 µg g-1 in all samples throughout the 
experiment. 
Most applications of stable isotope probing are limited to assimilatory processes. 
Bacterial removal of butyrate from the faecal stream has –to our knowledge- not yet 
been described in the human intestinal tract.  
The GC-FID analysis of SCFAs showed a slight increase in butyrate concentrations 
during the first four hours of the incubation period and stable concentrations 
thereafter. This finding indicated that either no butyrate was consumed or that its 
production exceeded its consumption during the first four hours after butyrate pulse 
before reaching equilibrium. The flattening of the butyrate production curve after four 
hours might indicate that butyrate production rate decreases due to for example 
depletion of substrates and inhibition through increased pH. Under physiological 
conditions SCFAs are constantly removed from the gut lumen by the gut epithelium, 
which could not be mimicked in this in vitro experiment. Inhibition of colonic 
Bacteroides spp. and E.coli by decreased pH has previously been shown [210], leading 
to enrichment of acid-tolerant species able to exploit the acidic niche created during 
the course of the experiment. Accumulation of butyrate itself is less likely to inhibit its 
production, since in the samples pulsed with an excess of butyrate this SCFA was still 
produced too until four hour after the pulse. On the other hand, the flattening of the 
butyrate production curve might also indicate that after four hours the consumption 
and production of butyrate reached equilibrium.  
The assessment of heavy carbon in the extracted RNA did not show enrichment of 13C. 
For isotope ratio analysis 5 µg RNA were cut with sucrose in order to reach the 
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minimum amount of 25µg carbon necessary. If butyrate consumption was only a 
minor process within the GI microbiota, only a small amount of RNA would have been 
labelled. Heavy label might have been diluted to such an extent as to remain 
undetected after cutting with sucrose. 
In the heavy butyrate pulsed samples, peak RNA abundances were seen in the high 
density fractions and in the light density fractions. The abundance pattern of RNA in 
the individual fractions suggested presence of heavy RNA in fractions with density 
1.79 to 1.82 g ml-1. RNA fractionation of the control samples yielded a continuous 
increase of RNA abundance with decreasing density for the H2O control samples, and 
ambiguous RNA abundance in 12C-pulsed fractions. Some RNA was distributed down 
the entire gradient in all samples, thus making an unambiguous identification of heavy 
label incorporation difficult. 
DGGE bandpatterns of the heavy pulse sample after 4 hours showed enrichment of 
some bands in the heavy fractions nourishing the assumption that some heavy 
butyrate might have been incorporated into bacterial RNA. DGGE bandpatterns of 
control samples showed highly similar bandpatterns in all fractions. 
To see which sequences were enriched in the heavy fractions, clone libraries were 
constructed and selected clones sequenced.  
Sequence 1 (clone 45) was classified as a member of the family Erysipelotrichaceae. Its 
closest relative (99.2% similarity) was bacterium AY916175 previously found in a 
faecal sample [54]. The Erysipelotrichaceae are capable of forming filaments, 
immobile ad non-sporulating. Members of this family are facultative anaerobic, 
chemoautotrophic, straight or slightly curved bacilli. Erysipelotrichaceae sp. have been 
described in various environments such as sludge, poultry, pigs, emus, the poultry red 
mite and other animals [211]. In the pig, some Erysipelothrix spp. are pathogenic and 
cause large economic losses [212].  
Coprobacillus cateniformis-related species of the class Erysipelotrichi and the family 
Erysipelotrichaceae have been described as ubiquitous in human faeces [213]. 
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Coprobacillus cateniformis has a G+C-content of 32.1 to 33.1 mol% and is a non-spore 
forming rod [214].  
Sequence 2 (cut1) was cut out and found to be 99.2% similar to bacterium EU775497 
from Gorilla gorilla faeces and to DQ801012 from human faeces. Due to the short 
length of cut out sequences this sequence was analysed in FASTA and BLASTn and not 
applying the ribosomal database project tools. However, EU775497 was classified as 
Clostridiales, Ruminococcacaea sp. 
Several Ruminococcaceae spp. have been described to ferment cellulose in the gastro-
intestinal tracts of cattle and humans. R.hydrogenotrophicus is able to grow with 
H2/CO2 as energy source. A study from Finland identified Ruminococcus bromii-like 
and Ruminococcus torques-related sequences as ubiquitous in human faeces [213].  
Sequence 3 (clone 31) was identified as Alistipes sp. Its closest related type strain is 
Alistipes putredinisT. Alistipes spp. have been described as strictly anaerobic, bile-
resistant, pigment-producing gram-negative rods [215] frequently prevalent in 
humans. Similar to bacteria of the Bacteroides fragilis group Alistipes spp. are resistant 
to kanamycin, vancomycin and colistin [215]. 
Sequence 4 (clone49) was found to be 98.1% similar to uncultured bacterium 
DQ905754 [203] previously found in human faeces. It was classified as 
Lachnospiraceae incertae sedis. Lachnospira spp. and are known to ferment pectin in 
cattle and sheep.  
Sequence 6 (clone 27,8) was identified as a Betaproteobacterium of the genus 
Sutterella. Its closest relatives (99.7% and 99.5% similarity) FJ719241 and FJ031979 
have previously been found in dog and cat faeces. FJ454832 with a similarity to 
sequence 7 of 98.9% was found in human faeces [202]. Sutterella spp. have previously 
been found in humans and dogs [216]. Sutterella spp. are described to be anaerobic, 
Gram negativ microbes that are resistant to bile, inactive on sugars and capable of 
reducing nitrate and nitrite. 
Sequence 7 (clones 26, 50) was classified as a Clostridiales sp.  
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The sequences related to Ruminococcaceae, comprising also the genus Lachnospira 
have been grouped according to phylogenetic analysis into Clostridium cluster XIVa 
[188]. This suprageneric cluster consists of a phenotypically heterogeneous collection 
of organisms. Representatives of Clostridium cluster XIVa have beed described as 
producers of butyrate, but have not yet been associated with consumption of this 
short chain fatty acid before. Eubacterium siraeum, matching next to clone 19, has 
been described to possess cellobiose 2-epimerase, catalyzing the reversible 
epimerization of cellobiose to 4-O-beta-D-glucopyranosyl-D-mannose [217]. In 
addition to cello-oliogosaccharides, cellobiose 2-epimerase-like hypothetical proteins 
are suggested to convert lactose to epilactose [217]. Consumption of butyric acid has 
previously been described for Clostridium cluster III and IV.  
Figure 7 shows a phylogenetic tree comparing the cloned sequences with known 
syntrophic bacteria (underlined). It became apparent that the clones from this study 
did not form a distinct group, wheras most of the reportedly syntrophic bacteria 
formed a cluster according to their 16S rRNA sequence similarity. Tepodanaerobacter 
syntrophicus is an exception; its sequence divergence from other syntrophic 
organisms suggests that the ability for syntrophic life might not be limited to a 
narrowly defined cluster of bacteria. A G+C content comparison with a large gut 
microbiota dataset consisting of 1226 full-length 16S rDNA sequences showed that –
with the exception of bifidobacterium-like sequences- G+C contents of clones 
corresponded to average and below average GC contents found in the Eckburg 
dataset of 2005.  
False-positive results may have arisen from several sources. Firstly, the migration of 
RNA in the CsTFA gradient follows a normal distribution. Thus all fractions contain 
traces of RNA. Apart from the peak of labelled RNA in the heavy fractions non-labelled 
RNA might have migrated as well in small quantities. In particular G+C-rich sequences 
such as those related to bifidobacteria might have constituted false-positive findings 
in the heavy fractions. Furthermore, PCR bias might have possibly distorted the DGGE 
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fingerprints as it has been previously described for all PCR-based molecular techniques 
[84].  
 
7.5 conclusion 
DGGE bandpattern analysis showed that some sequences were enriched in heavy 
fractions of a sample pulsed with 13C-butyrate. Control samples pulsed with 12C-
butyrate or water lacked such enrichment; they showed uniform bandpatterns in all 
fractions.  
The 13C incorporation could not be unambiguously proven, since isotope ratio 
analysis of RNA, and the analysis of SCFAs in the samples did not corroborate the 
results of DGGE analysis. Furthermore, the results showed that during gradient 
centrifugation and fractionation RNA was distributed down the entire gradient, thus 
weakening the evidence from the DGGE experiments. 
This pilot study generated some evidence that butyrate consumption took place in the 
GI communities assessed, but further experiments are necessary to strengthen this 
interpretation.  
No assumptions can be made from this experiment to which extent the gastro-
intestinal microbiota contributes to butyrate removal from the faecal stream since no 
labelled metabolites were analysed. Butyrate consumption is likely to be a minor 
process compared to the large substrate turnover rate of the enormous diversity and 
abundance of colonic microbes. 
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ABSTRACT 
Aims: This study aimed at determining ageing-related shifts in diversity and 
composition of key members of the fecal microbiota by comparing institutionalized 
elderly (n=17, 78-94 yrs) and young volunteers (n=17, 18-31 yrs). 
Methods and Results: A combination of molecular methods was used to characterize 
the diversity and relative abundance of total gastro-intestinal flora, along with 
relevant subsets within the genera Bacteroides, Bifidobacteria and Clostridium cluster 
IV. The institutionalized elderly harbored significantly higher numbers of Bacteroides 
cells than control (28.5 % ± 8.6%; 21.4 % ± 7.7%; p=0.016) but contained less 
Bifidobacteria (1.3 % 0.9, 2.7 % ± 3.2%, p=0.026) and Clostridium cluster IV (26.9%  
11.7%, 36.36%  11.26%, p=0.036). The elderly also displayed less total Bacteria 
diversity and less diversity with the Clostridium cluster IV (p<0.016) and Bacteroides. 
Conclusion: Despite high individual variations, our analyses indicate the composition 
of microbiota in the elderly comprises a less diverse subset of young healthy 
microbiota. 
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Significance and Impact of the Study: A better understanding of the individual 
composition of the human microbiota and the effects of ageing might result in the 
development of specifically targeted supplementation for elderly citizens in order to 
support healthy ageing.  
 
INTRODUCTION 
It is estimated that between 60-80 % of the microbial diversity resident within the 
human gastro-intestinal tract (GI) has yet to be cultivated (Suau et al. 1999). However, 
the use of culture-independent molecular methods has enabled researchers to 
identify important characteristics of this community. We now know that the 
composition of GI microbiota is highly distinct between individuals (Dethlefsen et al. 
2006). Despite this variability, some general features are apparent. There appears to 
be a ‘core microbiota’ of approximately 300 phylotypes which is quite resilient to 
external influences (Dore 2007). In addition to this core group, there are also 
‘passengers’ or transients, sometimes in great numbers, sometimes below detection 
limit (Favier et al. 2003), and members that are unique to some individual (Turnbaugh 
et al. 2009). A number of factors have been identified which influence community 
composition. The type of bacteria introduced to the environment is determined by 
those associated with food sources (Duncan et al. 2007; Pryde et al. 2002). The nature 
and composition of non-digestible carbohydrates in a diet can further stimulate 
different types of bacteria (Kolida and Gibson 2007), whilst hereditary dispositions and 
personal gut environmental factors may account for unique personal characteristics 
(Eckburg and Relman 2007). 
Correlations between the GI microbiota and diseases such as allergenicity (Shreiner et 
al. 2008), inflammatory bowel diseases (Sokol et al. 2006) and individual dispositions 
such as obesity (Zhang et al. 2009 ) have been discussed.  
The colon harbors butyrate-producing species of several genera such as Clostridium, 
Eubacterium and Fusobacterium (Pryde et al. 2002). Among strains that produce high 
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levels of butyrate in vitro are those related to Faecalibacterium prausnitzii, an 
ubiquitous member of Clostridium cluster IV (Pryde et al. 2002). Bacteroidetes species 
have been reported to show high variations between individuals, although Bacteroides 
thetaiotaomicron is found in all human beings (Layton et al. 2006). Both Bacteroidetes 
and Clostridium cluster IV are known to be involved in beneficial functions, including 
nutrient absorption, production of short chain fatty acids (SCFAs) and epithelial cell 
maturation and maintenance (Woodmansey 2007).  
Another important subgroup of the human GI microbiota is the Bifidobacteria. 
Stimulation of these bacteria has previously been shown after prebiotic intervention 
with inulin and fructo-oligosaccharides (Kolida and Gibson 2007). Furthermore, they 
have been shown to be involved in prevention of atopic disease (Ouwehand et al. 
2007), obesity and insulin resistance via enhanced barrier function of the gut 
epithelium (Cani et al. 2007). 
With ageing, a decrease in beneficial organisms such as Lactobacilli and Bifidobacteria, 
amongst other anaerobes, and an increase in the number of facultative anaerobes 
(Guigoz et al. 2008) have been reported. Population cross-sectional studies with 
relevant numbers of healthy elderly also show age-related changes in GI microbiota. 
These include a consistent global increase in nonpathogenic Gram-negative bacteria 
(mainly Enterobacteria), as well as country-specific changes in Bifidobacteria (Guigoz 
et al. 2008). This, along with a general reduction in species diversity within most 
bacterial groups, changes to diet and altered digestive physiologies such as intestinal 
transit time, may result in increased putrefaction in the colon and a greater 
susceptibility to disease. The aged gut is characterized by increased proteolytic 
activity, decreased amylolytic activity and reduced levels of SCFA (Woodmansey 
2007). Ageing is associated with reduced levels of prostaglandins such as PGE2 and 
PGF2  as shown in specimens of stomach and duodenum biopsies (Tiihonen et al. 
2008). Subclinical intestinal inflammation in elderly populations has been detected 
and is believed to contribute to impaired immune functions, the underlying cause of 
mortality beyond 75-80 years of age (Guigoz et al. 2008).  
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Analyses of individual dispositions associated with changes of the microbiota should 
consider quantitative and qualitative aspects of gut community structure. Analysis of 
stool samples can target changes in colonic microbiota, since feces are representative 
of inter-individual differences (Turnbaugh et al. 2007). 
The aim of this work was to investigate shifts in GI microbiota associated with aging, 
by comparing institutionalized elderly with young healthy volunteers. To analyze 
changes in total bacterial community composition, along with specific compositional 
changes within the Bacteroidetes, Bifidobacteria and Clostridia cluster IV, we used the 
polymerase chain reaction (PCR) based community fingerprinting method Denaturing 
Gradient Gel Electrophoresis. The resolution of this method allows for the 
characterization of the dominant members of a targeted microbial community. 
Further, we used quantitative-PCR (q-PCR) to determine the relative load of 
Bacteriodetes, Bifidobacteria and Clostridia cluster IV groups within our samples. Thus, 
use of these methods in combination allowed the characterization of both diversity 
and relative abundance of our targeted organisms. 
 
MATERIAL AND METHODS 
Probands 
Seventeen institutionalized elderly aged 86 ± 8 years, BMI 21.75  5.08, from a 
geriatric department in Vienna and 17 students from Vienna joined the study. 
Probands were interviewed following a questionnaire assessing: age; gender; body 
length and weight; individual health status, including chronic or acute diseases and 
blood lipid levels; and life-style aspects, such as physical activity and dietary habits. 
Five percent of geriatric patients suffered from manifest diabetes mellitus type 2. Ten 
patients were bed-ridden and seven mobile. Causes for loss of mobility were 
Parkinson’s disease, dementia and osteoporosis. Nursing staff reported the 
application of NSAIDs (non-steroidal anti-inflammatory drugs) on demand. Seventeen 
young healthy volunteers were aged 24 ± 2.5 years, BMI 22.68  3.41 and their dietary 
habits were typical for Central Europe.  
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Study populations were gender balanced, with 55% females in the group of elderly 
and 50% in the young group. Only non-pregnant probands with no diagnosed gastro-
intestinal disease and no antibiotic or chemotherapeutic treatment three months 
prior to sampling were included in the study. All probands agreed to participate in the 
study and gave their informed consent. 
 
Sampling and DNA extraction from Stools and Type Strains 
From each proband, three stool samples were taken within the course of a week and 
immediately stored at –70°C. Portions of the three samples from each patient were 
pooled, a 200 mg aliquot was treated twice for 45 sec in a bead-beater (Mini-
Beadbeater-8) and DNA extracted with the QIAamp® DNA Stool Mini Kit (QIAGEN) 
following the manufacturer’s protocol and then immediately stored at –20°C.  
Type strains known to be associated with GI microbiota were grown, and DNA 
extracted, for use as part of the markers in DGGE analysis (see below). Type strains L. 
casei DSM 20011T, L. delbrueckii subsp. lactis DSM 20072T, Bacteroides fragilis DSM 
2151T, Bacteroides thetaiotaomicron DSM 2079T, Bifidobacterium longum DSM20219T, 
B.longum DSM 20211, B.pseudolongum DSM 20099 and B.thermophilus DSM 20210 
were anaerobically cultivated on blood agar, E.coli IMBH 252/07 and clones were 
aerobically cultivated on LB-agar (liquid broth medium). The biomass was 
resuspended in sterile phosphate buffered saline (1x PBS from 10x PBS Roti stock, 
ROTH). Tenfold dilutions from these suspensions in sterile 1x PBS were plated in 
duplicate on blood agar or LB-agar, colony forming units (CFU/ml) were counted and 
DNA extracted from serial dilutions. DNA was extracted from clones using the Wizard® 
Plus.SV Minpreps DNA Purification System (Promega). The DNA of all Gram-negative 
bacteria was extracted with the DNA Mini Kit (QIAGEN), for Gram- positive bacteria, 
the FastDNA Spin Kit for Soil (MP-Biomedicals) was used following the instructions of 
the manufacturer.  
 
Polymerase Chain Reaction (PCR) 
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PCR was used to amplify 16S ribosomal RNA gene sequences from type strains and 
Bacteria in stool samples for use in DGGE analysis and manufacture of clone libraries 
(see below). All reactions were carried out using a ready-to-use mastermix (Promega) 
with 1.5mM MgCl2. Bovine serum albumin (10mg/ml, Fermentas) was added to a final 
concentration of 400 g/ml, primer concentration in the reaction volume was 0.5µM. 
Amplifications were carried out in a Robocycler (Stratagene). 
 
Clone libraries 
Clone libraries were constructed from stool samples to identify dominant members of 
the Clostridium cluster IV and the Bacteroidetes. Selected clones were then used, 
along with the cultured type strains, to generate appropriate reference markers for 
DGGE analysis. Amplifications were carried out using primer pair 27f Edwards et al. 
1989) and sg-Clep-R (Matsuki et al. 2004), which are specific for members of the 
Clostridium cluster IV, and  32f and 708r (Bernhard and Field 2000) which are specific 
for members of the Bacteroides. Amplified products were cloned into a p-GEM Easy 
Vector (Promega) following the instructions of the manufacturer. Clone libraries were 
screened as previously described (Schabereiter-Gurtner et al. 2001). Clone inserts 
were sequenced by ‘DNA confidence’ (Vienna). Nucleotide sequences were corrected 
for vector and primer sequences in CodonCode Aligner (www.codoncode.com) and 
taxonomically identified by comparison to previously published sequences using the 
online tools of the ribosomal database project (http://rdp.cme.msu.edu/). 
 
DGGE 
PCR amplifications of 16S rRNA gene fragments from total DNA extracted from stool 
samples were carried out using the specific primer sets outlined in Table 2. 
Separate DGGE gels were run to analyse samples for patterns in a) total Bacteria, b) 
Bifidobacteria, c) Clostridium cluster IV and d) Bacteroides. DGGE gels were prepared 
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as described previously (Muyzer and Smalla 1998) with a linear gradient of 25-65% for 
Bacteria (general), 30-65% for Bifidobacteria, 20-50% for Bacteroides and 30-50% for 
Clostridium cluster IV, using a gradient mixer (Hoefer SG 30) and a peristaltic pump. 
We generated reference markers appropriate for each set of DGGE analyses (i.e. a 
different reference marker was used for each of a,b,c and d above) to enable 
meaningful comparisons across multiple gels and to provide putative identification of 
some bands. These reference markers contained fragments of 16S rRNA genes from 
cultured bacteria and clones generated from fecal material (as described above). Each 
marker was loaded in triplicate on each gel to allow gel-to-gel comparison. The 
reference marker for DGGE fingerprinting of general Bacteria consisted of E.coli IMBH 
252/07, Enterococcus faecium DSM 20477T, Bacteroides thetaiotaomicron DSM 2079T, 
Bifidobacterium longum DSM 20219T, Clostridium perfringens (laboratory isolate), 
clone BT11 (98.8% similarity with Bacteroides uniformis JCM 5828T), clone BT17 
(96.0% similarity with Bacteroides vulgatusT and bacterium LY88 previously identified 
in human feces (Eckburg et al. 2005)) and clone CL16 (98.4% similarity with an 
uncultured bacterium from human feces (Turnbaugh et al. 2006) and 96.7% similarity 
with Faecalibacterium prausnitziiT). The reference marker for Bifidobacteria specific 
DGGE analysis consisted of Enterococcus faecium DSM 20477T, E.coli IMBH 252/07, 
Bifidobacterium longum DSM 20219T, B. longum DSM 20211, B. thermophilus DSM 
20210T and B. pseudolongum DSM 20099T. The reference marker for Bacteroides 
specific DGGE analysis was composed of Bacteroides thetaiotaomicron DSM 2079T, 
fecal clones Bt 17 and Bt11 and Enterococcus faecium DSM 20477T. The reference 
marker for Clostridium cluster IV DGGE analysis was constructed from 7 clones all 
representing previously uncultured species from cluster IV: Similarities with type 
strains from this cluster were 81.8%, 96.6%, 96.7% and 97.8% similarity with 
Faecalibacterium prausnitziiT, 92.1% and 92.9% similarity with Eubacterium 
desmolansT and 95.9% similarity with Subdoligranulum variabileT.  
 
TaqMan RTQ-PCR 
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The TaqMan-assay was carried out in a Rotorgene 3000 (Corbett Life Science) in 
duplicate in a volume of 10 µl containing 5 µl TaqMan SensiMix DNA Kit (Quantace), 1 
µl of each primer and probe (final concentrations table 1) and 2 µl of the 100-fold 
dilution of the template. All probes were labeled with 6-FAM at the 5’ end and carried 
a BHQ-1 quencher at the 3’ end. TaqMan Probe (Clep-P) for Clostridium cluster IV was 
designed with CLC DNA Workbench (www.clcbio.com). Analysis with ProbeMatch 
(rdp.9.58) indicated that Clep-P binds to all members of Clostridium cluster IV. The 
PCR program for bifidobacteria, Bacteroides and universal bacteria consisted of 
denaturing at 95°C for 3min and 45 cycles of 95°/60°C for 15/ 45 sec. The amplification 
program for clostridium cluster IV was: denaturation at 95° for 5 min and 45 cycles at 
95°/ 55°C for 30/ 45 sec.  
DNA of Bacteroides thetaiotaomicronT and Bifidobacterium longumT, clone CL16 and 
one fecal sample were used to construct standard curves for comparison of PCR 
reaction efficiencies among different experiments and enumeration of all bacterial 
groups. Reaction efficiency (E) was estimated using the slope of the standard curve 
and the formula E=10(-1/slope) -1 as described elsewhere (Penders et al. 2005). 
Quantification was done using standard curves obtained from known concentrations 
of organisms containing the respective amplicons for each set of primers. The 
percentage of bacterial group rRNA gene copies in relation to total rRNA gene copies 
(relative abundance) was calculated for each individual, and the mean was determined 
for each subject group. Relative quantification (% of bacteria) was performed using 
Rotor-Gene 3000 calculation software (Corbett operator manual) and Excel. Cross 
reactivity with non-target strains was tested using the Probe-Match tool at the RDP 
website and using the strains mentioned above. 
Statistical analysis.  
Food frequency data were analyzed based on Chi-square approximation as 
implemented in SPSS. P values <0.05 were considered significant. Band comparison 
tables were analyzed with principal component analysis (PCA) using the default 
settings in ‘R-software environment for statistical computing’ (www.r-project.org) 
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until 100% variance was explained. Transformed data were plot in a bi-plot as a 
function of the first two principal components. Clustering was applied to DGGE 
fingerprinting data as implemented in the GelComparII environment (www.applied-
maths.com). Clustering was performed based on Dice coefficient as well as based on 
Pearson correlation. Those methods are supplementary to each other, clustering after 
Dice takes band positions into account, whereas Pearson correlation based clustering 
analyzes the densitometric curves of each fingerprint. UPGMA dendrograms were 
generated and Jackknife analysis was performed using average similarities and 100 
resamplings. Jackknife analysis is a leave-one-out method that tests the reliability of 
the clustering similar to bootstrap analysis. Shannon and Simpson’s diversity index 
were calculated on binary band information (presence-absence) with the default 
settings implemented in the ‘vegan’ package in ‘R’. Shannon index is defined as H = -  
pi ln pi, where pi is the proportional abundance of species i. For Simpson’s index D, this 
is 1-  ((pi)^2), where pi is the relative frequency of the i-th species. Prior to 
application of Student’s t-test for diversity indices and qPCR data, equality of variances 
of the three datasets was tested using the F-test as implemented in Microsoft Excel.  
 
RESULTS 
 
Dietary aspects 
Analysis of the participant’s dietary habits indicated similar consumption patterns of 
fruits, vegetables and milk products in both groups. Young volunteers stated 
significantly less frequent (Chi2 Test; p<0.04) consumption of meat than elderly 
probands and regular consumption of whole grain products several times a week. The 
institutionalized elderly of this study did not consume any whole grain products at all 
but received supplements with soluble fiber (Benfiber , Novartis). 
 
TaqMan-quantification 
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TaqMan assays were set up quantifying bacterial sub-populations as percentage of the 
total bacterial DNA. We detected no cross-reactivity of group-specific primers and 
probes with non-target strains. Test-retest variations were between 2.7% and 5.2%, 
values after relative quantification varied by less than 4%. The sensitivity was 
corresponding to a 100 000 fold dilution of DNA from feces, that is 20 copies of 16S 
rRNA gene per reaction.  
The elderly harbored only 69% 21.6% of the total bacterial load in their faeces compared to 
control (figure 1). Bacteroides were found to represent a larger percentage than 
Bifidobacteria in all samples (figure 1) and the institutionalized elderly harbored 
significantly more Bacteroides than young volunteers (p=0.016). Although relative 
levels of Bifidobacteria  were highly variable among samples, the differences between 
young and elderly probands were statistically significant (p=0.026). Furthermore, 
elderly citizens had significantly less members of Clostridium cluster IV (figure 1) in 
their fecal microbiota than young volunteers (p=0.036). 
 
DGGE bandpattern analysis 
DGGE fingerprinting with primer pair 341GC-518, which amplified the total microbial 
community, showed high inter-individual variations (figure 2). The mean numbers of 
bands per individual were 16.6 ± 3 bands for institutionalized elderly and 20 ± 3 bands 
in control. Two bands, highlighted in figure 2, occurred significantly less frequently in 
elderly probands. Shannon and Simpson indices of diversity were significantly lower 
for elderly than control (figure 3). The highly diverse dataset was subjected to 
principal component analysis (PCA). Extraction of underlying components within the 
dataset indicated grouping of samples according to their variance (figure 4) along the 
first two principal components. Cluster analysis could separate the fingerprints of 
young and elderly (figure 5). Jackknife analysis suggested that the dominant bacteria 
of the elderly microbiota are a subpopulation of the microbiota of young individuals: 
Predictability of groupings was 100% for young and only 13.33% for elderly.  
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Bifidobacteria 
An average of thirteen bands were observed in individual DGGE bandpatterns 
obtained with the primer pair specific for Bifidobacteria. Two bands with the same 
melting behaviour as the type strains B.longum DSM 20219T and B.pseudolongum 
DSM 20099T in our marker were abundant in the majority of probands. PCA was 
performed and the first two PC’s explained 23.64% of variance (figure 4). Although 
cluster analysis showed high similarity of young and elderly bandpatterns, jackknife 
testing demonstrated greater similarity of bandpattern for control than for elderly 
(expressed in predictability of groupings: 91.67% for control and 35.72% for elderly). 
PCA supported these results and could not separate young and elderly according to 
variances in the dominant bifidobacteria of their microbiota. 
 
Bacteroides 
DGGE fingerprints obtained with the Bacteroides specific primers contained an 
average of 7.6 ± 2.5 bands for the elderly, whilst young individuals averaged 9.5 ±3 
bands. Diversity indices (figure 3) showed a tendency to be lower for elderly than for 
control. PCA results suggest a tendency for less Bacteroides diversity with ageing 
(figure 4). Elderly subjects grouped along the first principal component. Clustering of 
Pearson correlations could separate young and elderly individuals according to DGGE 
fingerprinting. Jackknife analysis using average similarities could predict groupings of 
young bandpattern with 76.92% reliability and 75% for elderly. 
 
Clostridium cluster IV 
DGGE fingerprints obtained with the Clostridium cluster IV specific primers yielded an 
average of 10 ±3 .5 bands per elderly individual and 13 ± 3 bands per young individual. 
Diversity indices (figure 2) were significantly (p=0.02) lower for aged citizens than for 
the young. One band that occurred more frequently in the young than in the elderly 
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had the same melting characteristics as a band in our marker. This band was 
generated from a clone from our library related to the genus Faecalibacterium. This 
clone had the highest similarity (99.2%) to an uncultured bacterium EF403698 and 
also displayed 96.6% similarity to Faecalibacterium prausnitziiT. Three more bands 
occurred more frequently in the young than in elderly. These bands were identified 
from our clone libraries as relating to the genera Ruminococcus (clone had 95.9% 
similarity to Ruminococcus bromiiT, 99% similarity to uncultured AJ408987 from 
human colon) and Subdoligranulum (clones had 94.7%/ 97.5% similarity to 
Subdoligranulum variabileT, and 97.9%/ 98% similarity to uncultured bacterium 
DQ793301). 
PCA (figure 4) indicated separation of young and elderly according to their Clostridium 
cluster IV DGGE fingerprints along PC1.  
Clustering and Jackknife analysis did not result in distinct clustering of elderly and 
young individuals. Clostridium cluster IV representatives in the elderly microbiota are 
most likely to be a subset of the species present in young individuals: Only in 35.71% 
of resamplings elderly bandpattern grouped with each other, whereas Jackknife value 
for young individuals was 100%. 
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DISCUSSION 
Metagenomic analysis of the human GI microbiota is presently the subject of large 
research consortia and has already substantiated the concepts of a ‘core microbiome’ 
and inter-individual variations (Turnbaugh et al. 2007). However, the collection of data 
on ‘reference microbiota’ is far from complete and thus no definition of a healthy 
microbiota is available yet. Important information comes from analyses addressing the 
abundance and diversity of specific bacterial populations with relevance to disease, 
diet or probiotic intervention. We used a combined molecular approach to compare 
patterns in several target GI microbial groups between the institutionalized elderly 
and young healthy volunteers. The community fingerprinting method PCR-DGGE was 
used to compare the diversity present in total Bacteria and also specifically within the 
Clostridium cluster IV, Bifidobacteria and Bacteroides, whilst q-PCR was used to 
quantify the relative population abundance of these same bacterial groups in all 
samples. 
Our results demonstrate some significant shifts in patterns in GI microbiota between 
our study groups. Faeces from the institutionalized elderly had less total Bacterial 
abundance and lower total Bacterial diversity than that from the young subjects, 
However, samples from the elderly displayed an increase in the relative abundance of 
Bacteroides, although this group tended to display less diversity than Bacteroides in 
the young. The relative abundance of the Bifidobacteria and Clostridium cluster IV 
were significantly higher in the young, and the Clostridium cluster IV also displayed 
greater diversity in the young. Furthermore, cluster analysis revealed that for all 
microbial groups analysed, the members of the GI microbiota in the elderly could be 
considered a subset of that present in the young. 
The results of our Bifidobacteria analysis are in agreement with previous studies which 
have identified a reduction and loss of diversity of Bifidobacteria associated with aging 
(Woodmansey et al. 2007, Hopkins et al. (2002)) or hospitalization of aged citizens 
(Bartosch et al. 2004). Our study population of elderly was supplemented with soluble 
fiber. This prebiotic intervention alone was apparently not able to antagonize ageing-
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related changes in the Bifidobacteria. In this respect Ouwehand et al. (2008) recently 
reported that supplementation with lactitol and a probiotic Lactobacillus led to an 
increase in Bifidobacteria in the microbiota of elderly. 
Bartosch et al (2004) also reported a marked reduction in the abundance of 
Faecalibacterium prausnitzii, a member of the Clostridium cluster IV which decreased 
in our aged group. However several studies (Hopkins et al. 2002, Woodmansey et al. 
2007 and Bartosch et al. 2004) have reported a decrease in the relative abundance of 
the Bacteroides, whereas our aged study population displayed a relative increase in 
abundance of this group. Like us, all the previous studies reported a decrease in 
Bacteroides diversity. Increased levels of Bacteroides have been found in individuals 
with infectious colitis (Sokol et al. 2006). Discrepancies in changes of the Bacteroides 
abundance might be due to country-specific differences in this bacterial subgroup as 
indicated by Mueller et al. (2006). Mueller et al. (2006) also observed gender effects 
within Bacteroides, with levels being generally higher in males than in females. Our 
study populations were gender balanced with volunteers being 55% females in the 
group of elderly and 50% in the young. The results presented here do not support 
gender differences in Bacteroides abundance. Reductions in amylolytic activity 
observed in a healthy elderly population have been correlated with the occurrence 
and diversity of Bacteroides (Woodmansey 2007). 
 
Reduced numbers of Bacteria in the fecal content of elderly reflect the physiological 
alterations associated with ageing. These include prolonged colonic transit time and 
reduced dietary energy requirement and food uptake (Morley et al. 2007). Further 
reductions in the relative abundance of  important sub-populations such as 
Clostridium cluster IV and Bifidobacteria might result in reduced formation of SCFAs, 
altered epithelial cell maturation and maintenance, and altered barrier function of the 
gut epithelium in elderly probands. Those changes in the GI microbiota have 
previously been linked to impaired immune functions prevalent in individuals of 
advanced age and may result in a greater susceptibility to disease. 
 142 
 
 
Improved analytical concepts for the characterization of the microbiota of consumers 
and patients might become important as a rationale for individualized probiotic 
intervention. Probiotic supplementation is a promising concept in restoring impaired 
functions or enhancing specific desirable functions of the microbiota. Encouraging 
effects of probiotic supplementation have been reported for aspects such as direction 
of host immunity, pathogen defense, maintenance of integrity of the gut epithelium, 
alleviation of lactose intolerance symptoms and immune effects, such as in atopic 
disease. For further insight into the relationships between phylogenetic information 
and metabolic activities, sequence information in addition to 16S rRNA based 
fingerprinting will be mandatory. 
 
CONCLUSION 
Studies comparing elderly and young volunteer microbiota with PCR-DGGE 
fingerprinting and qPCR are still rare. We found that ageing is associated with less 
overall bacteria and significantly decreased Clostridium cluster IV and bifidobacteria 
and an increase of Bacteroides. Diversity of dominant bacteria, Bacteroides and 
Clostridia cluster IV were reduced. Those changes in the GI microbiota are suggested 
to be cause and effect of impaired immune functions in individuals of advanced age 
and may result in a greater susceptibility to disease. 
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Tables: 
 
Table 1: Primers and probes used for quantification of fecal bacteria using TaqMan 
assays targeting 16S rRNA coding regions.  
Target organism 
Primer or 
probe 
Sequence (5' - 3') 
Fragment 
Size (bp) 
Conc. 
[nM] 
Reference 
Bifidobacteria Fwd primer  GCG TGC TTA ACA CAT GCA AGT C 125 300  
 Rev primer  CAC CCG TTT CCA GGA GCT ATT  300  
 
Probe  
(FAM)- TCA CGC ATT ACT CAC CCG 
TTC GCC -(BHQ-1) 
 150 
(Penders et al. 
2005) 
Bacteroides AllBac296f GAG AGG AAG GTC CCC CAC 106 300  
 AllBac412r CGC TAC TTG GCT GGT TCA G  300  
 AllBac375Bh
qr 
(FAM)-CCA TTG ACC AAT ATT CCT 
CAC TGC TGC CT-(BHQ-1) 
 100 
(Layton et al. 
2006) 
Bacteria 
(general) 
BAC-338-F ACT CCT ACG GGA GGC AG 468 1000  
 BAC-805-R GAC TAC CAG GGT ATC TAA TCC   1000  
 
BAC-516-P 
(FAM)-TGC CAG CAG CCG CGG TAA 
TAC-(BHQ-1) 
 200 (Yu 2005) 
Clostridium 
cluster IV 
sg-Clep-F GCA CAA GCA GTG GAG T 239 400   
 
sg-Clep-R CTT CCT CCG TTT TGT CAA  400 
(Matsuki et al. 
2004) 
 
 
Clep-Pa 
(FAM)-AGG GTT GCG CTC GTT-
(BHQ-1) 
 200 This study 
a position of target site (numbering corresponding to E . coli 16S rRNA gene) 1082 to 
1107. 
 
Table 2: Primers applied for PCR-DGGE fingerprinting of 16S rRNA coding regions. 
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Target 
organism 
Primer 
pairs 
Sequence (5’-3’) Ann.temp 
(°C) 
Reference 
bacteria 27f GTGCTGCAGAGAGTTTGATCCT
GGCTCAG 
57 (Edwards et al. 
1989)  
 985r GTAAGGTTCTTCGCGTT 57 (Heuer et al. 1999) 
 341f-GC CCT ACG GGA GGC AGC AG 55 (Muyzer et al. 1993) 
 518r ATT ACC GCG GCT GCT GG 55 (Neefs et al. 1991) 
Bacteroides 32f 
AACGCTAGCTACAGGCTT 56 
(Bernhard and Field 
2000) 
 708r 
CAATCGGAGTTCTTCGTG 56 
(Bernhard and Field 
2000) 
bifidobacteria g-BifidF CTCCTGGAAACGGGTGG 58 (Matsuki et al. 2002) 
 g-BifidR 
 GGTGTTCTTCCCGATATCTACA 58 
 (Matsuki et al. 
2002) 
Clostridia 
cluster IV 
sg-Clep-F-
GC see table 1 55  
 sg-Clep-R    
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Figures 
 
 
 
Figure 1: Proportions of Bacteroides, Bifidobacteria and Clostridium cluster IV of the 
total bacterial load in stool samples of institutionalized elderly and young healthy 
volunteers. Total amount of bacteria is depicted relative to the mean counts for 
healthy young young. 
 
 
Figure 2: PCR-DGGE bandpattern of 16S rRNA coding regions of dominant bacteria 
amplified with primer pair 341GC-518. Bands that were observed more frequently in 
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young than in elderly are indicated with arrows. Organisms and sequences listed were 
used for the construction of the reference lanes. 
A, G, I, J, young; B, C, E, F, elderly; D, H, reference lanes 
 
 
 
Figure 3: Diversity indices derived from DGGE fingerprinting of 16S rRNA coding 
regions. 
Y, young; E, elderly; Cl.IV, Clostridium cluster IV; B, Bacteroides, Bif, bifidobacteria; *, p 
< 0.05. 
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Figure 4: PCA of DGGE fingerprints of 16S rRNA coding regions of dominant bacteria in 
fecal samples.  
Y, young; O, elderly 
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Figure 5: UPMGA dendrogram showing clustering (Dice) based on the similarities of 
DGGE fingerprints of dominant bacteria obtained with primer pair 341GC-518.  
   , elderly;      , young 
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Abstract 
Background/Aims: The aim of this study was to investigate the quantitative and 
qualitative changes of Bacteria, Bacteroides, Bifidobacteria and Clostridium cluster IV 
in faecal microbiota associated with vegetarian diet.  
Methods: Bacterial abundances were measured in faecal samples of 15 vegetarians 
and 14 omnivores using quantitative PCR (qPCR). Diversity was assessed with PCR-
DGGE fingerprinting, PCA (principal components analysis) and Shannon diversity 
index. 
Results: Vegetarians had 12 % higher abundance of bacterial DNA than omnivores, a 
tendency for less Clostridium cluster IV (31.86 ± 17.00 %; 36.64 ± 14.22 %) and higher 
abundance of Bacteroides (23.93 % ± 10.35 %; 21.26 ± 8.05 %), not significant due to 
high interindividual variations. PCA suggested a grouping of Bacteria and members of 
Clostridium cluster IV. Two bands appeared significantly more frequently in omnivores 
than in vegetarians (p<0.005 and p<0.022). One was identified as Faecalibacterium sp. 
and the other was 97.9 % similar to the uncultured gut bacterium DQ793301. 
Conclusions: Vegetarian diet affects the intestinal microbiota, especially decreasing 
the amount and changing the diversity of Clostridium cluster IV. It remains to be 
determined how these shifts might affect host metabolism and disease risks. 
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Introduction 
During the last few decades, vegetarian diets that are frequently associated with little 
or no animal protein, low fat and high fibre content have known a growing popularity 
in the Western world and this trend is likely to continue in the future [1, 2]. 
Vegetarianism has been associated with decreased risk for diseases such as heart 
diseases, various cancers and has been linked to a lower BMI and an overall decline in 
mortality [1]. Different lifestyle factors and diets were shown to have a significant 
impact on the faecal microbiota [3-6]. 
The highly diverse microbiota of the human gastrointestinal tract has been associated 
with colorectal cancer [7], inflammatory bowel diseases [8, 9], obesity [10], metabolic 
syndrome [11] and atopic diseases [12]. Two of the most predominant subpopulations 
in the human faecal microbiota are the Clostridium cluster IV (Clostridium leptum 
subgroup) and Bacteroides [13-15]. Some members of these populations are fibrolytic 
and produce butyrate and propionate [16, 17]. The metabolic activities of these 
organisms have a significant influence on colonic health as butyrate is known as the 
major energy source for colonocytes [16] and as an epigenetic regulator of gene 
expression in colonic epithelium [18]. Epigenetic modifications have also been 
implicated in changes of gene expression associated with vegetarian diet [19, 20].  
Another important subgroup of the human microbiota is that of the Bifidobacteria. 
Stimulation of Bifidobacteria has previously been shown after prebiotic intervention 
with inulin and fructo-oligosaccharides [21]. Bifidobacteria have been shown to be 
involved in prevention of atopic disease [22] and prevention of obesity and insulin 
resistance via enhanced barrier function of the gut epithelium [23]. 
To our knowledge, only one investigation [24] of vegetarian microbiota has been 
performed with molecular methods. This analysis of a single individual revealed that 
Clostridium cluster XIVa, Clostridium cluster IV, Clostridium cluster XVIII were the 
major components of the vegetarian gut microbiota [24].  
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In the present study, we applied qPCR and PCR-DGGE fingerprinting to investigate the 
dominant microbiota in 14 young omnivores and 15 vegetarians assessing Clostridium 
cluster IV, Bacteroides and Bifidobacteria. Analyses of faecal samples have been 
shown to reflect adequate important changes [25]. 
Material and Methods 
Participants 
Twenty-nine healthy young individuals, 15 vegetarians (aged 19-34 years, BMI 22.06  
3.82) and 14 omnivores (aged 21-31 years, BMI 21.02  2.71) were compared. A 
questionnaire about dietary habits and health activities was given to all participants. 
Exclusion criteria were the use of antibiotics, chemotherapeutic treatment, pre- and 
probiotics three months prior to sampling. All trial subjects agreed to participate in 
the study and gave their informed consent. 
 
Sampling and DNA extraction 
Stool samples were immediately stored at –20°C after sampling. DNA was extracted 
using the DNA Stool Mini Kit (Qiagen) following the manufacturers’ protocol with 
minor modifications [26, 27] and immediately stored at -20°C.  
 
TaqMan qPCR 
Bacterial 16S rRNA was quantified by TaqMan qPCR using previously published 
primers and probes (table 1). TaqMan Probe (Clept-P) for Clostridium cluster IV was 
designed with CLC DNA Workbench (http://www.clcbio.com). DNA of Bacteroides 
thetaiotaomicronT and Bifidobacterium longumT, clone CL16 and one faecal sample 
were used to generate standard curves for comparison of PCR reaction efficiencies 
among different experiments and enumeration of all bacterial groups. Relative 
abundances of bacterial subgroups were calculated in relation to total 16S rRNA gene 
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copies for each individual using Rotor-Gene 3000 calculation software (Corbett 
operator manual) and Excel. 
 
PCR, DGGE fingerprinting  
16S rRNA coding regions were amplified using a ready-to-use mastermix (Promega) in 
a Robocycler (Stratagene). Group specific primers (table 2) were applied at the 
temperatures indicated in table 2. Reference markers containing fragments of 16S 
rRNA coding regions were loaded to each gel in triplicate to allow gel-to-gel 
comparison. DGGE gels were prepared as described previously [28] with a linear 
gradient of 25-65% for Bacteria, 30-65% for Bifidobacteria, 20-50% for Bacteroides 
and 30-50% for Clostridium cluster IV using a gradient mixer (Hoefer SG 30) and a 
peristaltic pump.  
 
Statistical analysis 
We analyzed qPCR results in Excel applying F-test and Student’s T-test. Food 
frequency data and interesting bands of DGGE fingerprints were analyzed based on 
Chi-square approximation as implemented in SPSS15. PCR-DGGE band comparison 
tables were created in GelComparII (www.applied-maths.com) and analyzed with 
principal component analysis (PCA) using the default settings in ‘R-software 
environment for statistical computing (www.r-project.org) until 100% variance 
explained. The plots show the transformed data with the first two principal 
components as x- and y- axis. Shannon diversity indices were calculated on binary 
band information (presence-absence) with the default settings implemented in the 
‘vegan’ package in ‘R’. Shannon index is defined as H = -  pi ln pi, where pi is the 
proportional abundance of species i. All tests were double sided, p<0.05 was 
considered as significant. 
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Results 
Dietary aspects 
Analysis of the participants’ dietary habits indicated similar consumption patterns of 
liquids, alcohol, fruits, grains and milk products in both groups. Exercise levels were 
comparable. Omnivores stated significantly less frequent (Chi2 Test; p<0.027) 
consumption of vegetables than vegetarians. Three of the vegetarians assessed 
followed a vegan diet; all others followed a lacto-ovo vegetarian diet. Five vegetarians 
stated to eat fish a few times a year. 
 
Relative quantitation  
Bifidobacteria, members of Clostridium cluster IV and Bacteroides were quantified as 
percentage of the total bacterial DNA (figure 1). No cross reactivity of group-specific 
primers and probes with non-target strains could be detected. Test-retest variations 
were between 2.7 % and 5.2 %, values after relative quantification varied for less than 
4 %. Vegetarians showed 12 % higher counts of bacterial DNA than omnivores but 
these differences were not significant due to high interindividual deviations. The mean 
proportion of Clostridium cluster IV in stool samples of vegetarians was 31.86 ± 17.00 
% and in omnivores 36.64 ± 14.22 %. The mean percentage of Bacteroides in 
vegetarians was 23.93 % ± 10.35 % and in omnivores 21.26 ± 8.05 %, while the mean 
proportion of Bifidobacteria in vegetarians (1.52 ± 1.29 %) was unchanged to 
omnivores (1.59 ± 1.73 %). The three vegans did not stand out in the group of 
vegetarians. 
 
PCR-DGGE quantitative analysis 
The highly diverse datasets of all bacterial groups were subjected to principal 
component analysis (PCA), which extracts underlying components within the dataset, 
separating samples according to their variance. This procedure resulted in a 
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separation of omnivores and vegetarians according to their Clostridium cluster IV 
fingerprint. Some grouping was also visible in the dominant Bacteria dataset (figure 2). 
The mean numbers of bands observed with a primer pair (341-518) targeting most 
bacteria were 20.1 ± 3.3 for omnivores and 18.07 ± 3.7 for vegetarians. The 
fingerprints of bacterial subgroups were similar for all participants. Bacteroides 
bandpatterns were composed of 9.5 ± 2.9 bands, Clostridium cluster IV of 12.75 ± 3.37 
and 13.2 ± 3.1 bands related to Bifidobacterium spp. Shannon diversity indices based 
on the DGGE fingerprinting were similar for all bacterial groups. However, two bands 
(figure 3) from Clostridium cluster IV were more prevalent in omnivores than in 
vegetarians (Chi2 Test; p<0.005; p<0.022). The first sequence was 96.7 % similar to 
Faecalibacterium prausnitziiT and 99.5 % to Faecalibacterium prausnitzii AJ270469. 
The second sequence matched next to Clostridium sp. BI-114T (similarity 94.7%) and 
uncultured bacterium, identified in a human faecal sample, DQ793301 (similarity 97.9 
%) assigned to the familiy Ruminococcaceae [29].  
 
Discussion 
 
Vegetarianism has been frequently associated with a decreased risk for different 
diseases. Therefore, we wanted to explore how vegetarian diet influences the human 
intestinal microbiota.  
We found 12 % higher counts of bacterial DNA in vegetarians than in omnivores. A 
decreased transit time of stool correlating with higher bacterial cell mass due to 
higher dietary fibre intake [30, 31], as well as pre-biotic consequences might 
contribute to this observation.  
We could also see a tendency for higher abundance of Bacteroides and lower 
abundance of Clostridium cluster IV in faecal microbiota of vegetarians compared to 
omnivores. Bacteroides can utilize a wide variety of carbon sources, and they account 
for the majority of polysaccharide digestion in the large intestine [32, 33]. 
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Nevertheless, members of Clostridium cluster IV have the same ability. We assume 
that dietary fibre favours the growth of Bacteroides. 
Clostridium cluster IV and Bacteroides also play an important role in the hydrolysis and 
fermentation of endogenous mucins and probably dietary protein, as well as in the 
conversion of bile acids and the production of toxins [33-35]. In a cross-sectional study 
of different European populations, Mueller et al. detected the highest levels of the 
Clostridium cluster IV in the Swedish study population, whose dietary habits were 
characterized by a high consumption of fish and meat [36]. Therefore, we suppose 
that higher meat consumptions may increase the abundance of the Clostridium cluster 
IV in the gut microbiota. A higher prevalence of this subgroup was discussed to be 
associated with obesity and cancer [7, 10].  
Clostridium cluster XIVa has also been discussed to be affected by vegetarian diet in a 
study with only one patient [24]. We could not find noticeable differences for this 
subgroup in our samples (using qPCR according to [37, 38], data not shown). 
PCR-DGGE fingerprinting of dominant Bacteria and Clostridium cluster IV indicated a 
grouping of vegetarians and omnivores in our study. Clustering of Clostridium cluster 
IV fingerprints might be due to the observation that two sequences identified as 
Faecalibacterium sp. and Ruminococcaceae sp. were more prevalent in omnivores 
than in vegetarians, probably due to effects of higher meat consumption as discussed 
for Clostridium cluster IV in general.  
Despite of enormous interindividual variations, we observed a tendency for smaller 
abundances of Clostridium cluster IV in vegetarians. This might suggest a smaller 
capacity for energy gain from food in vegetarians. Higher abundances of fibrolytic 
Bacteroides were found and might compensate for reductions in Clostridium cluster 
IV. This shift in these nutritionally important bacterial subgroups might account for the 
distinct grouping of omnivores and vegetarians in PCA of dominant bacterial 
fingerprints. Summarizing, it remains to be determined if these shifts result in 
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differential metabolite profiles that might in turn affect host metabolism and disease 
risks. 
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Tables 
 
Table 1: Primers and probes used for quantification of faecal bacteria using TaqMan 
assays targeting 16S rRNA coding regions.  
Target organism 
Primer and 
probe 
Sequence (5' - 3') 
Size 
(bp) 
Conc. 
(nM) 
Refere
nce 
Bifidobacterium 
spp. 
Forward 
primer  
GCG TGC TTA ACA CAT GCA 
AGT C 
125 300  
 Reverse 
primer  
CAC CCG TTT CCA GGA GCT 
ATT 
 300  
 
Probe  
(FAM)- TCA CGC ATT ACT CAC 
CCG TTC GCC -(BHQ-1) 
 150 [39] 
Bacteroides AllBac296f GAG AGG AAG GTC CCC CAC 106 300  
 AllBac412r CGC TAC TTG GCT GGT TCA G  300  
 AllBac375Bh
qr 
(FAM)-CCA TTG ACC AAT ATT 
CCT CAC TGC TGC CT-(BHQ-1) 
 100 [40] 
All Bacteria BAC-338-F ACT CCT ACG GGA GGC AG 468 1000  
 BAC-805-R GAC TAC CAG GGT ATC TAA  1000  
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TCC  
 
BAC-516-P 
(FAM)-TGC CAG CAG CCG CGG 
TAA TAC-(BHQ-1) 
 200 [41] 
Clostridium cluster 
IV 
sg-Clept-F GCA CAA GCA GTG GAG T 239 400   
 sg-Clept-R3 CTT CCT CCG TTT TGT CAA  400 [37] 
 
Clept-P++ 
(FAM)-AGG GTT GCG CTC GTT-
(BHQ-1) 
 200 
This 
study 
++ position of target site (numbering corresponding to E . coli 16S rRNA gene) 1082 to 
1107. 
 
Table 2: Primers applied for PCR-DGGE fingerprinting of 16S rRNA coding regions. 
Target 
organism 
Primer 
pairs 
Sequence (5’-3’) 
Ann. 
temp 
(°C) 
Reference 
All Bacteria 27f GTGCTGCAGAGAGTTTGATCCTGGCTCAG 57 [42] 
 985r GTAAGGTTCTTCGCGTT 57 [43] 
 341f-GC CCT ACG GGA GGC AGC AG 55 [23] 
 518r ATT ACC GCG GCT GCT GG 55 [44] 
Bacteroides 32f AACGCTAGCTACAGGCTT 56 [45] 
 708r CAATCGGAGTTCTTCGTG 56 [45] 
Bifidobacteri
a 
g-BifidF CTCCTGGAAACGGGTGG 58 [46] 
 g-BifidR GGTGTTCTTCCCGATATCTACA 58 [46] 
Clostridium 
cluster IV 
sg-Clept-
F-GC 
See table 1 55 [47] 
 
sg-Clept-
R3 
See table 1  [47] 
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Figures 
 
 
Figure 1: PCR-DGGE bandpatterns of 16S rRNA coding regions of Clostridium cluster IV 
amplified with primer pair sg-Clept-F-GC/sg-Clept-R. Bands that were observed more 
frequently in omnivores than in vegetarians are indicated with a black box. 1: 94.7% 
similarity to Clostridium sp. BI-114T and 97.9 % similarity to uncultured bacterium 
DQ793301; 2: 96.7 % similar to Faecalibacterium prausnitziiT and 99.5 % to 
Faecalibacterium prausnitzii AJ270469 1: Clostridium sp. BI-114T (similarity 94.7%) and 
uncultured bacterium DQ793301 (similarity 97.9 %). 
, omnivores; , vegetarians; REF, reference lane 
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Figure 2: PCA of DGGE fingerprints of 16S rRNA coding regions of dominant Bacteria, 
Clostridium cluster IV, Bacteroides and Bifidobacteria in faecal samples.  
, omnivores; , vegetarians 
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Abstract:  
Butyrate is a bacterial metabolite of the human gastro-intestinal microbiota with 
considerable importance for colonic health.  
We compared butyryl-CoA CoA transferase gene abundances with a 16S rRNA gene 
quantification of bacteria, Clostridium cluster IV & XIVa in order to assess the butyrate 
production capacities in human microbiota samples. 
Faecal samples of young healthy omnivores (n=15, age: 24 ± 2.5 yrs/BMI 22.68  3.4), 
vegetarians (n=15, age: 26 ± 5 yrs/ BMI 21.02 ± 2.71) and elderly (n=15, age: 86 ± 8 yrs 
/ BMI 21.75  5.08) were analysed in quantitative PCR (qPCR). Diet and lifestyle was 
assessed in questionnaire-based interviews.  
Elderly had significantly less copies of the butyryl-CoA CoA-transferase gene than 
omnivores (p=0.014) and vegetarians (p=0.048). The butyrate gene variant related to 
Roseburia/E.rectale spp. was significantly more variable in vegetarians than in elderly. 
At the same time the Clostridium cluster XIVa was more abundant in vegetarians 
(p=0.049) and omnivores (p=0.0018). Our results indicate that vegetarian as well as 
omnivore diet has a similar potential to shape a healthy microbiota. 
The elderly microbiota was characterized by low butyrate production capacity, 
possibly contributing to the development of degenerative diseases and anorexia in 
advanced age. 
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Introduction 
The human gastrointestinal (GI) tract harbours a microbiota, whose number of cells 
exceeds the human body cells by a factor of 10 or 100 (1). Recent evidence suggests 
that 1000- 1150 different species are capable of living in the gut ecosystem (2). An 
individual harbours at least 160 species (2), with great inter-individual variations in 
species diversity and evenness.  
It has previously been suggested that the microbiota composition is influenced by diet 
(3) (4) (5), health status (6) (7), age (8) (9) as well as genetic factors (10).The GI-
microbiota produces short chain fatty acids (SCFAs), mainly acetate, propionate and 
butyrate, as intermediates and end products of the degradation of dietary 
compounds. Acetate and propionate are metabolites for gluconeogenesis in the liver 
(11). Butyrate is the major energy source for colonocytes and is known to regulate 
various processes in the human distal gut.  
Butyrate has been of particular interest due to its anticancerogenic and anti-
inflammatory potential (12), effect on the intestinal barrier (13), visceral pain (14) role 
in satiety (15) and oxidative stress (16). Butyrate induces apoptosis in colorectal 
tumour cell lines, reduces metastasis, and protects from genotoxic carcinogens by 
enhancing expression of phase II detoxification enzymes (17).  
Two of the most important groups of butyrate producers appear to be 
Faecalibacterium prausnitzii from the Clostridium leptum cluster (or Clostridium 
cluster IV), and the Eubacterium rectale/Rosebura spp. which belong to the 
Clostridium coccoides cluster (or Clostridium cluster XIVa). The distribution of butyrate 
production among firmicute bacteria is uneven, and the abundant clusters IV and XIVa 
indicate both producers and nonproducers of butyrate (18).  
Faecalibacerium praunsnitzii is a net acetate utilizer able to hydrolyse starch, inulin, 
fructose and oligofructose. Strains of F.prausnitzii differ in their ability to utilize 
cellobiose, maltose and melezitose (18). Within the genus Roseburia the ability to 
utilize polysaccharides such as amylopectin, inulin (cichory), and xylan in pure cultures 
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is widespread, whereas some strains appear to survive by metabolic cross-feeding 
(19). In spite of their ability to utilize polysaccharides in pure culture, Roseburia spp. 
have been described to compete poorly for these substrates in mixed culture 
fermentor systems (19). 
In human feeding trials, isolated dietary compounds have been shown to promote 
growth of butyrate producers (20, 32). For example, the consumption of inulin 
significantly stimulated growth of F.prausnitzii The abundance of Roseburia spp. in 
response to inulin supplementation increased in those individuals who harboured 
Roseburia inulinovorans, otherwise decreased (20). 
Butyrate is readily taken up by the gut mucosa, so that faecal levels give little 
information on the butyrate producing capacity of the gut microbiota. Therefore, a 
functionally based approach was suggested for the enumeration of butyrate-
producing bacteria (21) targeting the butyryl-CoA CoA transferase gene. This gene was 
described to be well conserved phylogenetically (21). Furthermore, the butyryl-CoA 
CoA transferase route, using acetate as a co-substrate, was suggested to be the most 
important route for butyrate production in the gut ecosystem (22). Alternative routes 
for the final steps of butyrate sysnthesis in anaerobic bacteria occur via butyrate 
kinase or phosphotransbutyrylase that were found to occur in only a minority of 
bacteria (23) in the human GI tract. 
To our knowledge, it has not yet been described if complex dietary behaviours or 
other epidemiologically defined host factors have a measurable influence on butyrate 
production. We compared butyryl-CoA CoA transferase gene abundances in young 
healthy omnivores, vegetarians and institutionalized elderly by real-time PCR together 
with a 16S rRNA gene quantification of Clostridium cluster IV & XIVa. 
 
Materials and Methods 
Study subjects: 
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Group of individuals and sample material used in this study was the same as that used 
by Zwielehner et al. (2009) and Liszt et al. (2009) (24, 25). The geriatric group (elderly) 
based on 15 institutionalized subjects (age: 86 ± 8 yrs / BMI 21.75  5.08) from a 
geriatric department in Vienna. The vegetarian diet group (vegetarian) consisted of 15 
young healthy subjects with a vegetarian (age: 26 ± 5 yrs/ BMI 21.02 ± 2.71). 
Seventeen young healthy subjects (age: 24 ± 2.5 yrs/BMI 22.68  3.4) with a Central 
European diet formed the mixed diet group (omnivores). 
All volunteers were interviewed using a questionnaire assessing: age, gender, body 
height, weight, individual health status (including chronic or acute diseases and blood 
lipid levels), life-style aspects such as physical activity and dietary habits. Group 
populations were gender balanced. Only non-pregnants and probands without 
digestive/gastrointestinal symptoms and no antibiotic or chemotherapeutic treatment 
three months prior to sampling participated on this study. All probands agreed to 
participate in the study and gave their informed consent. Approval was obtained from 
the viennese Human Ethics committee (3., Thomas-Klestil-Platz 8/2).  
 
Quantification of specific metabolic genes and 16S rRNA genes by real-time PCR 
(qPCR) 
The butyryl-CoA CoA transferase gene was amplified with degenerate primers 
BCoATscrF 5’- GCIGAICATTTCACITGGAAYWSITGGCAYATG –3’ and BCoATscrR 5’- 
CCTGCCTTTGCAATRTCIACRAANGC –3’ as described elsewhere (20) on a Rotor-Gene 
3000A (QIAGEN) using the SensiMix Sybr (QIAGEN). Absolute quantification was 
performed using a purified PCR product of know concentration and known length. 
Amplification with primer pair BcoATscr resulted in clearly distinguishable peaks. 
Those peaks were grouped according to their melt temperatures as previously 
described (23). These different peaks (presented as dF/dT) were attributed to 
Eubacterium hallii & SS2/1 (83.2-84.54°C), Roseburia/Eubacterium rectale spp. (85.84-
87.07°C) and Faecalibacterium prausnitzii (88.08-89.53°C) (23). Clostridium clusters IV 
and XIVa were quantified on a Rotor-Gene 3000A (QIAGEN) using the SensiMix Taq 
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(QIAGEN). Dominant bacteria were amplified as previously described (26). The 
Clostridium leptum cluster was quantified using CleptF 5’-gcacaagcagtggagt-3’, CleptR 
5’-cttcctccgttttgtcaa-3’ (27) and CleptP 5’- (FAM)-AGG GTT GCG CTC GTT-(BHQ-1)-3’ 
(24). The Clostridium coccoides cluster was amplified using 195F 5’- 
GCAGTGGGGAATATTGCA-3’ (28), Ccocc-F-P 5’- (FAM)- AAATGACGGTACCTGACTAA-
(BHQ-1)-3’ and Ccocc-R 5’- CTTTGAGTTTCATTCTTGCGAA-3’ (27). Amplification 
programs included an initial denaturation at 95°C for 10 min followed by 40 cycles 
consisting of denaturation at 95°C for 30 s, annealing at 53°C (butyryl-CoA CoA 
transferase gene) 55°C (bacteria, Clostridium cluster IV), 56°C (Clostridium cluster 
XIVa) for 30 s and extension at 72°C for 50 s. Samples were quantified using a cloned 
sequence with known concentration in the case of Clostridium cluster IV and Blautia 
coccoidesT pure culture for cluster XIVa. Clone libraries obtained with primer pair 
195F- CcoccR and CleptF-CleptR were analysed to confirm the specificity of the chosen 
primers. 
 
Data analysis 
All statistical analyses were calculated using Origin Pro (www.originlab.com). The F-
test was used to test equality of variances. Normality was determined applying the 
Kolmogorov-Smirnov test. ANOVA was performed using the nonparametric Kruskal-
Wallis test. Normally distributed data series were pairwise compared using the 
Student’s t-test. Spearman’s rank correlation coefficient was determined between the 
abundance of clostridial cluster IV and XIVa and the corresponding butyrate gene melt 
peaks (88.08-89.53°C) and (85.84 – 87.07°C, 83.2-84.54°C). 
 
Results 
Dietary analysis 
Exercise levels (vegetarians to omnivores) were comparable. Analysis of the 
participants’ dietary habits indicated similar consumption in respect of fruit and milk 
products in the individual groups. Vegetarians stated significantly more frequent (Chi2 
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Test; p<0.027) consumption of vegetables than omnivores but similar consumption 
patterns of carbohydrates, including whole grain products several times a week. The 
elderly group stated significantly more frequent (Chi2 Test; p<0.04) consumption of 
meat and similar vegetable consumption than young omnivores. The elderly did not 
consume any whole grain products. Because many well known SCFA systhesising 
bacteria belong to the clostridial clusters IV and XIVa we analysed those bacterial 
subgroups relative to total bacterial DNA. 
 
Relative Quantitation 
Vegetarians had 12 ± 62% more bacterial DNA than omnivores. Elderly had 31 ± 21% 
less bacterial DNA than young omnivores. These differences were not significant due 
to high individual variations. Many well-known SCFA synthesising bacteria belong to 
Clostridium clusters IV and XIVa. These clostridial clusters XIVa und IV were quantified 
relative to total bacterial DNA (figure 1). The Clostridium cluster IV was significantly 
more abundant in omnivores (36.3 ± 11.2%) than in elderly (27 ± 11.7%, p=0.036). 
Vegetarians harboured Clostridium cluster IV at 31.86 ± 17.00%. The Clostridium 
cluster XIVa was significantly more abundant in omnivores (19.01 ± 6.7%, p=0.0018) 
and vegetarians (14.52 ± 5.6%, p=0.049) than in elderly (9.89 ± 6.64%). 
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Figure 1: Relative quantities of Clostridium cluster IV and XIVa based on group-specific 
qPCR of 16S rRNA genes. 
 
Detection of butyryl-CoA CoA-transferase genes in faeces by RT-PCR 
The butyryl-CoA CoA transferase gene was analysed applying the BCoATscr primer pair 
[1] (figure 2). Elderly (11.07 ± 14.84ng/µl) had significantly less copies of the butyryl-
CoA CoA-transferase gene than omnivores (38.66 ± 35.04 ng/µl, p=0.014) and 
vegetarians (106.89 ± 164.41ng/µl, p=0.048).  
Given even disribution of the butyryl-CoA CoA transferase gene among the gastro-
intestinal bacteria, those values would correlate with the overall abundance of 
bacteria on an individual level. Spearman’s rank correlation test showed that the 
abundance of the butyryl-CoA CoA transferase gene did not correlate with bacterial 
abundance. 
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Figure 2: Quantification of the butyryl-CoA CoA transferase gene in faecal samples. 
Asterisk indicates a significant difference at the 95% confidence interval, rectangular 
marks represent mean levels; medians are indicated with a line. 
 
To evaluate diversity and abundance of different variants of the butyryl-CoA CoA 
transferase gene melt curves from faecal samples (figure 3) were divided into three 
areas as described by Louis et al. (20). Peaks broadly represent bacteria related to 
Eubacterium hallii and SS2/1 (83.2 – 84.54°C), Roseburia/E.rectale spp. (85.84 – 
87.07°C) and F.prausnitzii (88.08 – 89.53°C). 
The Eubacterium hallii / SS2/1 melt peak tended to be higher in vegetarians (p=0.08) 
and omnivores (p=0.09) than in elderly.  
In both omnivores and vegetarians 12 out of the 15 participants harboured a 
E.rectale/Roseburia spp. melt peak, whereas only 6 elderly did. ANOVA showed that 
the abundance of this particular butyrate gene differed significantly between 
vegetarians and elderly (p=0.04).  
* 
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One of the most abundant representatives of Clostridium cluster IV in human faeces is 
F.prausnitzii. The abundance of the melt peak attributed to F.prausnitzii did not differ 
in vegetarians, omnivores and elderly. 
To see if the abundance of the butyryl-CoA CoA transferase genes of 
E.rectale/Roseburia spp. correlated with the abundance of Clostridium cluster XIVa at 
an individual level, spearman’s rank correlation test was calculated. The same test was 
used to find out if the abundance of the F.prausnitzii butyryl-CoA CoA transferase 
gene correlated with the abundance of Clostridium cluster IV. No correlation between 
abundance of the phylogenetically conserved butyrate genes with the clostridial 
clusters could be found. 
 
Figure 3: Quantification of butyryl-CoA CoA transferase genes grouped according to 
their melt curves.  
v, vegetarian; o, omnivore; e, elderly; rectangular marks represent mean levels; 
medians are indicated with a line. 
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Discussion 
 
To our knowledge, it has not yet been described if complex dietary behaviours or other 
epidemiologically defined host factors have a measurable influence on butyrate 
production. This study asks if elderly, young omnivores and young vegetarians differ in 
abundances of butyryl-CoA CoA transferase genes and polysaccharide degrading 
bacteria of the clostridial clusters IV and XIVa. Furthermore, we ask if these functional 
gene-based and 16S rRNA gene-based abundances correlate with each other. 
Young vegetarians and omnivores had significantly more copies of the butyryl-CoA 
CoA-transferase gene than elderly. Analysis of the overall abundance of bacterial 16S 
rRNA genes revealed that vegetarians harboured more bacteria than omnivores; 
lowest numbers of bacteria were found in elderly individuals in spite of great 
individual variations. On an individual scale butyryl-CoA CoA transferase gene 
abundance did not correlate with overall bacterial 16S rRNA gene abundance. 
In a melt curve analysis three groups of butyryl-CoA CoA transferase genes could be   
identified. Louis et al. (20) found that melt curve patterns corresponded well with 16S 
rRNA gene abundances of E.hallii/SS2/1, Roseburia/E.rectale spp. and F.prausnitzii.  
The butyrate gene variant related to Roseburia/E.rectale spp. was significantly more 
variable in vegetarians than in elderly. At the same time the Clostridium cluster XIVa 
was more abundant in vegetarians. The abundance of the Clostridium cluster XIVa did 
not correlate with the abundances of the butyrate gene variant related to 
Roseburia/E.rectale spp.  
The Clostridium cluster IV was significantly more abundant in omnivores than in 
elderly. One of the most abundant representative of Clostridium cluster IV in human 
faeces is F.prausnitzii. The abundance of the melt peak attributed to F.prausnitzii did 
not differ in vegetarians, omnivores and elderly. 
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The primer pairs used here broadly target the clostridial clusters IV and XIVa. As 
previously described (18) the abundance of butyrate producers in cluster IV and XIVa 
is uneven. 
Vegetarian diet might have –in some individuals- favoured growth of 
Roseburia/E.rectale spp. that carry the butyryl-CoA CoA transferase gene, without 
causing an increase of the entire Clostridium cluster XIVa.  
In other vegetarians, Clostridium cluster XIVa occurred at high abundance without a 
concomitant increase of the butyratyl-CoA CoA transferase gene of 
Roseburia/E.rectale spp.  
In our study omnivores had a similar potential to harbour members of Clostridium 
cluster IV and XIVa and butyryl-CoA CoA transferase than vegetarians. We conclude 
that both vegetarian as well as omnivore diet have a similar potential to shape a 
healthy microbiota.  
Our results point out that elderly harbour less Clostridium cluster IV and XIVa in 
already low levels of overall bacterial. Together with lower abundance of the butyryl-
CoA CoA transferase gene, our results indicate that the elderly microbiota might be 
characterized by low butyrate production capacity. Considering the important 
nutritive, anti-inflammatory and anticancerogenic potential of butyrate in the human 
colon, these findings point out that these microbiota specificities might contribute to 
the development of degenerative diseases (8) and anorexia in advanced age. 
Determining the indigenous microbiota composition might be a suitable strategy to 
learn if/which dietary intervention with prebiotic fibre might be useful to enhance 
butyrate production in the colon sustainably. In individuals who do not harbour 
butyric acid producing species, probiotic supplementation or the administration of 
coated butyrate capsules might be better alternatives than increased ingestion of 
dietary fibre. 
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Physical activity has been described as an important factor for gut motility and 
intestinal passage time (29). Gut motility and intestinal passage time have been 
described to be major determinants of bacterial growth in the gut ecosystem (29). In 
addition to lower physical activity, elderly study participants did not consume any 
whole grain products, whereas young volunteers did state regular consumption of 
such fibre-rich products. Further research is required to investigate the possibility of 
deliberately introducing butyrate-producing species into the human GI-tract via 
probiotic supplementation. 
Assessment of dietary behaviour is affected by bias, because quick and affordable                             
methods based on questionnaires rely on self-reporting (30) and accurate, well 
maintained food databases. 
Quantification of selected biomarkers might be better suited for an individualized                              
assessment of GI-health and microbiota function. 
In addition to the possible bias inherent to all PCR based methods, amplification of the 
16S rRNA gene can be particularly biased because bacteria can have multiple operons 
for the 16S rRNA gene (31). Thus, quantification of the butyryl-CoA CoA transferase 
gene might is a suitable biomarker for butyrate production capacity and GI-health in 
addition to quantification of the 16S rRNA genes of Clostridium cluster IV and XIVa 
alone. 
Our melt curve analysis assumes that the intensity of individual peaks represent the 
initial proportion of the different butyryl-CoA CoA transferase gene variants. Bias 
might have come from different amplification efficiencies of the phylogenetically 
conserved gene variants.  
The use of degenerate primers carries a certain risk for unspecific amplification of non-
target DNA. As a rough estimation of the accuracy of our amplification, we checked 
every PCR product in 2% agarose gels where all PCR products gave bands of the 
expected size. 
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A more detailed dietary analysis, possibly also including a weighing log of all the food 
ingested will be necessary in the future to gain further insight into the effects of diet 
on the GI microbiota. Quantification of the butyryl-CoA CoA transferase gene might be 
a suitable biomarker for butyrate production capacity together with quantification of 
the clostridial clusters IV and XIVa. 
 
ACKNOWLEDGEMENTS 
We cordially thank all volunteers who took part in this study, Dr. Katrin Sterflinger and 
Dr. Guadalupe Pinar for granting access to their DNA quantification machinery and Dr. 
Konrad Domig for growing anaerobic reference bacteria. The FWF science fund Austria 
funded this study. 
 
1. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal 
microbial flora. Science 2005;308:1635-8. 
2. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by 
metagenomic sequencing. Nature;464:59-65. 
3. Hayashi H, Sakamoto M, Benno Y. Fecal microbial diversity in a strict vegetarian 
as determined by molecular analysis and cultivation. Microbiol Immunol 
2002;46:819-31. 
4. Benus RF, van der Werf TS, Welling GW, et al. Association between 
Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy 
human subjects. Br J Nutr:1-8. 
5. Mai V, McCrary QM, Sinha R, Glei M. Associations between dietary habits and 
body mass index with gut microbiota composition and fecal water genotoxicity: 
an observational study in African American and Caucasian American 
volunteers. Nutr J 2009;8:49. 
6. Swidsinski A, Loening-Baucke V, Vaneechoutte M, Doerffel Y. Active Crohn's 
disease and ulcerative colitis can be specifically diagnosed and monitored 
 184 
 
based on the biostructure of the fecal flora. Inflamm Bowel Dis 2008;14:147-
61. 
7. Larsen N, Vogensen FK, van den Berg FW, et al. Gut microbiota in human adults 
with type 2 diabetes differs from non-diabetic adults. PLoS One;5:e9085. 
8. Guigoz Y, Dore J, Schiffrin EJ. The inflammatory status of old age can be 
nurtured from the intestinal environment. Curr Opin Clin Nutr Metab Care 
2008;11:13-20. 
9. Mariat D, Firmesse O, Levenez F, et al. The Firmicutes/Bacteroidetes ratio of 
the human microbiota changes with age. BMC Microbiol 2009;9:123. 
10. Khachatryan ZA, Ktsoyan ZA, Manukyan GP, Kelly D, Ghazaryan KA, Aminov RI. 
Predominant role of host genetics in controlling the composition of gut 
microbiota. PLoS One 2008;3:e3064. 
11. Kiefer J, Beyer-Sehlmeyer G, Pool-Zobel BL. Mixtures of SCFA, composed 
according to physiologically available concentrations in the gut lumen, 
modulate histone acetylation in human HT29 colon cancer cells. Br J Nutr 
2006;96:803-10. 
12. Csordas A. Butyrate, aspirin and colorectal cancer. Eur J Cancer Prev 
1996;5:221-31. 
13. Peng L, He Z, Chen W, Holzman IR, Lin J. Effects of butyrate on intestinal barrier 
function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr Res 
2007;61:37-41. 
14. Vanhoutvin SA, Troost FJ, Kilkens TO, et al. The effects of butyrate enemas on 
visceral perception in healthy volunteers. Neurogastroenterol Motil 
2009;21:952-e76. 
15. Cani PD, Lecourt E, Dewulf EM, et al. Gut microbiota fermentation of prebiotics 
increases satietogenic and incretin gut peptide production with consequences 
for appetite sensation and glucose response after a meal. Am J Clin Nutr 
2009;90:1236-43. 
16. Hamer HM, Jonkers DM, Bast A, et al. Butyrate modulates oxidative stress in 
the colonic mucosa of healthy humans. Clin Nutr 2009;28:88-93. 
 185 
 
17. Comalada M, Bailon E, de Haro O, et al. The effects of short-chain fatty acids on 
colon epithelial proliferation and survival depend on the cellular phenotype. J 
Cancer Res Clin Oncol 2006;132:487-97. 
18. Pryde SE, Duncan SH, Hold GL, Stewart CS, Flint HJ. The microbiology of 
butyrate formation in the human colon. FEMS Microbiol Lett 2002;217:133-9. 
19. Duncan SH, Scott KP, Ramsay AG, et al. Effects of alternative dietary substrates 
on competition between human colonic bacteria in an anaerobic fermentor 
system. Appl Environ Microbiol 2003;69:1136-42. 
20. Louis P, Young P, Holtrop G, Flint HJ. Diversity of human colonic butyrate-
producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-
transferase gene. Environ Microbiol 2009. 
21. Louis P, Scott KP, Duncan SH, Flint HJ. Understanding the effects of diet on 
bacterial metabolism in the large intestine. J Appl Microbiol 2007;102:1197-
208. 
22. Duncan SH, Holtrop G, Lobley GE, Calder AG, Stewart CS, Flint HJ. Contribution 
of acetate to butyrate formation by human faecal bacteria. Br J Nutr 
2004;91:915-23. 
23. Louis P, Duncan SH, McCrae SI, Millar J, Jackson MS, Flint HJ. Restricted 
distribution of the butyrate kinase pathway among butyrate-producing bacteria 
from the human colon. J Bacteriol 2004;186:2099-106. 
24. Liszt K, Zwielehner J, Handschur M, Hippe B, Thaler R, Haslberger AG. 
Characterization of bacteria, clostridia and Bacteroides in faeces of vegetarians 
using qPCR and PCR-DGGE fingerprinting. Ann Nutr Metab 2009;54:253-7. 
25. Zwielehner J, Liszt K, Handschur M, Lassl C, Lapin A, Haslberger AG. Combined 
PCR-DGGE fingerprinting and quantitative-PCR indicates shifts in fecal 
population sizes and diversity of Bacteroides, bifidobacteria and Clostridium 
cluster IV in institutionalized elderly. Exp Gerontol 2009;44:440-6. 
26. Yu Y, Lee C, Kim J, Hwang S. Group-specific primer and probe sets to detect 
methanogenic communities using quantitative real-time polymerase chain 
reaction. Biotechnol Bioeng 2005;89:670-9. 
 186 
 
27. Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R. Use of 16S rRNA gene-
targeted group-specific primers for real-time PCR analysis of predominant 
bacteria in human feces. Appl Environ Microbiol 2004;70:7220-8. 
28. Meier H, Amann R, Ludwig W, Schleifer KH. Specific oligonucleotide probes for 
in situ detection of a major group of gram-positive bacteria with low DNA G + C 
content. Syst Appl Microbiol 1999;22:186-96. 
29. Bhutto A, Morley JE. The clinical significance of gastrointestinal changes with 
aging. Curr Opin Clin Nutr Metab Care 2008;11:651-60. 
30. Klingberg S, Hallenberg E, Lorentzon M, Mellstrom D, Ohlsson C, Hulthen L. 
Characteristics of under- and over-reporters of energy intake among 18-20-
year-old males: the Gothenburg Osteoporosis and Obesity Determinants 
(GOOD) study. Public Health Nutr 2008;11:1117-23. 
31. Klappenbach JA, Saxman PR, Cole JR, Schmidt TM. rrndb: the Ribosomal RNA 
Operon Copy Number Database. Nucleic Acids Res 2001;29:181-4. 
32. Hernot DC, Boileau TW, Bauer LL, Middelbos IS, Murphy MR, Swanson KS, 
Fahey GC Jr. In vitro fermentation profiles, gas production rates, and 
microbiota modulation as affected by certain fructans, 
galactooligosaccharides, and polydextrose. J Agric Food Chem. 2009 Feb 
25;57(4):1354-61. 
 
 
 
 
  
 187 
 
10.2 Changes in human fecal microbiota due to chemotherapy analyzed 
by TaqMan-PCR and PCR-DGGE fingerprinting 
 
Zwielehner, J.1, Lassl, C.1, Pointner, A.1, Hippe, B.1, Ruckser, R.2, Haslberger, A.G.1* 
 
1 Department  of Nutritional Sciences, Vienna, Austria 
2 Sozialmedizinisches Zentrum Ost, Vienna, Austria 
 
 
Abstract 
We investigated whether chemotherapy  antibiotics against different kinds of cancer 
change the gastrointestinal microbiota with special regard to the genera Bacteroides, 
bifidobacteria, Clostridium cluster IV and XIVa and the potential appearance of 
Clostridium difficile. 
Feces of eleven ambulant patients receiving chemotherapy ± accompanying 
antibiotics were analyzed before and after the onset of treatment at four time points 
in comparison to 9 gender-, age- and lifestyle-matched healthy controls. We targeted 
16S rRNA genes of bacteria, Bacteroides, bifidobacteria, Clostridium cluster IV and 
XIVa as well as C. difficile with TaqMan qPCR and denaturing gradient gel 
electrophoresis (DGGE) fingerprinting. 
Molecular analysis of the fecal microbiota showed that chemotherapeutic ± antibiotic 
treatment significantly decreased the abundance of bacteria. After the end of 
chemotherapeutic cycles the microbiota recovered within a few days sometimes even 
showing a “rebound-effect”. The chemotherapeutical treatment marginally affected 
the genus Bacteroides while the genera Clostridium cluster IV and XIVa were more 
sensitive to chemotherapy and antibiotic treatment. DGGE fingerprinting showed 
decreased diversity of bacteria and Clostridium cluster XIVa and altered diversity of 
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Clostridium cluster IV in response to chemotherapy. The incidence of C. difficile in two 
out of eleven subjects was accompanied by a decrease of the genera bifidobacteria 
and Clostridium cluster IV. 
Despite high individual variations, these results suggest that changes in the human 
microbiota are a side effect of chemotherapy  antibiotic treatment. Perturbed 
microbiota could be one cause for severe gastrointestinal disturbances and therefore 
may be a target for specific mitigation with safe pre- and probiotics. 
 
Introduction 
The intestinal ecosystem constitutes the microbiota that can be pictured as a 
microbial organ placed within a host organism and involves a dynamic interplay 
between food, host cells and microbes (Turroni et al., 2008). The microbiota plays 
several significant roles in the digestion of food, energy regulation, generation of 
short-chain fatty acids, vitamin synthesis, prevention of colonization by pathogens and 
protection against cell injury (Tlaskalova-Hogenova et al., 2004; Backhed et al., 2005; 
De La Cochetiere et al., 2005; Eckburg et al., 2005; Turnbaugh et al., 2009). Moreover, 
the gut microbiota influences the host by directing intestinal epithelial cell 
proliferation and differentiation, pH, and the development of the immune system 
(Turroni et al., 2008). Recent culture-independent molecular studies on healthy 
individuals have shown that the intestinal microbiota is specific to the host and 
resistant to modifications over time (De La Cochetiere et al., 2005). 
A healthy microbiota contains a balanced composition of many classes of bacteria 
(Round & Mazmanian, 2009). The fecal microbiota is dominated by the Clostridium 
coccoides group - clostridial cluster XIVa (lately reclassified by Liu et al. as Blautia 
coccoides) the Clostridium leptum group - Clostridium cluster IV and the Bacteroides 
(Liu et al., 2008; Maukonen et al., 2008). All three groups are known to positively 
affect the gut health through nutrient absorption, production of short chain fatty acids 
(SCFAs) and epithelial cell maturation (Maukonen et al., 2006; Woodmansey, 2007). 
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Moreover, the subgroup bifidobacteria seems to be an important part of the GI 
microbiota, being involved in the prevention of atopic disease, obesity and insulin 
resistance via enhanced barrier function of the gut epithelium (Zwielehner et al., 
2009). 
To prevent the invasion of endogenous bacteria from oral cavity and the 
gastrointestinal tract, three defense mechanisms are considered to be relevant: innate 
immunity, mechanical mucosal barrier, and colonization resistance (van Vliet et al., 
2009). However, chemotherapy and the use of antibiotics damage the rapidly 
generated mucosal cells of the gastrointestinal tract and disrupt the ecological 
balance, allowing pathogens such as Clostridium difficile to grow (Nyhlen et al., 2002; 
Guarner & Malagelada, 2003). This bacterium is thought to be the causative agent in 
up to 20% of antibiotic-associated diarrhea (AAD) cases (Koning et al., 2008). It is 
evident that the intestinal microbial ecosystem has an important but incompletely 
defined role in mucosal protection (Croswell et al., 2009). 
Mucositis is a major oncological problem, caused by the cytotoxic effects of cancer 
chemotherapy and radiotherapy. Approximately 40% of patients receiving standard 
dose chemotherapy and up to 100% of patients receiving high dose chemotherapy 
and stem cell or bone marrow transplantation suffer from abdominal pain, ulceration, 
bloating and vomiting (Stringer et al., 2007; Stringer et al., 2009). Although 
gastrointestinal disturbances (mucositis, diarrhoea and constipation) and 
immunosuppression are well recognised side-effects of cancer treatment, very little 
research has been conducted into the underlying mechanisms and the changes in the 
composition of the microbiota. Because of these changes, nutrient absorption and 
other intestinal functions involving the microbiota may also be altered (Gibson & 
Keefe, 2006).  
For this reason, we investigated shifts in fecal microbiota of patients receiving cancer 
chemotherapy with or without antibiotics in comparison to healthy control 
individuals. We sampled at four time points before or after chemotherapy to study 
changes in fecal microbiota over the course of time. In this study we aimed to clarify 
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how chemotherapy agents influence fecal bacteria, Bacteroides, bifidobacteria, 
Clostridium cluster IV, Clostridium cluster XIVa and C. difficile using culture-
independent methods assessing abundance and diversity. Furthermore, we 
hypothesize that the human fecal microbiota is resilient in its ability to return to its 
original composition after cycles of chemotherapy. 
 
Material and Methods 
Study participants and study design 
Eleven subjects receiving chemotherapy with or without antimicrobial therapy (aged 
55 ± 14 years, BMI 28 ± 7) from the Sozialmedizinisches Zentrum Ost in Vienna and 
nine healthy individuals (aged 55 ± 21 years, BMI 24 ± 5) joined this study. Fecal 
samples of each ambulant oncology patient were collected at four time points within 
two weeks before and after the onset of treatment. Two out of eleven patients had 
never received any chemotherapy before, while the others had a history of 
chemotherapy. One subject receiving chemotherapy additionally suffered from 
rheumatism while another subject suffered from diabetes mellitus type II, 
hypertension and obesity. Anonymous medical records reported types of malignancies 
as well as chemotherapeutic and antimicrobial treatment. Four individuals suffered 
from a form of leukaemia, three patients suffered from a form of lymphoma (non-
hodgekin). Other malignancies were breast cancer, bladder cancer ovarian 
arrhenoblastoma and multiple myeloma. Among the chemotherapeutic regimens 
were bendamustin, bortezomib, cytarabin, dexamethosane, doxorubicin, etoposid, 
gemcitabine, idarubicin and melphalan. Leukaemia patients furthermore received G-
CSF (neupogen) and/or radiated erythrocyte concentrate. 
Stool samples of healthy individuals were collected once. Study populations were 
gender balanced, with 55% females in both oncology patients and healthy controls. 
We interviewed all study participants assessing: age; gender; body length; weight; 
health status (chronic and acute diseases); life-style aspects such as cigarette and 
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alcohol consumption as well as physical activity. Dietary habits were assessed using a 
food frequency questionnaire. Exclusion criteria for healthy controls were (a) 
antimicrobial medication (b) chemotherapeutic treatment and (c) pre- and probiotics 
at least three months before sample collection.  
All subjects gave written informed consent. The ethics committee of Vienna approved 
the study. 
 
Stool sample processing 
After collection, stool samples were brought to the laboratory and immediately stored 
at -70°C. A 200 mg aliquot of each sample was treated twice for 45 s in a bead-beater 
(Mini-Beadbeater-8). Thereafter DNA was extracted using the QIAamp® DNA Stool 
Mini Kit (QIAGEN) following the manufacturer’s protocol. Finally we stored the DNA at 
-20°C until analysis. 
 
Type strains 
We used type strains, known to be part of the human gastrointestinal microbiota and 
cloned sequences, to design a DGGE standard lane marker. Type strains Bacteroides 
thetaiotaomicron DSM 2079T, Enterococcus faecium DSM 20477T, Lactobaccilus reuteri 
ATCC 55730T, Bifidobacterium longum ssp. longum DSM 20097T, Escherichia coli IMBH 
252/07 and clones CL16 and CC34 (see below) were used creating a comparable 
standard lane marker for DGGE gels analyzing all bacteria (figure 1). 
 
Clone library 
To create a standard lane marker for DGGE analysis and to identify dominant 
members of the Clostridium cluster XIVa we constructed a clone library from stool 
samples. For this purpose PCR products amplified with primers 195-F (Meier et al., 
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1999) and Ccocc-R (Matsuki et al., 2004) were inserted into a p-GEM Easy Vector 
(Promega) following the instructions of the manufacturer. Nucleotide sequences were 
corrected for primer and vector sequences in CodonCodeAligner 
(www.codoncode.com) and taxonomically identified using the online tools of the 
ribosomal database project (http:// rdp.cme.msu.edu/). The clone library used for 
creating a standard lane marker for DGGE analysis of Clostridium cluster IV has 
previously been described (Zwielehner et al., 2009). 
 
Polymerase chain reaction (PCR) 
PCR was carried out amplifying 16S rRNA gene sequences from bacteria in fecal 
samples, type strains and cloned sequences for DGGE analysis as well as for creation 
of the clone library using group-specific and kingdom-specific primers (table 1). The 
PCR reaction mixture consisted of ready-to-use mastermix (Promega) with 1.5 mM 
MgCl2, 500 nM of primers and 2 µl of template DNA. When amplifying fecal samples, 
bovine serum albumin (Fermentas) was added to a final concentration of 400µg/ml. 
We used a Robocycler (Stratagene) for all amplifications. 
 
PCR-DGGE-fingerprinting 
DGGE was performed as described by Muyzer et. al. (Muyzer et al., 1993). Primer pairs 
and annealing temperatures to analyze the diversity of (a) bacteria, (b) Clostridium 
cluster IV and (c) Clostridium cluster XIVa are described in table 1.  
PCR products were separated by polyacrylamid gels with a denaturing gradient of 30-
60% for predominant bacteria, 30-50% for Clostridium cluster IV and 35-50% for 
Clostridium cluster XIVa. Electrophoresis was performed for 9 h at 129 V at 60°C 
(predominant bacteria), 5 h at 200V at 60°C (Clostridium cluster IV) and 7 h at 200 V at 
60°C (Clostridium cluster XIVa). We created a standard lane marker for each DGGE 
analysis assay to ensure reliable gel-to-gel comparison. These standard lane markers 
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(described above) were loaded in triplicate on each gel to adjust for gradient-
variations within gels.  
 
Table: 16S rRNA gene primers used for PCR-DGGE fingerprinting. 
Target 
organism 
Primer 
pairs 
Sequence (5’-3’) 
Ann. 
temp 
(°C) 
Reference 
All bacteria 27f 
GTGCTGCAGAGAGTTTGATCCTGGC
TCAG 
57 [103] 
 985r GTAAGGTTCTTCGCGTT 57 [104] 
 341f-GC CCT ACG GGA GGC AGC AG 55 [63] 
 518r ATT ACC GCG GCT GCT GG 55 [91] 
Bacteroides 32f AACGCTAGCTACAGGCTT 56 [97] 
 708r CAATCGGAGTTCTTCGTG 56 [97] 
bifidobacteri
a 
g-BifidF CTCCTGGAAACGGGTGG 58 [105] 
 g-BifidR GGTGTTCTTCCCGATATCTACA 58 [105] 
Clostridium 
cluster IV 
sg-Clept-
F-GC 
GCA CAA GCA GTG GAG T 55 [129] 
 
sg-Clept-
R3 
CTT CCT CCG TTT TGT CAA  [129] 
Clostridium CcoccF- AAATGACGGTACCTGACTAA 55 [129] 
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cluster XIVa GC 
 CcoccR CTTTGAGTTTCATTCTTGCGAA  [129] 
GC-clamp  
CGCCCGGGGCGCGCCCCGGGCGGC
CCGGGGGCACCGGGGG 
 [63] 
 
 
Quantitative TaqMan-PCR 
The abundance of bacteria and bacterial subgroups was measured by 16S rRNA gene-
targeting TaqMan qPCR. Optimal annealing temperature of the PCR primer pairs and 
expected product sizes (table 2) were ascertained using a Robocycler (Stratagene), 
before the TaqMan-assay was performed in a Rotorgene 3000 (Corbett Life Science). 
We analyzed each sample in duplicate. Amplification reactions were carried out in a 
total volume of 10µl consisting of 5µl Taq-Man SensiMix DNA Kit (Quantance), 1µl of 
each primer and Taq-Man-probe (concentrations see table 2) and 10ng of bacterial 
DNA. Amplification programs included an initial denaturation at 95°C for 10 min 
followed by 40 cycles consisting of denaturation at 95°C for 30 s, annealing at 55°C 
(bacteria, Clostridium cluster IV), 56°C (Clostridium cluster XIVa), 58°C (C. difficile) or 
60 °C (bacteroides, Bifidobacteria) for 30 s and extension at 72°C for 50 s.  
We used tenfold serial DNA dilutions of type strains Bacteroides thetaiotaomicronT, 
Bifidobacterium longum ssp. longumT and C. difficile as well as the clones CL16 and 
CC34 and one fecal sample to construct standard curves for comparison of PCR 
reaction efficiencies among different experiments.  
We quantified DNA of Bacteroides thetaiotaomicronT, Bifidobacterium longum ssp. 
longumT and C. difficile, using the nanodrop method and calculated DNA copiel/µl 
through mean G+C content of each strain. Quantification of clones CL16 (Clostridium 
leptum 16) and CC34 (Clostridium coccoides 34) was done determining the numbers of 
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CFU (colony forming units). Relative percentages of bacterial subgroups were 
calculated in relation to total rRNA gene copies amplified with primer pair BAC-338-F 
and BAC-805-R (Yu et al., 2005).  
We reviewed sensitivity of PCR reactions with stepwise dilutions of standard curve 
DNA until we achieved sensitive detection levels of PCR. The specificity was confirmed 
using non-target DNA. 
 
Table 2: Primers and probes used for relative quantification of bacterial 16S rRNA 
genes. 
Target organism 
Primer and 
probe 
Sequence (5' - 3') 
Size 
(bp) 
Conc. 
(nM) 
Reference 
Bifidobacterium spp. Forward 
primer  
GCG TGC TTA ACA CAT 
GCA AGT C 
125 300  
 Reverse 
primer  
CAC CCG TTT CCA GGA 
GCT ATT 
 300  
 
Probe  
(FAM)- TCA CGC ATT 
ACT CAC CCG TTC GCC  
-(BHQ-1) 
 150 [100] 
Bacteroides 
AllBac296f 
GAG AGG AAG GTC 
CCC CAC 
106 300  
 
AllBac412r 
CGC TAC TTG GCT GGT 
TCA G 
 300  
 AllBac375Bhq
r 
(FAM)-CCA TTG ACC 
AAT ATT CCT CAC TGC 
 100 [101] 
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TGC CT-(BHQ-1) 
All bacteria 
BAC-338-F 
ACT CCT ACG GGA GGC 
AG 
468 1000  
 
BAC-805-R 
GAC TAC CAG GGT ATC 
TAA TCC  
 1000  
 
BAC-516-P 
(FAM)-TGC CAG CAG 
CCG CGG TAA TAC-
(BHQ-1) 
 200 [102] 
Clostridium cluster 
IV 
sg-Clept-F 
GCA CAA GCA GTG 
GAG T 
239 400   
 
sg-Clept-R3 
CTT CCT CCG TTT TGT 
CAA 
 400 [96] 
 
Clept-P++ 
(FAM)-AGG GTT GCG 
CTC GTT-(BHQ-1) 
 200 This study 
Clostridium cluster 
XIVa 
195F 
GCA GTG GGG AAT ATT 
GCA 
 500  
 
CcoccR 
CTT TGA GTT TCA TTC 
TTG CGA A 
 500 [96] 
 
CcoccP 
(6-FAM)-
AAATGACGGTACCTGAC
TAA-(BHQ-1) 
 150 [96] 
Clostridium diffficile 
CdiffF 
TTG AGC GAT TTA CTT 
CGG TAA AGA 
 1000 [100] 
 CdiffR TGT ACT GGC TCA CCT 151 1000  
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TTG ATA TTC A 
 
CdiffP 
(6-FAM)-CCA CGC GTT 
ACT CAC CCG TCC G-
(BHQ-1) 
 200  
 
 
 
Statistical analysis 
Statistical evaluation of differences between groups (chemotherapy and control) and 
changes within the chemotherapy group (all time points before and after 
chemotherapy) was carried out using the OriginPro version 8 (OriginLab, 
Northampton, MA). For two group comparisons of independent ordinal and interval 
values we used the two-sample-T-test and the nonparametric Mann-Whitney-U-test. 
For the analysis of related data we used the paired-sample-T-test or the non-
parametric Wilcoxon signed-rank test. P values <0.05 were considered statistically 
significant. 
We analyzed PCR-DGGE fingerprints in GelComparII (www.applied-maths.com) and 
applied principal component analysis (PCA) using the default settings in ‘R-software 
environment for statistical computing’ (www.r-project.org) until 100% variance was 
explained. Shannon and Simpson diversity indices were calculated on quantitative 
band information with the default settings implemented in the ‘vegan’ package in ‘R’. 
Shannon index is defined as H = -  pi ln pi, where pi is the proportional abundance of 
species i. For Simpson index, given as 1 - D, this is 1 - (( pi)^2), pi is the relative 
frequency of the i-th species (Zwielehner et al., 2009). In short, the higher the 
Simpson (0-1) and Shannon indices are, the higher the diversity.  
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RESULTS 
Dietary aspects 
We assessed the participants` dietary habits using a food frequency questionnaire. All 
study participants (patients and controls) were omnivores and showed similar 
consumption patterns of liquids, alcohol, fruits, vegetables, grains and milk products. 
Healthy controls stated more frequent consumption of fruits, whole grain products 
and alcohol several times a week compared to patients receiving chemotherapy.  
 
Chemotherapeutic treatment with or without antibiotics decreases absolute 
bacterial numbers in comparison to healthy controls 
To investigate whether chemotherapy with or without antibiotics changes the human 
GI microbiota composition in contrast to healthy individuals and over a time period, 
we investigated absolute numbers and relative percentages of bacterial subgroups. 
The ambulant patients receiving chemotherapy harboured only 25 ± 22% of the 
absolute bacterial load in their feces compared to healthy controls and with it less 
Bacteroides, bifidobacteria, Clostridium cluster IV and XIVa. Despite high inter- and 
intraindividual variations the differences in absolute numbers of bacteria (p = 0.02), 
Bacteriodes (p=0.01), bifidobacteria (p=0.001) and Clostridium cluster XIVa (p=0.001) 
were statistically significant. Furthermore, oncology patients had less absolute 
numbers of Clostridium cluster IV, but not significantly. Abundance of all bacterial 
subgroups declined after chemotherapeutical intervention often followed by a 
rebound of bacterial abundance (figure 2).  
Subject ON007 shows a sharp decline at time point 4 of all bacteria and bacterial 
subgroups following blood stem cell transplantation and medical intervention. 
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Clostridium cluster IV and XIVa show great alterations due to chemotherapeutical 
interventions, while the geni Bacteroides and bifidobacteria seem to be marginally 
affected 
In contrast to absolute numbers in figure 2, figure 3 shows the relative quantification 
of Bacteroides, bifidobacteria, Clostridium cluster IV, Clostridium cluster XIVa and C. 
difficile as percentage of total bacterial DNA. The mean proportion of Bacteroides in 
stool samples was 27 ± 12% in chemotherapy patients and 23 ± 12% in healthy 
individuals. The mean percentage of bifidobacteria in patients was 1.17 ± 1% and 1% ± 
0.7% in controls. Patients harboured on average 16 ± 11% of Clostridium cluster IV and 
20 ± 14% of Clostridium cluster XIVa, while controls harboured 10 ± 7% and 34 ± 22% 
of clostridial clusters IV and XIVa.  
It can be seen in figure 4A that there is a difference between the oncology and control 
group with regard to the subgroups Clostridium cluster IV and XIVa. Oncology patients 
harboured significantly more (p = 0.02) Clostridium cluster IV and less Clostridium 
cluster XIVa (p= 0,057) than healthy controls. 
 
Clostridium cluster IV higher before chemotherapy than after. 
 
Figure 4B illustrates the differences of the fecal microbiota composition before and 
after chemotherapeutic cycles. The mean percentage of Clostridium cluster IV before 
chemotherapy was 22 ± 10% compared to after chemotherapeutic cycles with 14 ± 9% 
of all analyzed bacteria. Hence, there is a significant difference (p = 0.01). The average 
amount of Bacteroides, bifidobacteria and Clostridium cluster XIVa were 30 ± 12%, 1.2 
± 1.7% and 22 ± 11% at time points before chemotherapy and 28 ± 12%, 1.6 ±1.5% 
and 24 ± 17% after chemotherapy.  
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C. difficile colonization found in individuals receiving chemotherapeutic and 
antibiotic treatment 
To find out whether the chemotherapeutic and antibiotic disruption favours the 
growth of pathogens, we investigated the abundance of C. difficile. Two out of eleven 
patients (18%) receiving chemotherapy harboured C. difficile. Patient ON009 
harboured C. difficile at four time points investigated with a mean proportion of 0.4 ± 
0.7%, showing the highest level (1.22%) at sampling point 3 (highlighted in figure 3), 
when chemotherapeutic and antibiotic treatment took place. Pathogenic C. difficile 
grew up at time point 3 in patient ON011 (3.90% of all analyzed bacteria, highlighted 
in figure 3) after chemotherapeutic intervention at time point 2. 
 
PCR-DGGE fingerprinting analysis shows decreased diversity of bacteria and 
Clostridium cluster XIVa in response to medical treatment compared to healthy 
individuals 
 
DGGE fingerprinting analyses of bacteria, Clostridium cluster IV and Clostridium cluster 
XIVa indicate a highly diverse dataset between individuals and uniqueness of fecal 
microbiota. The mean numbers of bands per patient receiving chemotherapy were 
21.8 ± 5 for bacteria, 9 ± 5 bands for clostridium cluster IV and of 14.9 ± 7 bands for 
clostridium cluster XIVa. DGGE profiles of healthy controls had 23.1 ± 5 bands for 
bacteria, 9 ± 5 for clostridium cluster IV and 18.9 ± 7 for clostridium cluster XIVa. The 
number of bands as well as Shannon and Simpson diversity indices (figure 5) show a 
lower diversity of bacteria (figures 5A, 5B) and Clostridium cluster XIVa (figure 5E, 5F) 
in oncology patients. In line with increased abundance of cluster IV oncology patients 
had greater diversity of Clostridium cluster IV according to DGGE fingerprints (figure 
5C, 5D). The dataset was subjected to principal component analysis (PCA). PCA 
analysis extracts underlying components of samples according to their variance. 
Graphs A and B in figure 6 display PCA of Clostridium cluster IV fingerprints. While 
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graph A distinguishes between oncology patients and healthy controls, graph B 
indicates separation of participants before and after chemotherapy and healthy 
individuals according to their Clostridium cluster IV DGGE fingerprints. PCA analysis 
shows increased variability in the DGGE fingerprints of individuals under therapy 
compared to healthy controls. Chemotherapy resulted in distinctive clustering of 
bandpatterns before and after chemotherapy.  
 
Discussion 
Chemotherapeutic and antibiotic use has both benefits and risks. Even if 
chemotherapy and antibiotics are used as life-prolonging measures for critically ill 
patients and to fight life-threatening infections, both are associated with severe side 
effects such as mucositis, diarrhoea or constipation. These side effects increase the 
cost of health services, and are often life-threatening (Stringer et al., 2007). 
Chemotherapeutic and antibiotic treatment has a detrimental impact on the host 
microbial ecosystem, which is important for host mucosal protection (Croswell et al., 
2009) and thereby increases the risk of infection (van Vliet et al., 2009). Overgrowth of 
species with potential pathogenicity such as toxigenic C. difficile and inflammatory 
complications are among the most common serious complications of chemotherapy 
and antibiotic treatment among patients with cancer (Guarner & Malagelada, 2003; 
van Vliet et al., 2009). 
In this study, we investigated how the use of cancer chemotherapy mostly with 
antibiotic treatment perturbs the fecal microbial ecosystem during the course of 
therapy. We assessed if the microbiota is able to return to its original profile after 
chemotherapeutic and antibiotic intervention with special interest in the abundance 
of C. difficile. We used a combination of molecular methods to compare abundance 
(qPCR) and diversity (PCR-DGGE) of bacteria, Bacteroides, bifidobacteria, Clostridium 
cluster IV, Clostridium cluster XIVa and C. difficile between groups and different time 
points of chemotherapy.  
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As mentioned above, we used feces as source of information. Fecal microbial 
communities are composed of autochthonous gut members and by transient bacteria. 
Even though the analysis of fecal samples may overestimate the actual composition of 
the GIT microbiota of humans we chose fecal samples to investigate the microbial 
composition of the intestinal microbiota because they are easy to collect, do not 
involve any ethical issues and reflect shifts in microbial population composition 
(Turroni et al., 2008). 
In this study we used type strains Bacteroides thetaiotaomicronT, Bifidobacterium 
longum ssp. longumT and C. difficile as well as the clones CL16 and CC34 for 
quantification of fecal microbiota. However, a mixture of different strains for qPCR 
standards would show a better image of the human microbiota. Therefore absolute 
amounts should be considered as semiquantitative. 
The majority of previous studies on the effect of chemotherapy on human fecal 
microbiota used standard microbiological culture techniques (Nyhlen et al., 2002; 
Stringer et al., 2007). While other studies focused on the colonization with pathogenic 
bacteria (Schalk et al., 2009; van Vliet et al., 2009) among patients with cancer and 
chemotherapy-induced diarrhea (Stringer et al., 2007; Abd El-Atti et al., 2009), to our 
knowledge, we are the first to show changes in fecal bacteria, Bacteroides, 
bifidobacteria, Clostridium cluster IV, Clostridium cluster XIVa populations in addition 
to C. difficile analysis. However, the results of our Bacteroides analysis are not in 
agreement with the results of Nyhlèn et al., 2007 (Nyhlen et al., 2002) who showed 
increased counts of Bacteroides spp. of samples obtained during chemotherapy, but 
with the microflora stable in most patients. Discrepancies in changes of the 
Bacteroides abundance might be due to differences in detection techniques. Nyhlèn et 
al., 2007 also reported significantly increased counts of yeast in patients, making it a 
focus for further research in immunocompromised patients. 
Our results indicate significant effects of chemotherapy and antibiotic treatment on 
intestinal microbiota. Despite high individual variations, we show a significantly lower 
absolute bacterial load in feces of patients receiving chemotherapy in comparison to 
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healthy controls. These findings are in line with data from van Vliet et al, 2009, who 
reported 100-fold lower total bacterial numbers during chemotherapy treatment than 
in healthy controls. In addition to lower abundance of bacteria and determined 
bacterial subgroups, PCR-DGGE fingerprints indicate lower diversity of bacteria and 
Clostridium cluster XIVa in oncology patients. The abundance of fecal microbiota 
decreases after cycles of chemotherapy. After the end of chemotherapeutic 
administration the bacterial abundance recovers within a few days sometimes even 
showing a “rebound-effect”. Relative numbers of Clostridium cluster IV and XIV show 
great alterations due to chemotherapeutical interventions, while the genera 
Bacteroides and bifidobacteria seem to be less affected. Interestingly, oncology 
patients harboured significantly more Clostridium cluster IV at higher diversity 
compared to healthy controls. This suggests that this class of bacteria is less 
susceptible to disruption by chemotherapeutic intervention. The incidence of C. 
difficile in subjects ON009 and ON011 is accompanied by a decrease of the genera 
bifidobacteria and Clostridium cluster IV. Further research is needed to elucidate if 
there is a causal relationship between growth of C. difficile and decreased abundance 
of bifidobacteria and Clostridium cluster IV. 
Species richness was assessed using PCR-DGGE fingerprinting. Each lane of a PCR-
DGGE gel represents a microbial fingerprint of a fecal sample; each band within a lane 
corresponds to one bacterial species, although different species may sometimes be 
represented by the same band (van Vliet et al., 2009). It has also been observed that 
one bacterial strain may form several bands due to multipe 16S rRNA operons eg 
Escherichia coliT (FIG. 3). The limitations of DGGE in microbial analysis have been 
previously described (Muyzer & Smalla, 1998). Nevertheless, substantial information 
about species composition can be obtained from very complex microbial communities 
such as the gut microbiota (Muyzer & Smalla, 1998).  
The oncology patients assessed here suffered from a variety of malignancies and 
received different chemotherapy treatment regimes. Only two participants (ON001 
and ON008) had never received any cancer therapy before, while all others had a 
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history of chemotherapeutic treatment. Therefore we could not hypothesize changes 
due to the beginning of the treatment. Most cancer patients also receive antibiotics. 
Microbial profiles were similar in individuals under chemotherapy regardless if they 
received antimicrobial treatment or not. The effects on the intestinal microbiota 
described here are thus unlikely to be due to antibiotics alone. Van Vliet et al. 2009 
tested the effect of chemotherapy in vitro and showed a direct bacteriostatic effect of 
chemotherapeutics on bacterial growth.  
Further research is needed to show whether changes in bacterial colonization play a 
role in the development and maintenance of mucosal barrier function, infection and 
inflammation (van Vliet et al., 2009). 
The use of prebiotics, probiotics and bacterial products, such as butyrate to prevent 
mucosal barrier injury and its complications could be a promising concept in restoring 
impaired functions or enhancing specific desirable functions of the microbiota 
(Zwielehner et al., 2009). The use of pro- and prebiotics to affect the composition and 
metabolic activity of the fecal microbiota in times of cancer chemotherapy and 
immunosuppression might be part of future research.  
In conclusion, chemotherapy treatment causes changes in fecal microbiota, which 
coincides with the development of C. difficile infection in some patients. These 
changes in microbiota may have systemic effects and may contribute to the 
development of chemotherapy-induced mucositis, influencing important beneficial 
functions of the microbial ecosystem.  
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FIGURES 
 
Figure 1: Changes of PCR-DGGE fingerprinting of 16S rRNA coding regions of dominant 
bacteria after chemotherapeutic treatment. Bands that become stronger or nearly 
disappear are indicated with arrows.  
A, B, C and D, samples of ON001 after chemotherapy; E, healthy control; SL, standard 
lane. 
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Figure 2: Impact of medical treatment (chemotherapy and antibiotics) on human fecal 
microbiota. Absolute numbers of  Bacteroides (Bac), bifidobacteria (Bif), Clostridium 
cluster IV (Clept) and XIVa (Ccocc), C. difficile (Cdiff) and unidentified bacteria analyzed 
by TaqMan-qPCR.  
ChT, Chemotherapy; Ab, Antibiotics; F, fever; T, blood stem cell transplantation; 
Subject ON001 received chemotherapy before first sampling. Subjects C001- C009 
belong to the healthy age- and gender matched control group. 
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Figure 3: Percentage of Bacteroides (Bac), bifidobacteria (Bif), Clostridium cluster IV 
(Clept) and XIVa (Ccocc), C. difficile (Cdiff) and unidentified bacteria of analyzed 
bacteria quantified by TaqMan-qPCR. Red circle indicates C. difficile. 
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Figure 4. (A) Relative abundances of fecal bacteria in patients receiving chemotherapy 
± antibiotics in comparison to healthy individuals. (B) Comparison of samples before 
and after chemotherapeutic cycles. Relative abundances of Bacteroides (bac), 
bifidobacteria (bif), Clostridium cluster IV (Clept) and cluster XIVa (Ccocc) are given 
relative to total bacteria. 
ON, oncology patient; C, healthy control; bac, Bacteroides; bif, bifidobacteria; Clept, 
Clostridium cluster IV; Ccocc, Clostridium cluster XIVa 
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Figure 5: Simpson and Shannon diversity indices derived from PCR-DGGE 
bandpatterns of 16S rRNA coding regions of (A, B) bacteria, (C, D) Clostridium cluster 
IV and (E, F) Clostridium cluster XIVa.  
ON, Oncology patients; C, healthy controls; ChT, chemotherapy 
 
 
 211 
 
 
Fure 6: Principal component analysis (PCA) of Clostridium cluster IV DGGE fingerprints 
of 16S rRNA coding regions in fecal samples of ambulant oncology patient and healthy 
controls. 
O, oncology pateints; C, healthy control; A, after chemotherapy; B, before 
chemotherapy. 
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11 Summary 
11.1 Aim 
 
The aim of this Ph.D. thesis was to test if epidemiologically defined population groups 
such as vegetarians, omnivores, the young and the elderly differ in their microbiota 
composition. Furthermore, the influences of chemotherapy and antibiotic treatment 
on the GI microbiota should be monitored during the course of treatment. 
Faecal samples of young healthy omnivores and vegetarians, institutionalized elderly 
and individuals undergoing immune-suppressive chemotherapy were analysed. Diet 
and lifestyle were assessed using an interviewer-conducted questionnaire. 
The objective was to compare abundance and species richness of Bacteria as well as 
subgroups such as bifidobacteria, Bacteroides, Clostridium leptum cluster, Clostridium 
coccoides cluster in faecal samples of omnivores, vegetarians, elderly and individuals 
undergoing chemotherapy. 
Molecular methods such as PCR-DGGE fingerprinting and qPCR as well as stable 
isotope probing were applied.  
To allow meaningful interpretation of the highly diverse DGGE fingerprinting datasets, 
clustering based on Pearson correlation and principal components analysis based on 
covariance were applied. As a step towards a functional characterization, the butyryl-
CoA CoA transferase gene was targeted in addition to the 16S rRNA gene used for 
phylogenetic identification. RNA-stable isotope probing was explored as a means of 
linking phylogenetic information with functional characteristics of gut microbial 
communities.  
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11.2 Introduction 
 
The highly diverse microbiota of the human gastrointestinal tract has been associated 
with the pathogenesis of colorectal cancer [111], inflammatory bowel diseases [112, 
113], obesity [27], metabolic syndrome [8] and atopic diseases [114]. The most 
predominant subpopulations in the human faecal microbiota are the Clostridium 
leptum subgroup, the Clostridium coccoides subgroup and Bacteroides [6, 115, 54]. 
Members of these populations contain short chain fatty acid (SCFA) producing 
fibrolytic bacteria [116, 117]. Another important subgroup of the human microbiota is 
that of the bifidobacteria. Stimulation of these bacteria has previously been shown 
after prebiotic intervention with inulin and fructo-oligosaccharides [92]. Bifidobacteria 
have been shown to be involved in prevention of atopic disease [122], and prevention 
of obesity and insulin resistance via enhanced barrier function of the gut epithelium 
[9]. SCFAs are derived from fermentation of non-digestible carbohydrates in the colon. 
The amount of SCFAs (primarily acetate, propionate and butyrate) produced in the 
colon depends on the site of fermentation, the diet and the composition of the 
residing microbiota, and can account for 5-15% of the total energy requirements for 
humans [173]. Due to rapid absorption and metabolism of SCFAs, their concentrations 
in the colon may differ. Acetate and propionate are metabolites for gluconeogenesis 
in the liver [15]. Butyrate is the major energy source for colonocytes and is known to 
regulate various processes in the human distal gut. Butyrate may have an effect on 
inflammation [158], oxidative stress [158], intestinal barrier function [159, 174, 175], 
visceral perception and rectal compliance [176] and may play a role in satiety [177, 
178]. The formation of toxic products and lower availability of SCFAs in the distal colon 
were suggested to be involved in the pathogenesis of ulcerative colitis and cancer 
[179, 180, 181]. It has previously been described that the colon epithelium very 
efficiently removes butyrate from the faecal stream [183]. Thus, measuring butyrate 
levels in faeces might be a less suitable biomarker for intestinal health than the 
abundance of butyrate-producing bacteria or functional genes involved in butyrate 
production. 
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11.3 Results and Discussion 
11.3.1 Vegetarian Microbiota 
 
Vegetarianism has been associated with decreased risk for diseases such as heart 
diseases, various cancers and has been linked to a lower BMI and an overall decline in 
mortality [123]. Different lifestyle factors and diets were shown to have a significant 
impact on the faecal microbiota [124, 109, 125]. Vegetarians had on average 12% 
more faecal bacteria than omnivores. Stephen et al showed in his study that a 
decreased transit time of stool is significant correlated to a higher bacterial cell mass 
[131]. The dietary questionnaire confirmed that vegetarians had a higher dietary fibre 
intake, which might have lead to a decreased transit time [132]. The higher abundance 
of bacteria in vegetarians may be attributed to that fact. 
Furthermore, a tendency for higher proportions of Bacteroides and lower proportions 
of Clostridium cluster IV was found in faecal microbiota of vegetarians compared to 
omnivores. Bacteroides can utilize a wide variety of carbon sources, and they account 
for the majority of polysaccharide digestion in the large intestine [133, 134]. 
Nevertheless, members of Clostridium leptum subgroup have the same ability. One 
explanation could be that the particular dietary fibres enhance the development of 
Bacteroides more in the omnivore volunteers. 
Mueller et al. detected in a cross-sectional study the highest levels of the Clostridium 
cluster IV in their Swedish study population, whose dietary habits were characterized 
by a high consumption of fish and meat [109]. Therefore, we suppose that higher 
meat consumptions may increase the abundance of the Clostridium leptum subgroup 
in the gut microbiota. A higher prevalence of this subgroup was discussed to be 
associated with obesity and cancer [111, 125], where also increased diversity was 
observed. PCR-DGGE fingerprinting of dominant bacteria and Clostridium cluster IV 
indicated a grouping of vegetarians and omnivores in our study. Clustering of 
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Clostridium cluster IV fingerprints might be due to the observation that two sequences 
identified as Faecalibacterium sp. and Ruminococcus sp. were more prevalent in 
omnivores than in vegetarians. As this two subspecies are known as dietary fibre 
degraders we did not expect this finding. Two possible explanations for this 
observation may be the before discussed fact of a higher meat consumption or the 
very complex network of cross-feeding species. However, certainly further 
investigations are needed to clarify this aspect. The Clostridium cluster XIVa also 
tended to be more abundant in omnivores (19.01 ± 6.7%) than in vegetarians (14.52 ± 
5.6%). The clostridial clusters IV and XIVa harbour many butyrate producing bacteria, 
e.g. Faecalibacterium prausnitzii, Eubacterium spp. and Roseburia spp.  
 Quantification of the butyryl-CoA CoA-transferase gene revealed a tendency towards 
higher levels of this important gene in vegetarians (106.89 ± 164.41ng/µl) than in 
omnivores (38.66 ± 35.04 ng/µl). Again, high individual differences were observed so 
that no significant differences could be found in young healthy omnivores and 
vegetarians. Butyryl-CoA CoA transferase gene abundance did not correlate with the 
overall abundance of bacteria. 
In a melt curve analysis three groups of butyryl-CoA CoA transferase genes were 
attributed to species related to E.hallii/SS2/1, Roseburia/E.rectale spp. and 
F.prausnitzii. The abundance of these gene variants did not correlate with the 
abundance of the clostridial clusters IV and XIVa. 
Vegetarian diet might have –in some individuals- favoured growth of 
Roseburia/E.rectale spp. that carry the butyryl-CoA CoA transferase gene, without 
causing an increase of the entire Clostridium cluster XIVa.  
In other vegetarians, Clostridium cluster XIVa occurred at high abundance without a 
concomitant increase of the butyryl-CoA CoA transferase gene of Roseburia/E.rectale 
spp.  
Omnivores tended to have higher abundances of Clostridium cluster IV and XIVa than 
vegetarians. The butyryl-CoA CoA transferase gene tended to be more abundant in 
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vegetarians. In conclusion, both vegetarian as well as omnivore diet have a similar 
potential to shape a healthy microbiota. The quantification of the butyryl-CoA CoA 
transferase gene is a valuable biomarker in addition to quantification of bacterial 
subgroups of the human GI microbiota.  
 
11.3.2 Elderly microbiota 
 
With ageing, decreases in beneficial organisms such as Lactobacilli and Bifidobacteria, 
amongst other anaerobes, and an increase in the number of facultative anaerobes 
[91] have been reported. Faeces from the institutionalized elderly had less total 
Bacterial abundance and lower total Bacterial diversity than that from the young 
subjects. In agreement with previous studies [13, 106, 95] ageing was associated with 
a loss of diversity of Bifidobacteria. However, samples from the elderly displayed an 
increase in the relative abundance of Bacteroides, although this group tended to 
display less diversity than Bacteroides in the young. The relative abundance of the 
Bifidobacteria and Clostridium cluster IV were significantly higher in the young, and 
the Clostridium cluster IV also displayed greater diversity in the young. The Clostridium 
cluster XIVa was significantly more abundant in the young (p=0.0018) than in the 
elderly. 
Furthermore, cluster analysis revealed that for all microbial groups analysed, the 
members of the GI microbiota in the elderly could be considered a subset of that 
present in the young.  
Elderly had significantly less copies of the butyryl-CoA CoA-transferase gene than 
young omnivores. On an individual scale butyryl-CoA CoA transferase gene abundance 
did not correlate with overall bacterial 16S rRNA gene abundance. 
The butyrate gene variant related to Roseburia/E.rectale spp. tended to be lower in 
the elderly than in the young. At the same time the Clostridium cluster XIVa was more 
abundant in the young. The abundance of the Clostridium cluster XIVa did not 
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correlate with the abundances of the butyrate gene variant related to 
Roseburia/E.rectale spp. on an individual scale. 
Our results point out that elderly harbour less Clostridium cluster IV and XIVa in 
already low levels of overall bacterial. Together with lower abundance of the butyryl-
CoA CoA transferase gene, our results indicate that the elderly microbiota might be 
characterized by low butyrate production capacity. Considering the important 
nutritive, anti-inflammatory and anticancerogenic potential of butyrate in the human 
colon, these findings point out that these microbiota specificities might contribute to 
the development of degenerative diseases [8] and anorexia in advanced age. 
 
11.3.3 Butyrate concentration and assessment of bacterial 
butyrate removal 
 
Faecal concentrations of butyrate ranged from below detection limit up to 0.094 µmol 
g-1 faeces (wt/w). The average value for omnivores was 0.023 µmol g-1 ± 0.027 µmol g-
1 faeces, for elderly 0.007 µmol g-1 ± 0.011 µmol g-1 faeces and for vegetarians 0.008 
µmol g-1 ± 0.008 µmol g-1 faeces. Butyrate concentrations found in the faeces of 
omnivores were highest among all individuals. In spite of high inter-individual 
differences these values were significantly different from butyrate in faeces of elderly 
(p= 0.04). As previously suggested, butyrate levels in faecal samples did not correlate 
with measured abundance of the butyryl-CoA CoA transferase gene. Discrepancies in 
gene abundance and faecal butyrate might be due to different ability of the gut 
epithelium to absorb butyrate, variable gene expression rate and enzyme activity and 
possibly also due to bacterial removal of butyrate from the faecal stream. 
In order to assess if gut bacteria are capable of consuming butyrate, a RNA-stable 
isotope probing experiment was performed. In this experiment labelled butyrate was 
fed to an anaerobically incubated faecal sample. Butyrate consuming microorganisms 
were subsequently identified because they incorporated the heavy label in their RNA. 
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Some previously undescribed species of Clostridiales and Erysipelotrichaceae were 
identified. Nevertheless the results suggest that bacterial butyrate removal from the 
faecal stream is likely to be a minor process in the human gastro-intestinal tract. 
 
11.3.4 Microbiota in individuals undergoing immune 
suppressive chemotherapy 
 
Chemotherapy and antibiotics are used as life-prolonging measures for critically ill 
patients and to fight life-threatening infections but are associated with severe side 
effects such as mucositis, diarrhoea or constipation [144]. Chemotherapeutic and 
antibiotic treatment has a detrimental impact on the host microbial ecosystem, which 
is important for host mucosal protection [141] and thereby increases the risk of 
infection [137]. Overgrowth of species with potential pathogenicity such as toxigenic 
C. difficile and inflammatory complications are among the most common serious 
complications of chemotherapy and antibiotic treatment among patients with cancer 
[138, 137]. 
Despite high individual variations, a significantly lower absolute bacterial load was 
found in faeces of patients receiving chemotherapy in comparison to healthy controls. 
These findings are in line with data from van Vliet et al, 2009, who reported 100-fold 
lower total bacterial numbers during chemotherapy treatment than in healthy 
controls. In addition to lower abundance of bacteria and determined bacterial 
subgroups, PCR-DGGE fingerprints indicate lower diversity of bacteria and Clostridium 
cluster XIVa in oncology patients. The abundance of faecal microbiota decreased after 
cycles of chemotherapy. After the end of chemotherapeutic administration the 
bacterial abundance recovered within a few days sometimes even showing a 
“rebound-effect”. Relative numbers of Clostridium cluster IV and XIV show great 
alterations due to chemotherapeutical interventions, while the genera Bacteroides 
and bifidobacteria seem to be less affected. Interestingly, oncology patients 
harboured significantly more Clostridium cluster IV at higher diversity compared to 
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healthy controls. This suggests that this class of bacteria is less susceptible to 
disruption by chemotherapeutic intervention. The incidence of C. difficile in subjects 
ON009 and ON011 was accompanied by a decrease of the Bifidobacteria and 
Clostridium cluster IV. Further research is needed to elucidate if there is a causal 
relationship between growth of C. difficile and decreased abundance of Bifidobacteria 
and Clostridium cluster IV. In conclusion, chemotherapy treatment causes changes in 
faecal microbiota, which coincide with the development of C. difficile infection in 
some patients. These changes in microbiota may have systemic effects and may 
contribute to the development of chemotherapy-induced mucositis, influencing 
important beneficial functions of the microbial ecosystem.  
11.4 Conclusion 
 
The chosen approach combining quantitative PCR and qualitative PCR-DGGE 
fingerprinting showed that the human microbiota is highly variable between 
individuals. In spite of this enormous variability, some significant differences between 
elderly and young could be shown. Young healthy vegetarians and omnivores tended 
to have characteristic microbiota as well, but the differences between these two 
epidemiologically defined populations were smaller than the interindividual 
differences. Interestingly, the Clostridium leptum cluster which harbors fiber-
degrading and butyrate-producing bacteria, was more diverse in individuals 
undergoing immune-suppressive chemotherapy and more abundant in young healthy 
omnivores. As a first step towards a characterization of microbiota functions, 
quantification of an important functional gene involved in butyrate production was 
performed. RNA-stable isotope probing was explored as a means to link phylogeny 
with function. Further research is needed to elucidate causal relationships between 
human behavior and microbiota composition and function. 
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12 Zusammenfassung 
12.1 Zielsetzung 
 
Die Fragestellung der vorliegenden Doktoratsarbeit war, ob epidemiologisch definierte 
Bevoelkerungsgruppen wie VegetarierInnen, MischkoestlerInnen, alte und junge 
Menschen sich hinsichtlich ihrer Mikrobiota-Zusammensetzung unterscheiden. 
Weiters war es ein Ziel die Einfluesse von Chemotherapie und Antibiotika auf die GI-
Mikrobiota im Vergleich zu gesunden Kontrollen zu charakterisieren. Stuhlproben von 
jungen Omnivoren, Vegetarierinnen, AltersheimbewohnerInnen und Individuen, die 
immunsuppressive Chemotherapie erhalten, wurden untersucht. 
Ernaehrungsgewohnheiten und Lebensstilfaktoren wurden in Interviews anhand eines 
Fragebogens erfasst. 
Moegliche Unterschiede sollten anhand der Abundanz und Fuelle an Spezies (richness) 
der dominierenden Bakterien und Bifidobakterien, Clostridium leptum cluster, 
clostridium coccoides cluster und Bacteroides beschrieben werden. 
Ausschliesslich molekulare Methoden, naemlich PCR-DGGE fingerprinting, quantitative 
PCR und stable isotope probing wurden angewandt. Um sinnvolle Interpretation der 
hoch diversen DGGE fingerprinting Daten zu erlauben, wurde Clustering basierend auf 
Pearson Korrelation und Hauptkomponentenanalyse basierend auf Kovarianz 
angewandt. Als ein Schritt in Richtung funktioneller Charakterisierung wurde das 
Butyryl-CoA CoA Transferase Gen zusaetzlich zur Quantifizierung des 16S rRNA Gens, 
anhand dessen phylogenetische Identifizierung vorgenommen wurde, durchgefuehrt. 
RNA-stable isotope probing wurde als vielversprechende Methode identifiziert, um 
phylogenetische Information mit funktionellen Charakteristika von mikrobiellen 
Gemeinschaften des Darms zu verbinden.  
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12.2 Einleitung 
 
Die hoch diverse Mikrobiota des menschlichen gastro-intestinalen Trakts wurde mit 
der Pathogenese von Kolorektalkrebs [111], chronisch entzuendlichen 
Darmerkrankungen [112, 113], Adipositas [27], metabolischem Syndrom [8] und 
atopischen Erkrankungen [114] in Zusammenhang gebracht. Die dominanten 
Subpopulationen der menschlichen Darmbakterien sind dem Clostridium leptum 
Cluster, dem Clostridium coccoides cluster und den Bacteroides zuzuordnen [6, 115, 
54]. Mitglieder dieser Populationen beinhalten fibrolytische Bakterien, die kurzkettige 
Fettsaeuren (SCFAs) produzieren [116, 117]. Eine weitere wichtige Untergruppe der 
menschlichen Mikrobiota ist die der Bifidobakterien. Stimulation dieser Bakterien 
wurde in der Vergangenheit durch prebiotische Intervention mit Inulin und 
Fructooligosacchariden beschrieben [92]. Bifidobakterien wurden mit der Praevention 
von atopischen Erkrankungen [122] und der Praevention von Adipositas und 
Insulinresistenz durch Verbesserung der Barrierefunktion des Darmepithels [9] 
assoziiert. SCFAs sind Derivate aus der Fermentation von unverdaulichen 
Kohlenhydraten im Colon. Welche Menge an SCFAs (hauptsaechlich Acetat, Propionat 
udn Butyrat) gebildet wird, haengt von dem Fermentationsort, der Ernaerung und der 
Zusammensetzung der Mikrobiota ab. SCFAs koennen 5-15% des menschlichen 
Energiebedarfs decken [173]. Die Konzentration von SCFAs im Colon koennen 
unterschiedlich hoch sein, weil sie rasch absorbiert und metabolisiert werden. Acetat 
und Propionat sind Metaboliten fuer die Gluconeogenese in der Leber [15]. Butyrat ist 
die Hauptenergiequelle fuer Colonocyten und reguliert diverse Prozesse im distalen 
Darm. Butyrat hat moeglicherweise einen Einfluss auf Entzuendungen [158], 
oxidativen Stess [158], intestinale Barrierefunktion [159, 174, 175], viscerale 
Wahrnehmung und rektale Compliance [176] und koennte im Zusammenhang mit 
Hunger und Saettigung eine Rolle spielen [177, 178]. Es wurde vorgeschlagen dass die 
Bildung toxischer Produkte und geringere Verfuegbarkeit von SCFAs im distalen Colon 
in die Pathogenese von Ulcerativer Colitis und Krebs [179, 180, 181] involviert sind. Es 
wurde beschrieben, dass das Colonepithel sehr effizient Butyrat aus dem faekalen 
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Strom entfernt [183]. Daher scheint Butyratbestimmung in Stuhl als Darmgesundheits- 
Biomarker weniger geeignet als die Abundanz Butyrat-produzierender Bakteren oder 
funktioneller Gene, deren Produkte in der Butyratproduktion involviert sind. 
 
12.3 Resultate und Diskussion 
12.3.1 Mikrobiota in VegetarierInnen 
 
Vegetarismus wurde mit geringerem Krankheitsrisiko fuer Herzerkrankungen und 
verschiedenen Krebsarten assoziiert. Weiters wurden niedrigerer BMI und insgesamt 
niedrigere Mortalitaetsrate in Vegetariern beschrieben [123]. Verschiedene Lebenstile 
und Ernaehrungsformen [124, 125, 109] wurden als signifikante Einflussfaktoren auf 
die faekale Mikrobiota beschrieben. VegetarierInnen hatten durchschnittlich 12% 
mehr faekale Bakterien als Omnivoren. Stphen et al. zeigten, dass eine verringerte 
Stuhl- Transitzeit signifikant mit einer hoeheren bakteriellen Zellmasse korreliert 
[131]. Die Ernaehrungserhebung zeigte, dass Vegetarier eine hoehere 
Faserstoffaufnahme hatten, was zu einer verringerten Darmpassagezeit gefuert haben 
koennte [132]. Die hoehere Abundanz von Bakterien koennte darauf 
zurueckzufuehren sein. 
Weiters, wurde in VegetarierInnen im Vergleich zu Omnivoren eine Tendenz fuer 
einen hoeheren Bacteroides Anteile und einen niedrigeren Anteil von Clostridium 
cluster IV gefunden. Bacteroides koennen ein breites Spektrum an Kohlenstoffquellen 
verwerten, sie sind hauptverantwortlich an der Polisaccharidverdauung im Dickdarm 
beteiligt [133, 134]. Bakterien des Clostridium leptum cluster haben die gleichen 
Faehigkeiten. Moeglicherweise foerdern bestimmte Faserstoffe in der omnivoren 
Ernaehrung die Bacteroides mehr als unverdauliche Polysaccharide der vegetarischen 
Ernaehrung. 
Mueller et al. fanden die hoechsten Anteile von Clostridium cluster IV in ihrer 
schwedischen Studienpopulation, deren Ernaehrung von hohem Fleisch- und 
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Fischkonsum charakterisiert war [109]. Daher liegt die Vermutung nahe, dass 
Fleischkonsum die Mikrobiota-Populationen des Clostridium leptum clusters 
besonders foerdert. Eine hoehere Prevalenz dieser Subgruppe wurde auch im 
Zusammenhang mit Adipositas und Krebs [111, 125] diskutiert, wo auch eine erhoehte 
Diversitaet beobachtet wurde. PCR-DGGE fingerprinting der dominanten Bakterien 
und Clostridium cluster IV resultierte in Gruppierung von VegetarierInnen und 
Omnivoren. Clustering der Clostridium leptum Subgruppe anhand der DGGE 
fingerprints koennte darauf zurueckzufuehren sein, dass zwei Sequenzen, die als 
Faecalibacterium sp. und Ruminococcus sp. identifiziert wurden, in Omniovren 
haeufiger vorkamen als in VegetarierInnen in der hier vorliegenden Arbeit. Da diese 
zwei Spezies als Degradierer von Faserstoffen bekannt sind, war diese Beobachtung 
unerwartet. Zwei moegliche Erklaerungen fuer diese Beobachtung koennte der oben 
diskutierte Fleischkonsum sein, zum anderen koennte dieser Unterschied auch auf die 
komplexen Nahrungsstrategie des “cross-feeding“ im Mikrobiota zurueckzufuehren 
sein. Fuer eine eindeutige Interpretation dieses Aspekts sind zukuenftige Forschungen 
vonnoeten. Der Clostridium coccoides cluster (XIVa) zeigte die Tendenz in Omnivoren 
(19.01 ± 6.7%) haeufiger vorzukommen als in VegetarierInnen (14.52 ± 5.6%). Sowohl 
der Clostridium cluster IV als auch der cluster XIVa beinhalten viele Butyrat-
produzierende Spezies, z.B.: Faecalibacterium prausnitzii, Eubacterium spp. und 
Roseburia spp.  
Quantifizierung des Butyryl-CoA CoA transferase Gens liess eine Tendenz zu hoeheren 
Levels dieses Gens in Vegetariern (106.89 ± 164.41ng/µl) als in Omivoren (38.66 ± 
35.04 ng/µl) erkennen. Wieder wurden grosse indivudelle Unterschiede beobachtet, 
weswegen keine signifikanten Unterschiede zwischen jungen, gesunden Omnivoren 
und VegetarierInnen gefunden werden konnten. Die Abundanz des Butyryl-CoA CoA 
transferase Gens korrelierte nicht mit der Gesamthaeufigkeit der Bakterien. 
In einer Schmelzkurvenanalyse wurden drei Varianten des Butyryl-CoA coA transferase 
Gens identifiziert, die Spezies um E.hallii / SS2/1, Roseburia/E.rectale spp. und 
F.prausnitzii zugeordnet wurden. Die Abundanz dieser drei Genvarianten korrelierten 
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nicht mit den Abundanzen der beiden clostridialen cluster IV und XIVa. Vegetarische 
Ernaehrung hat wohl in manchen Individuen das Aufkommen von Roseburia/E.rectale 
spp., die diese Variante des Butyratgens tragen, gefoerdert, ohne den Clostridium 
cluster XIVa insgesamt in seiner Abundanz zu erhoehen. In anderen VegetarierInnen 
war der cluster XIVa sehr abundant, ohne aber mit einer hohen Abundanz der 
Roseburia/E.rectale Butyratgenvariante einherzugehen. 
Omnivoren tendierten im Vergleich zu VegetarierInnen zu einer hoeheren Abundanz 
der clostridialen Cluster IV und XIVa. Das Butyryl-CoA coA transferase Gen war jedoch 
abundanter in VegetarierInnen. Zusammenfassend laesst sich schliessen, dass sowohl 
die omnivore als auch die vegetarische Ernaehrung ein aehnliches Potential haben, 
eine gesunde Mikrobiota zu formen. Die Quantifizierung des Butyryl-CoA coA 
transferase Gens kann zusammen mit der Quantifizierung bakterieller 
Subpopulationen der menschlichen Mikrobiota als nuetzlicher Biomarker dienen. 
 
12.3.2 Die Zusammensetzung der Mikrobiota betagter 
Menschen 
 
Es wurde beschrieben, dass mit hoeherem Alter eine Abnahme von Anaerobiern wie 
Laktobazillen und Bifidobakterien und eine Zunahme der fakultativ anaeroben 
Bakterien einhergeht [91]. Faeces von betagten Bewohnern eines Pflegeheims hatten 
insgesamt weniger Bakterien und geringere Diversitaet als junge MischkoestlerInnen. 
In Uebereinstimmung mit frueheren Studien [13, 106, 95] war auch hier das hohe 
Alter mit einer Abnahme der Bifidobakterien-Diversitaet assoziiert. Bacteroides 
nahmen einen hoehern Anteil an der Mikrobiota ein, jedoch bei tendenziell 
niedrigerer Diversitaet als in Jungen. Die relative Abundanz der Bifidobakterien und 
Clostridium cluster IV war in Jungen signifikant hoeher als in Betagten. Der Clostridium 
leptum cluster war ausserdem diverser in den jungen als in den betagten 
StudienteilnehmerInnen. Der Clostridium cluster XIVa war signifikant (p=0.0018) 
haeufiger in Jungen als in Betagten. 
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Weiters zeigte die Clusteranalyse der DGGE fingerprints, dass die Mikrobiota von 
aelteren Menschen als ein Subset der jungen Mikrobiota angesehen werden kann. 
Betagte hatten signifikant weniger Kopien des Butyryl-CoA coA transferase Gens as 
Junge. Auf individualler Ebene korrelierte die Butyryl-CoA coA transferase Gen 
Abundanz nicht mit der Abundanz des bakteriellen 16S rRNA Gens. 
Die Butyrat- Genvariante der Roseburia/E.rectale spp. war tendentiell niedriger in 
Betagten als in Jungen. Damit uebereinstimmend, nahm der Clostridium cluster XIVa 
in Jungen einen hoeheren Anteil der Mikrobiota ein. Die Abundanz des clusters XIVa 
korrelierte nicht mit der Abundanz des Roseburia/E.rectale spp. Butyryl-CoA coA 
transferase Gens. 
Unsere Resultate weisen darauf hin, dass die Mikrobiota betagter Menschen weniger 
Clostridium cluster IV und XIVa in insgesamt weniger Bakterien aufweist. Zusammen 
mit niedrigen Levels des Butyryl-CoA CoA transferase Gens kann geschlossen werden, 
dass die Mikrobiota in hohem Alter eine geringere Butyratproduktionskapazitaet hat. 
Unter Beruecksichtigung der wichtigen nutritiven, anti-inflammatorischen und 
antikanzerogenen Eigenschaften des Butyrat ist es durchaus vorstellbar dass diese 
Mikrobiota Eigenschaften zur Entwicklung degenerativer Erkrankungen [8] und 
Anorexie im hohen Alter beitraegt. 
 
12.3.3 Butyratkonzentrationen und der Beitrag bakteriellen 
Butyratverbrauchs 
 
Faekale Butyrat-Konzentrationen reichten von unter dem Detektionslimit bis zu 0.094 
µmol g-1 faeces (wt/w). Durchschnittswerte waren fuer Omnivoren 0,023 µmol g-1 ± 
0,027 µmol g-1 faeces, fuer VegetarierInnen 0.008 µmol g-1 ± 0.008 µmol g-1 und fuer 
Betagte 0.007 µmol g-1 ± 0.011 µmol g-1 faeces. Die Butyratkonzentrationen waren in 
Omnivoren am hoechsten unter allen StudienteilnehmerInnen. Trotz hoher 
individueller Unterschiede waren sie signifikant hoeher als in Betagten (p=0.04). Wie 
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schon frueher beschrieben, korrelierten die gemessenen Butyratkonzentrationen 
nicht mit der Abundanz des Butyryl-CoA CoA transferase Gens. Diese Diskrepanz 
koennte aufrund unterschiedlicher Absorptionsrate des Epithels, variabler 
Genexpression und Enzymaktivitaet und moeglicherweise auch durch bakteriellen 
Verbrauch des gebildeten Butyrats zustande gekommen sein. 
Um die Moeglichkeit zu pruefen, dass Darmbakterien Butyrat verbrauchen koennen, 
wurde ein RNA-stable isotope proing (RNA-SIP) Experiment durchgefuehrt. In diesem 
Experiment wurde eine Stuhlprobe unter anaeroben Bedingungen mit 13C-Butyrat 
inkubiert. Butyrat konsumierende Bakterien konnten daraufhin identifiziert werden, 
weil sie den schweren Kohlenstoff in ihre RNA inkorporiert hatten. Einige zuvor nicht 
beschriebene Spezies der Clostridiales und Erysipelotrichaceae wurden identifiziert. 
Die Resultate weisen darauf hin, dass bakterieller Verbrauch der Buttersaeure ein 
unwesentlicher Prozess im menschlichen gastro-intestinalen Trakt ist. 
 
12.3.4 Mikrobiota in Individuen unter immunsuppressiver 
Chemotherapie 
 
Chemotherapie und die Gabe von Antibiotika sind lebensverlaengernde Massnahmen 
fuer kritisch kranke PatientInnen und helfen, lebensbedrohliche Infektionen 
abzuwehren. Sie gehen of mit schweren Nebenwirkungen wie Mukositis, Diarrhoe 
oder Obstipation [144] einher. Chemotherapie und Antibiotika haben einen 
nachteiligen Einfluss auf das mikrobielle Oekosystem, das fuer den mukosalen Schutz 
des Menschen [141] wichtig ist, und erhoeht so das Infektionsrisiko [137]. 
Ueberbordendes Wachstum von Spezies mit potentieller Pathogenitaet wie toxigene 
C.difficile und entzuendliche Komplikationen sind mit die schwersten Komplikationen 
der Chemotherapie und Antibiotikagabe bei KrebspatientInnen [138, 137]. 
Trotz hoher indivieller Variationen wurden signifikant weniger Bakterien in 
Chemotherapie-PatientInnen gefunen als in gesunden Kontrollen. Diese Beobachtung 
bestaetigt eine fruehere Arbeit von van Vliet et al. 2009, die eine 100-fache Reduktion 
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der Darmbakterien waehrend Chemotherapie beschreibt. Zusaetzlich zu Verringerung 
der Bakterien insgesamt ergab PCR-DGGE fingerprinting geringere Diversitaet der 
Bakterien und Clostridium cluster XIVa in KrebspatientInnen. Die Abundanz der 
faekalen Mikrobiota nahm nach Chemotherapie-Zyklen ab. Nach dem Ende der 
Chemotherapiegabe erholte sich die Mikrobiota innerhalb weniger Tage und zeigt 
manchmal sogar einen Aufschwung ueber Anfangsniveau hinaus. Relative Haeufigkeit 
der Clostridium cluster IV und XIVa schwankten stark infolge Chemotherapie, wogegen 
Bacteroides und Bifidobakterien weniger stark betroffen waren. Interessanterweise 
wiesen PatientInnen hoehere relative Abundanz des Clostridium cluster IV als gesunde 
Kontrollen auf, sogar bei hoeherer Diversitaet. Dies legt den Schluss nahe, dass diese 
Gruppe von Bakterien weniger anfaellig fuer Chemotherapie ist. Die Inzidenz von 
C.difficile in PatientIn ON009 und ON011 ging mit einer Abnahme von Bifidobakterien 
und Clostridium cluster IV einher. Weitere Forschung ist noetig um zu klaeren, ob es 
zwischen dem Aufkommen von C.difficile und verringerter Abundanz von 
Bifidobakterien und Clostridium cluster IV einen kausalen Zusammenhang gibt.  
Zusammenfassend ist festzuhalten, dass Chemotherapie die faekale Mikrobiota 
veraendert, und diese Veraenderungen mit dem Aufkommen von C.difficile in 
manchen PatientInnen einhergehen. Diese Veraenderungen koennten systemische 
Effekte haben und moeglicherweise zu Chemotherapie-induzierter Mukositis 
beitragen indem sie die nutzbringenden Funktionen der GI Mikrobiota beeinflussen. 
 
12.4 Schlussbetrachtung 
 
Die gewaehlte Herangehensweise mittels quantiative PCR und qualitativem PCR-DGGE 
fingerprinting zeigte das die menschliche Mikrobiota individuell sehr variabel ist. Trotz 
dieser enormen Variabilitaet konnten einige signifikante Unterschiede zwischen 
betagten und jungen Menschen gezeigt werden. Junge gesunde VegetarierInnen und 
Omnivoren hatten tendentiell charakteristische Mikrobiota-Zusammensetzungen, 
aber die Unterschiede zwischen den einzelnen Individuen waren groesser als die 
 231 
 
Unterschiede zwischen diesen beiden epidemiologisch definierten Gruppen. 
Interessanterweise war der Clostridium leptum cluster, der Faserdegradierer und 
Butyratproduzenten beherbergt, in Chemotherapie-PatientInnen diverser als in 
gesunden Kontrollen und relativ haeufiver in Omnivoren als in VegetarierInnen. Als ein 
erster Schritt in Richtung Charakterisierung der Mikrobiota Funktionen, wurde ein fuer 
die Butyratproduktion wichtiges funktionelles Gen quantifiziert. RNA-stable isotope 
probing wurde als ein Werkzeug identifiziert, mit dem phylogenetische Information 
mit Funktion verlinkt werden kann. Weitere Forschungsarbeit ist von Noeten, um 
kausale Zusammenhaenge zwischen menschlichem Verhalten und der 
Zusammensetzung und Funktion der Mikrobiota zu beleuchten. 
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